| Package | Version | Identity | Name/Title | Status | Date | Auth |
|---|
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-ContactPoint-extension  | BC ContactPoint Extension | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-ContactPoint-model | BC ContactPoint Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-ContentType-model | BC ContentType Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Count-model | BC Count Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Country-model | BC Country Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-CreationTime-model | BC CreationTime Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Denominator-model | BC Denominator Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Details-extension | BC Details Extension | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Details-model | BC Details Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-DisplayText-model | BC DisplayText Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-District-model | BC District Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-EffectiveTimePeriod-model | BC EffectiveTimePeriod Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-EmbeddedContent-model | BC EmbeddedContent Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-GeopoliticalLocation-model | BC GeopoliticalLocation Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Hash-model | BC Hash Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-HumanName-extension | BC HumanName Extension | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-HumanName-model | BC HumanName Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-IntegerQuantity-model | BC IntegerQuantity Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Language-extension | BC Language Extension | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Language-model | BC Language Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-LowerBound-model | BC LowerBound Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Media-extension | BC Media Extension | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Media-model | BC Media Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Numerator-model | BC Numerator Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-PostalCode-model | BC PostalCode Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-PriorityRank-model | BC PriorityRank Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Purpose-model | BC Purpose Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Quantity-model | BC Quantity Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Range-model | BC Range Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Ratio-model | BC Ratio Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Ratio | BC Ratio Profile | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-ReceivedTime-model | BC ReceivedTime Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-ResourceLocation-model | BC ResourceLocation Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-ResourceSize-model | BC ResourceSize Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-SimpleQuantity-model | BC SimpleQuantity Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-State-model | BC State Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-TelecomNumberOrAddress-model | BC TelecomNumberOrAddress Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-TimePeriod-model | BC TimePeriod Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-TimePeriodEnd-model | BC TimePeriodEnd Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-TimePeriodStart-model | BC TimePeriodStart Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Title-model | BC Title Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Type-extension | BC Type Extension | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Type-model | BC Type Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Units-model | BC Units Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-UpperBound-model | BC UpperBound Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | StructureDefinition/shr-core-Version-model | BC Version Logical Model | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-context-DeltaFlagVS | BC DeltaFlagVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-context-PresenceContextVS | BC PresenceContextVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-element-AnatomicalDirectionVS | BC AnatomicalDirectionVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-element-AnatomicalLocationVS | BC AnatomicalLocationVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-entity-LanguageQualifierVS | BC LanguageQualifierVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-BreastCancerDetectionVS | BC BreastCancerDetectionVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-BreastCarcinomaHistologicTypeVS | BC BreastCarcinomaHistologicTypeVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-BreastLymphNodeGroupVS | BC BreastLymphNodeGroupVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-BreastSiteVS | BC BreastSiteVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-BreastSpecimenCollectionMethodVS | BC BreastSpecimenCollectionMethodVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-BreastSpecimenTypeVS | BC BreastSpecimenTypeVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-DCISNuclearGradeVS | BC DCISNuclearGradeVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2FISHMethodVS | BC HER2FISHMethodVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byIHCScoreVS | BC HER2byIHCScoreVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-Ki-67NuclearAntigenVS | BC Ki-67NuclearAntigenVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-LymphNodeClinicalMethodVS | BC LymphNodeClinicalMethodVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-LymphNodeInvolvementVS | BC LymphNodeInvolvementVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-LymphNodeMobilityVS | BC LymphNodeMobilityVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-LymphNodeSamplingMethodVS | BC LymphNodeSamplingMethodVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-MorphologyBehaviorVS | BC MorphologyBehaviorVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-RecurrenceRiskScoreInterpretationVS | BC RecurrenceRiskScoreInterpretationVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-StageTimingPrefixVS | BC StageTimingPrefixVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-StainingIntensityVS | BC StainingIntensityVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-TumorMarginDescriptionVS | BC TumorMarginDescriptionVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-AllUnitsVS | BC AllUnitsVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-ClockDirectionVS | BC ClockDirectionVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PerformanceGradingScaleVS | BC PerformanceGradingScaleVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeEquivocalIndeterminateVS | BC PositiveNegativeEquivocalIndeterminateVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeIndeterminateVS | BC PositiveNegativeIndeterminateVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeVS | BC PositiveNegativeVS ValueSet | draft | 2018-08 | hl7 |
| hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-YesNoUnknownVS | BC YesNoUnknownVS ValueSet | draft | 2018-08 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/admission-amb-type | Admission Amb Type | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/admission-imp-type | Admission Inpatient Type | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/admission-mvmnt-type | Admission Movement Type | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/cml-counseling-patient-state | CML Counseling Patient State | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/cml-counseling-type | CML Counseling Type Code | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/cml-medical-record-type | Chamileon Record Type | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/consultation-followup-flag | consultation Follow Up Flag | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/home-check-in | Home Check In | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/CodeSystem/hospitals-uri | Hospitals uris | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ImplementationGuide/il.fhir.r4.dgmc | Israel Division of Governmental Hospitals Profiles | draft | | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/StructureDefinition/consultation-question-flag | Extension - Consultation Question Flag | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/StructureDefinition/dgmc-cml-consultation-answer | DGMC Consultation Answer | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/StructureDefinition/dgmc-cml-consultation-request | DGMC Consultation Request | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.health.gov.il/StructureDefinition/dgmc-encounter-case | DGMC Encounter Namer Case | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.health.gov.il/StructureDefinition/dgmc-encounter-cml | DGMC Encounter Chameleon | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.health.gov.il/StructureDefinition/dgmc-encounter-movement | DGMC Encounter Namer Movement | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/StructureDefinition/dgmc-patient | DGMC Patient | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/admission-type | Admission Type codes | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-counseling-patient-state | CML Counseling Patient State | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-medical-record-type | Chamileon Record Type | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/cml-counseling-type-code | Counseling Type Code | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/encounter-diet-pref | Hospitals Uris Encounter Diet Preference | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr-case-number | Hospitals Uris Namer Case Number | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr2cml-identifier | Hospitals Uris Maner to Chameleon Identifier | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-counseling-answer | Hospitals Uris Chameleon Answer | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-medical-record | Hospitals Uris Chameleon Medical Record | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-pat-internal | Hospitals Uris Chameleon Patient Internal | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/cml-counseling-request | Hospitals Uris Chameleon Request | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr-pat-internal | Hospitals Uris Namer Patient Internal | draft | 2024-07 | hl7 |
| fhir.dgmc | R4 | http://fhir.dgmc.health.gov.il/ValueSet/hospitals-uri/nmr-pat-temp | Hospitals Uris Namer Patient Temp | draft | 2024-07 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://hl7.org/fhir/ConceptMap/101 | FHIR v3 Address Use Mapping | draft | 2012-06 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | https://ehealthontario.ca/fhir/DHDR/metadata-consumer | Digital Health Drug Repository FHIR Capability Statement | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database-3 | Drug Identification Number-DIN | active | 2022-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://cihi.ca/fhir/CodeSytem/aac-discharge-disposition | aac Discharge Disposition | active | 2019-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/ValueSet/dhdr-drug-service-coverage | Drug Service Coverage | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Encounter | Encounter | active | 2023-04 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-encounter-class | Encounter Class | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-encounter-participant-type | Encounter Participant Type | active | 2019-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://cihi.ca/fhir/ValueSet/aac-admit-category | Encounter Type | active | 2019-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://fhir.infoway-inforoute.ca/io/psca/ValueSet/LicensedNaturalHealthProducts | Licensed Natural Health Products | active | 2022-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Location | Location | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ValueSet/acCDR-location-physical-type | Location Physical Type | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Medication | Medication | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Medication-submission | Medication (Submission) | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Medication | Medication | active | 2022-01 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationAdministration-submission | MedicationAdministration (Submission) | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationAdministration | MedicationAdministration | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-MedicationDispense | MedicationDispense | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationDispense | MedicationDispense | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/ValueSet/dhdr-dispense-category | Dispense Category | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationDispense-submission | MedicationDispense (Submission) | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationRequest | MedicationRequest Prescription | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-MedicationRequest | MedicationRequestPrescription | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-OperationOutcome | OperationOutcome | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-OperationOutcome | OperationOutcome | active | 2021-11 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Organization-dispenser | OrganizationDispenser | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Organization | Organization | active | 2021-11 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Organization-submission | Organization (Submission) | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://terminology.hl7.org/CodeSystem/v3-ParticipationType | v3 Code System ParticipationType | active | 2018-08 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Patient-dispense | Patient | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Patient-submission | Patient (Submission) | active | 2022-09 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Patient | Patient | active | 2021-11 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Practitioner-submission | Practitioner (Submission) | active | 2022-09 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-Practitioner | Practitioner | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Practitioner-dispenser | PractitionerDispenser | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-consumer-profile-Practitioner-prescriber | PractitionerPrescriber | active | 2022-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-PractitionerRole | PractitionerRole | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-PractitionerRole-submission | PractitionerRole (Submission) | active | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-acCDR-province-code | v2 map for acCDR Province Code | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/CodeSystem/province-state-code | Province State Code | active | 2019-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-medicationadministration-effective-time | composition.medicationadministration.effective-time | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-medicationdispense-whenprepared | composition.medicationdispense.whenprepared | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-patient-birthDate | composition.patient.birthDate | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/Bundle-composition-patient-gender | composition.patient.gender | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/CodeSystem/accdr-bed-desc-code | accdr Bed Desc Code | active | 2023-08 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | https://ehealthontario.ca/fhir/CapabilityStatement/ca-on-medication-profile-CapabilityStatement-Repository | Digital Health Drug Repository FHIR Capability Statement | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | https://ehealthontario.ca/fhir/CapabilityStatement/ca-on-medication-profile-CapabilityStatement-Consumer | Digital Health Drug Repository FHIR Capability Statement | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | https://ehealthontario.ca/fhir/CapabilityStatement/ca-on-medication-profile-CapabilityStatement-BundleDocument-Source | Digital Health Drug Repository FHIR Capability Statement | active | 2023-10 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | https://ehealthontario.ca/fhir/DHDR/metadata-query | Digital Health Drug Repository FHIR Capability Statement | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | https://simplifier.net/guide/digitalhealthdrugrepositoryhl7fhirimplementationguide | Digital Health Drug Repository HL7 FHIR Implementation Guide | draft | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/ca-on-medications-patient-gender | PatientGenderSearchParameter | active | 2021-01 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/ca-on-medications-patient-identifier | PatientIdentifierSearchParameter | active | 2021-01 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/SearchParameter/ca-on-medications-patient-birthDate | PatientBirthDateSearchParameter | active | 2021-01 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/ValueSet/dhdr-medication-repeat-pattern | Medication Repeat Pattern | draft | | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ehealthontario.ca/fhir/StructureDefinition/ca-on-medications-profile-MedicationRequest-submission | MedicationRequest Prescription (Submission) | active | 2022-01 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-administrative-gender | v2 map for DHDR Administrative Gender | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-contact-point-use | v2 map for DHDR Contact Point Use | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-CDR-address-type | v2 map for DHDR Address Type | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-CDR-address-use | v2 map for DHDR Address Use | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-contact-point-system | v2 map for DHDR Address Type | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-DHDR-EncounterClass | v2 to FHIR map for DHDR Encounter Class | draft | 2023-02 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-medication-administration-status | v2 map for DHDR Medication Administration Status | draft | 2023-03 | hl7 |
| ca.on.dhdr.r4.v4 | R4 | http://ontariohealth.ca/fhir/ConceptMap/cm-medication-request-status | v2 map for DHDR Medication Request Status | draft | 2023-03 | hl7 |
| fhir.cdc.opioid-mme-r4 | R4 | CodeSystem/CDCMMEClinicalConversionFactors | CDC MME Clinical Conversion Factors | active | 2021-11 | hl7 |
| fhir.cdc.opioid-mme-r4 | R4 | CodeSystem/CDCMMEUsageContextCodes | CDC MME Usage Context Codes | active | 2021-11 | hl7 |
| fhir.cdc.opioid-mme-r4 | R4 | CodeSystem/cfct-example-CDCMMEClinicalConversionFactors | Example CDC MME Clinical Conversion Factors | active | 2021-11 | hl7 |
| fhir.cdc.opioid-mme-r4 | R4 | ImplementationGuide/fhir.cdc.opioid-mme-r4 | CDC MME CQL Calculator | active | 2021-11 | hl7 |
| fhir.cdc.opioid-mme-r4 | R4 | StructureDefinition/mmemedicationrequest | MMEMedicationRequest | draft | 2017-04 | hl7 |
| acme.base.r4 | R4 | https://fake-acme.org/fhir/ValueSet/birthsex | Birth Sex | active | 2022-06 | |
| acme.base.r4 | R4 | https://fake-acme.org/fhir/StructureDefinition/ACME-base-smoking-status | ACMECoreSmokingStatusProfile | draft | 2023-07 | |
| acme.base.r4 | R4 | https://fake-acme.org/fhir/StructureDefinition/ACME-base-observation-lab | ACMEbaseObservationLab | active | 2023-07 | |
| acme.base.r4 | R4 | https://fake-acme.org/fhir/StructureDefinition/ACME-base-organization | ACMEbaseOrganization | retired | 2023-07 | |
| acme.base.r4 | R4 | https://fake-acme.org/fhir/StructureDefinition/ACME-base-patient | ACMEbasePatient | draft | 2024-01 | |
| acme.base.r4 | R4 | https://fake-acme.org/fhir/StructureDefinition/ACME-base-practitioner | ACMEbasePractitioner | active | 2023-07 | |
| acme.base.r4 | R4 | /guide/acmebaseprofiles-r4?version=current | ACME Base Profiles R4 Implementation Guide | draft | | |
| rapportendoscopiequebec.test | R4 | http://hl7.org/fhir/us/mdi/ValueSet/ValueSet-yes-no-unknown-not-applicable | ValueSet - Yes No Unknown NotApplicable | active | 2023-09 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/VilleEndo | VilleEndo | active | 2024-05 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/ValueSet/VoieAdministrationEndo | VoieAdministrationEndo | active | 2024-05 | hl7 |
| rapportendoscopiequebec.test | R4 | http://hl7.org/fhir/administrative-gender | AdministrativeGender | active | 2023-06 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/CodeSystem/CodePostalEndo | code postal | active | 2024-04 | hl7 |
| rapportendoscopiequebec.test | R4 | http://terminology.hl7.org/CodeSystem/consentscope | Consent Scope Codes | active | 2024-04 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/Etablissement | Etablissement | active | 2024-04 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/InstallationEndo | installation | active | 2024-04 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/OrganisationOrdreEndo | Organisation ordre | active | 2024-04 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/TypeRessource | Type ressource endo | active | 2024-04 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/UCNI/CodeSystem/Villes | Ville | active | 2024-01 | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SearchParameter/identifierPHIN | identifierPHIN | active | | hl7 |
| rapportendoscopiequebec.test | R4 | https://extranet.ti.msss.rtss.qc.ca/FHIR/Endo/SearchParameter/mothersMaidenName | mothersMaidenName | active | | hl7 |
| fhir.cqf.common | R4 | ImplementationGuide/fhir.cqf.common | Clinical Quality Framework Common FHIR Assets | draft | 2021-11 | hl7 |
| fhir.cqf.common | R4 | ValueSet/active-condition | CQF Active Condition | active | 2019-07 | hl7 |
| fhir.cqf.common | R4 | ValueSet/inactive-condition | CQF Inactive Condition | active | 2019-07 | hl7 |
| hl7.fhir.us.bulkdata | R4 | ImplementationGuide/ig | FHIR Bulk Data Access | active | | hl7 |
| hl7.fhir.us.bulkdata | R4 | OperationDefinition/export | FHIR Bulk Data Export (Flat FHIR) - System Level Export | active | 2019-02 | hl7 |
| hl7.fhir.us.bulkdata | R4 | OperationDefinition/group-export | FHIR Bulk Data Export (Flat FHIR) - System Level Export | active | 2019-02 | hl7 |
| hl7.fhir.us.bulkdata | R4 | OperationDefinition/patient-export | FHIR Bulk Data Export (Flat FHIR) - System Level Export | active | 2019-02 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | CodeSystem/APCTemporaryCodeSystem | Associated Precondition Temporary Code System | draft | 2019-10 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | CodeSystem/SolorTemporaryCodeSystem | SNOMED CT Solor Extension Temporary Code System | draft | 2019-10 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | organization-hspc-organizationtype | HSPC Organization Type Code System | draft | 2015-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ImplementationGuide/hl7.fhir.us.vitalsigns | Vital Signs | active | 2020-08 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/AssociatedPreconditionExt | Associated Precondition | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/AverageBloodPressure | Average Blood Pressure | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BPDevice | BloodPressureDevice | draft | 2020-04 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BloodPressureCuffSizeExt | Blood Pressure Cuff Size | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BloodPressurePanel | Blood Pressure Panel | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BodyLength | BodyLength | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BodyMassIndex | BodyMassIndex | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BodyPositionExt | Body Position | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BodyTemperature | BodyTemperature | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/BodyWeight | BodyWeight | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/ClothingWornDuringMeasureExt | Clothing Worn During Measure Extension | draft | 2019-09 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/ExerciseAssociationExt | Exercise Association extension | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/HeadOccipitalFrontalCircumference | Head Occipital-Frontal Circumference | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/HeartRate | HeartRate | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/Height | Height | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/MeasurementDeviceExt | Measurement Device | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/MeasurementProtocolExt | Measurement Protocol | draft | 2020-06 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/MeasurementSettingExt | Measurement Setting | draft | 2020-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/MethodDeviceExt | Method/Device | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/OxygenSaturationArterialBlood | Oxygen Saturation in Arterial blood, method not specified | draft | 2020-01 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/OxygenSaturationArterialBloodPulseOx | Oxygen Saturation in Arterial Blood by Pulse Oximetery | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/RespiratoryRate | Respiratory Rate | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/SensorDescriptionExt | Sensor Description | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/SleepStatusExt | Sleep Status | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/TwentyFourHourBloodPressure | Twenty Four Hour Blood Pressure | draft | 2020-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | StructureDefinition/VitalSignsPanel | Vital Signs Panel | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/MeasSettingVS | Measurement Setting value set | draft | 2020-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/MeasurementProtocolVS | MeasurementProtocolVS | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/abnIntNumericNomVS | Abnormal Interpretation Numeric Nominal value set | draft | 2015-04 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bodyPositionVS | Body Position value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bodyTempMeasBodyLocationPrecoordVS | Body Temperature Measurement Body Location value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bodyTempMeasMethodDeviceVS | Body Temperature Measurement Method Device value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bodyWeightMeasurementAssociatedPrecondVS | Body Weight Measurement Associated Precondition value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bpCuffSizeVS | Blood Pressure Cuff Size value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bpMeasDeviceCSVS | Blood Pressure Measurement Device and Cuff Size value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bpMeasDeviceVS | Blood Pressure Measurement Device value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bpMeasMethodVS | Blood Pressure Measurement Method value set | draft | 2018-12 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/bpmeasbodylocationprecoord | Blood Pressure Measurement Body Location Precoodinated value set | draft | 2015-06 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/clothingWornDuringMeasureVS | Clothing Worn During Measure value set | draft | 2019-09 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/definedLimitsVS | Defined Limits value set | draft | 2018-11 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/exertionPhaseVS | Exertion Phase value set | draft | 2019-10 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/heartRateMeasBodyLocationPrecoordVS | Heart Rate Measurement Body Location Precoordinated value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/heartRateMeasDeviceVS | Heart Rate Measurement Device value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/heartRateMeasMethodVS | Heart Rate Measurement Method value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/heightBodyPositionVS | Height Body Position value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/heightLengthMeasDeviceVS | Height Length Measurement Device value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/heightLengthMeasMethodVS | Height Length Measurement Method value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/respiratoryRateMeasDeviceVS | Respiratory Rate Measurement Device value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/respiratoryRateMeasMethodVS | Respiratory Rate Measurement Method value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/sPO2BodyLocationVS | Oxygen Saturation Body Location value set | draft | 2018-11 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/sensorDescriptionVS | Sensor Description value set | draft | 2018-12 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/sleepStatusVS | Sleep Status value set | draft | 2018-12 | hl7 |
| hl7.fhir.us.vitalsigns | R4 | ValueSet/weightMeasurementDeviceVS | Weight Measurement Device value set | draft | 2019-05 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | CapabilityStatement/authoring-measure-repository | CQF Measures Authoring Measure Repository Capability Statement | active | 2021-03 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | CapabilityStatement/measure-calculation-service-example | Measure Calculation Service Capability Statement Example | draft | 2016-09 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | CapabilityStatement/publishable-measure-repository | CQF Measures Publishable Measure Repository Capability Statement | active | 2021-03 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | CapabilityStatement/shareable-measure-repository | CQF Measures Shareable Measure Repository Capability Statement | active | 2021-03 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | CodeSystem/intended-venue-codes | Intended Venue Codes | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/aggregate-method | Aggregate Method mapping | active | 2021-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/composite-measure-scoring | Composite Measure Scoring mapping | active | 2021-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/data-usages | Data Usage Mapping | active | 2021-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/improvement-notations | Improvement Notation Mapping | active | 2021-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/measure-populations | Measure Population criteria mapping | active | 2020-05 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/measure-scoring | Measure Scoring mapping | active | 2021-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ConceptMap/measure-types | Measure Type mapping | active | 2021-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ImplementationGuide/hl7.fhir.us.cqfmeasures | Quality Measure Implementation Guide | draft | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | OperationDefinition/cqfm-package | CQFM Package | draft | 2019-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/attestation-measure-cqfm | CQFM Attestation Measure | active | 2024-09 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cohort-measure-cqfm | CQFM Cohort Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/composite-measure-cqfm | CQFM Composite Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/computable-measure-cqfm | CQFM Computable Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-aggregateMethod | CQFM Aggregate Method | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-appliesTo | CQFM Applies To | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-component | CQFM Component | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-compositeScoring | CQFM Composite Scoring | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-criteriaReference | CQFM Criteria Reference | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-effectivePeriodAnchor | CQFM Effective Period Anchor | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-effectivePeriodDuration | CQFM Effective Period Duration | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-groupId | CQFM Group Id | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-improvementNotation | CQFM Improvement Notation | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-includeInReportType | CQFM Include In Report Type | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-isTestCase | CQFM Is Test Case | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-operation | CQFM Operation | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-populationBasis | CQFM Population Basis | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-rateAggregation | CQFM Rate Aggregation | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-riskAdjustment | CQFM Risk Adjustment | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-scoring | CQFM Scoring | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-scoringPrecision | CQFM Scoring Precision | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-scoringUnit | CQFM Scoring Unit | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-supplementalDataGuidance | CQFM Supplemental Data Guidance | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-testCaseDescription | CQFM Test Case Description | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-type | CQFM Type | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cqfm-weight | CQFM Weight | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cql-measure-cqfm | CQFM CQL Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/cv-measure-cqfm | CQFM Continuous Variable Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/device-softwaresystem-cqfm | CQFM Device | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/elm-measure-cqfm | CQFM ELM Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/executable-measure-cqfm | CQFM Executable Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/proportion-measure-cqfm | CQFM Proportion Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/publishable-measure-cqfm | CQFM Publishable Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/ratio-measure-cqfm | CQFM Ratio Measure | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | StructureDefinition/test-case-cqfm | CQFM Test Case | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ValueSet/chronic-liver-disease-legacy-example | Chronic Liver Disease Legacy Example | active | 2019-03 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ValueSet/intended-venue | Intended Venue | active | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | ValueSet/subject-type | Subject Type Value Set | active | 2024-08 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/BCSComponent | Breast Cancer Screening | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/CCSComponent | Cervical Cancer Screening | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXM108-FHIR | EXM108 - Venous Thromboembolism Prophylaxis | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXM124-FHIR | EXM124 - Cervical Cancer Screening | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXM125-FHIR | EXM125 - Breast Cancer Screening | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXM130-FHIR | EXM130 - Colorectal Cancer Screening Measure | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXM146-FHIR | EXM146 - Appropriate Testing for Children with Pharyngitis | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXM55-FHIR | EXM55 - Median Emergency Department Visit Duration | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/EXMLogic-FHIR | EXM Measure | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | http://example.org/fhir/measures/measure-ratio-exm | EXM Ratio Measure | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/HBPComponent | Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/MultiRateExample-FHIR | Multi-Rate Example Measure | draft | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/PVSComponent | Pneumococcal Vaccination Status for Older Adults | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessAllOrNothingComposite | Preventive Care and Wellness All-Or-Nothing Composite | draft | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessOpportunityComposite | Preventive Care and Wellness Opportunity Composite | draft | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessPatientLevelLinearComposite | Preventive Care and Wellness Patient-level Linear Composite | draft | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/PreventiveCareandWellnessWeightedComposite | Preventive Care and Wellness Weighted Composite | draft | 2024-11 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/TSCComponent | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/Terminology-FHIR | Terminology FHIR | active | 2022-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | http://example.org/fhir/measures/measure-pi-exm | EXM Promoting Interoperability Measure | active | 2023-05 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | Measure/measure-risk-adjustment-FHIR2 | Risk Adjustment FHIR DSTU2 | active | 2019-02 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | SearchParameter/Library-contained-parameter-name | LibraryContainedParameterName | draft | 2023-05 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | SearchParameter/Library-expansion-identifier | LibraryExpansionIdentifier | draft | 2023-05 | hl7 |
| hl7.fhir.us.cqfmeasures | R4 | SearchParameter/ValueSet-keyword | ValuesetKeyword | draft | 2023-06 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/CapabilityStatement/client | Argonaut Scheduling Client CapabilityStatement | active | 2018-03 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/CapabilityStatement/server | Argonaut Scheduling Server CapabilityStatement | active | 2018-03 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/CodeSystem/appt-type | Argonaut Appointment Type Codes | active | 2017-07 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/CodeSystem/status-reason | Argonaut Appointment Event Reason Codes | active | 2017-10 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/CodeSystem/visit-type | Argonaut Visit Type Codes | active | 2017-07 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ConceptMap/visit-appt-map | Argonaut Scheduiing Visit Type to Appointment Type Mapping | active | 2017-11 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ConceptMap/visit-snomed-map | Argonaut Scheduiing Visit Type to SNOMED CT Mapping | active | 2017-10 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ImplementationGuide/ig | Argo-Scheduling | active | | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/OperationDefinition/appointment-book | Appointment_Book | active | 2017-08 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/OperationDefinition/appointment-find | Appointment_Availability_Operation | active | 2017-10 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/OperationDefinition/appointment-hold | Appointment_Hold | active | 2017-08 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/OperationDefinition/slot-prefetch | Availability_Prefetch_Operation | active | 2018-02 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-appt | Argonaut Appointment Profile | active | 2017-06 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-coverage | Argonaut Coverage Profile | active | 2017-11 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-sched-notif | Argonaut Schedule Notification Profile | active | 2018-02 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/argo-sub-notif | Argonaut Scheduling Subscription Profile | active | 2018-02 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/avail-bundle | Argonaut Appointment Bundle Profile | active | 2018-01 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-status-reason | Reason For Current Status | active | 2017-06 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-subscription-eventfocus | Subscription Event Focus Extension | active | 2018-02 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-subscription-payloadprofile | Subscription Payload Profile Extension | active | 2018-02 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/extension-subscription-triggerevent | Subscription Trigger Event Extension | active | 2018-02 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/prefetch-slot | Argonaut Prefetch Slot Profile | active | 2018-01 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/StructureDefinition/slot-bundle | Argonaut Slot Bundle Profile | active | 2018-01 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/appt-type | Argonaut Appointment Types | active | 2017-07 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/argo-slot-status | Argonaut Slot Status Codes | active | 2018-03 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/sct-services | Argonaut Snomed CT Services | active | 2018-03 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/slot-bundle-type | Argonaut Slot BundleType Codes | active | 2017-01 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/specialty | Argonaut Scheduling Specialties | active | 2017-07 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/status-reason | Argonaut Appointment Event Reason Codes | active | 2017-10 | hl7 |
| fhir.argonaut.scheduling | R3 | http://fhir.org/guides/argonaut-scheduling/ValueSet/visit-type | Argonaut Visit Types | active | 2017-07 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/resources/ontology/DCM | DICOM Controlled Terminology Definitions | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/resources/ValueSet/all | All DICOM Controlled Terminology Definitions | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10.html | InterventionalDrug | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_100.html | QuantitativeDiagnosticImagingProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1000.html | CTTransversePlaneReferenceBasis | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10000.html | ScopeofAccumulation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10001.html | UIDType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10002.html | IrradiationEventType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10003.html | EquipmentPlaneIdentification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10004.html | FluoroMode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10005.html | XRayRadiationDoseProcedureTypeReported | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10006.html | XRayFilterMaterial | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10007.html | XRayFilterType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10008.html | DoseRelatedDistanceMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10009.html | Measured/Calculated | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1001.html | AnatomicalReferenceBasis | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10010.html | DoseMeasurementDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10011.html | EffectiveDoseEvaluationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10013.html | CTAcquisitionType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10014.html | CTIVContrastImagingTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10015.html | CTDoseReferenceAuthority | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10016.html | AnodeTargetMaterial | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10017.html | XRayGrid | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1002.html | AnatomicalReferenceBasisHead | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10020.html | SourceofProjectionXRayDoseInformation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10021.html | SourceofCTDoseInformation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10022.html | LabelType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10023.html | SizeSpecificDoseEstimationMethodforCT | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10024.html | WaterEquivalentDiameterMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10025.html | RadiationDoseReferencePoint | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1003.html | AnatomicalReferenceBasisSpine | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10030.html | DetectorType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10031.html | CR/DRMechanicalConfiguration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10032.html | ProjectionXRayAcquisitionDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10033.html | CTReconstructionAlgorithm | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10034.html | ReasonforRepeatingAcquisition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1004.html | AnatomicalReferenceBasisChest | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10040.html | RadiopharmaceuticalOrganDoseReferenceAuthority | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10041.html | SourceofRadioisotopeActivityInformation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10043.html | IntravenousExtravasationSymptom | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10044.html | RadiosensitiveOrgan | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10045.html | RadiopharmaceuticalPatientState | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10046.html | GFRMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10047.html | GFRMeasurementMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1005.html | AnatomicalReferenceBasisAbdomen/Pelvis | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10050.html | SummaryRadiationExposureQuantity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_1006.html | AnatomicalReferenceBasisExtremity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10060.html | OrganforRadiationDoseEstimate | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10061.html | AbsorbedRadiationDoseType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10062.html | EquivalentRadiationDoseType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10063.html | RadiationDoseEstimateDistributionRepresentation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10064.html | PatientModelType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10065.html | RadiationTransportModelType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10066.html | AttenuatorCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10067.html | RadiationAttenuatorMaterial | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_10068.html | EstimateMethodType | active | 2025-04 | hl7 |
| http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12320.html | GeneralUltrasoundReportDocumentTitle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12321.html | ElastographySite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12322.html | ElastographyMeasurementSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12323.html | UltrasoundRelevantPatientCondition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12324.html | ShearWaveDetectionMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12325.html | LiverUltrasoundStudyIndication | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12331.html | StructuralHeartProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12332.html | StructuralHeartDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12333.html | StructuralHeartMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12334.html | AorticValveStructuralMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12335.html | MitralValveStructuralMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12336.html | TricuspidValveStructuralMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12337.html | StructuralHeartEchoMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12338.html | LeftAtrialAppendageClosureMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12339.html | StructuralHeartProcedureAnatomicSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12341.html | IndicationforStructuralHeartProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12342.html | BradycardiacAgent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12343.html | TransesophagealEchocardiographyScanPlane | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12344.html | StructuralHeartMeasurementReportDocumentTitle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_12345.html | CardiacStructureCalcificationQualitativeEvaluation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_13.html | ImagingContrastAgentIngredient | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_18.html | RadiopharmaceuticalIsotope | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_19.html | PatientOrientation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_2.html | AnatomicModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_20.html | PatientOrientationModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_21.html | PatientEquipmentRelationship | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_210.html | QualitativeEvaluationModifierType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_211.html | QualitativeEvaluationModifierValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_212.html | GenericAnatomicLocationModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_217.html | VisualExplanation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_218.html | QuantitativeImageFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_219.html | GeometryGraphicalRepresentation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_220.html | SignificanceLevel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_221.html | MeasurementRangeConcept | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_222.html | Normality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_223.html | NormalRangeValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_224.html | SelectionMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_225.html | MeasurementUncertaintyConcept | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_226.html | PopulationStatisticalDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_227.html | SampleStatisticalDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_228.html | EquationorTable | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_23.html | CranioCaudadAngulation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_230.html | YesNo | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_231.html | YesNoOnly | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_240.html | PresentAbsent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_241.html | PresentAbsentOnly | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_242.html | NormalAbnormal | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_244.html | Laterality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_245.html | LateralitywithMedian | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_246.html | RelativeLaterality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_247.html | LateralityLeftRightOnly | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_25.html | Radiopharmaceutical | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_250.html | PositiveNegative | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_251.html | ComplicationSeverity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_252.html | SMLSizeDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_26.html | NuclearMedicineProjection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_27.html | BasicCardiacView | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_270.html | ObserverType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_271.html | ObservationSubjectClass | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_272.html | SpecificObservationSubjectClass | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_280.html | LongitudinalTemporalEventType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_281.html | SimilarityMeasure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_29.html | AcquisitionModality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_30.html | DICOMDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_300.html | MultienergyRelevantMaterial | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3000.html | AudioChannelSource | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3001.html | ECGLead | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3003.html | HemodynamicWaveformSource | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3004.html | ArterialPulseWaveform | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3005.html | RespirationWaveform | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_301.html | MultienergyMaterialUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3010.html | CardiovascularAnatomicStructure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3011.html | ElectrophysiologyAnatomicLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3014.html | CoronaryArterySegment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3015.html | CoronaryArtery | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3016.html | MajorCoronaryArtery | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3019.html | CardiovascularAnatomicStructureModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3020.html | AssessmentfromCADRADS™ | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3021.html | CADRADS™StenosisAssessmentModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3022.html | CADRADS™AssessmentModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3030.html | EEGLead | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3031.html | LeadLocationNearorinMuscle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3032.html | LeadLocationNearPeripheralNerve | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3033.html | EOGLead | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3034.html | BodyPositionChannel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3035.html | EEGAnnotation–NeurophysiologicEnumeration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3036.html | EMGAnnotation–NeurophysiologicalEnumeration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3037.html | EOGAnnotation–NeurophysiologicalEnumeration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3038.html | PatternEvent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3039.html | DevicerelatedandEnvironmentrelatedEvent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3040.html | EEGAnnotationNeurologicalMonitoringMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3041.html | NeurophysiologicStimulationMode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3042.html | AnalogWaveformFilter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3043.html | DigitalWaveformFilter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3044.html | WaveformFilterLookupTableInputFrequencyUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3045.html | WaveformFilterLookupTableOutputMagnitudeUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3046.html | SleepStage | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3047.html | WaveformAnnotationClassification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3048.html | WaveformAnnotationsDocumentTitle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3049.html | EEGProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3050.html | PatientConsciousness | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3083.html | UnitRadioactivity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3090.html | TimeSynchronizationChannelType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_31.html | AbstractPrior | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3101.html | CardiacProceduralStateValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3102.html | Rest/StressState | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3104.html | CardiacSynchronizationTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3106.html | PETCardiologyProtocol | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3107.html | PETCardiologyRadiopharmaceutical | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3108.html | NM/PETProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3110.html | NuclearCardiologyProtocol | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3111.html | NuclearCardiologyRadiopharmaceutical | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3112.html | AttenuationCorrection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3113.html | PerfusionDefectType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3114.html | StudyQuality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3115.html | StressImagingQualityIssue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3116.html | NMExtracardiacFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3117.html | AttenuationCorrectionMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3118.html | LevelofRisk | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3119.html | LVFunction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3120.html | PerfusionFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3121.html | PerfusionMorphology | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3122.html | VentricularEnlargement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_32.html | NonAcquisitionModality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3200.html | StressTestProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3201.html | IndicationsforStressTest | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3202.html | ChestPain | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3203.html | ExerciserDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3204.html | StressAgent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3205.html | IndicationsforPharmacologicalStressTest | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3206.html | NoninvasiveCardiacImagingProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3207.html | StressTestProcedurePhase | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3208.html | ExerciseECGSummaryCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3209.html | StressImagingSummaryCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3210.html | SpeedofResponse | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3211.html | BPResponse | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3212.html | TreadmillSpeed | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3213.html | StressHemodynamicFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3215.html | PerfusionFindingMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3217.html | ComparisonFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3220.html | StressSymptom | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3221.html | StressTestTerminationReason | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3227.html | QTcMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3228.html | ECGTimingMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3229.html | ECGAxisMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3230.html | ECGFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3231.html | STSegmentFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3232.html | STSegmentLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3233.html | STSegmentMorphology | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3234.html | EctopicBeatMorphology | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3235.html | PerfusionComparisonFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3236.html | ToleranceComparisonFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3237.html | WallMotionComparisonFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3238.html | StressScoringScale | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3239.html | PerceivedExertionScale | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3240.html | ElectrophysiologyMeasurementFunction/Technique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3241.html | HemodynamicMeasurementTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3250.html | CatheterizationProcedurePhase | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3254.html | ElectrophysiologyProcedurePhase | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3261.html | StressProtocol | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3262.html | ECGPatientStateValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3263.html | ElectrodePlacementValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3271.html | HemodynamicPhysiologicalChallenge | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_33.html | Modality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3335.html | ECGAnnotation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3337.html | HemodynamicAnnotation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3339.html | ElectrophysiologyAnnotation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_34.html | WaveformAcquisitionModality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3400.html | ProcedureLogTitle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3401.html | LogNoteType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3402.html | PatientStatusandEvent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3403.html | PercutaneousEntry | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3404.html | StaffAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3405.html | ProcedureActionValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3406.html | NoncoronaryTranscatheterIntervention | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3407.html | ObjectReferencePurpose | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3408.html | ConsumableAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3409.html | Drug/ContrastAdministration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3410.html | Drug/ContrastNumericParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3411.html | IntracoronaryDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3412.html | InterventionAction/Status | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3413.html | AdverseOutcome | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3414.html | ProcedureUrgency | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3415.html | CardiacRhythm | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3416.html | RespirationRhythm | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3418.html | LesionRisk | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3419.html | FindingTitle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3421.html | ProcedureAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3422.html | DeviceUseAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3423.html | NumericDeviceCharacteristic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3425.html | InterventionParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3426.html | ConsumablesParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3427.html | EquipmentEvent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3428.html | CardiovascularImagingProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3429.html | CatheterizationDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3430.html | DateTimeQualifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3440.html | PeripheralPulseLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3441.html | PatientAssessment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3442.html | PeripheralPulseMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3446.html | SkinCondition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3448.html | AirwayAssessment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3451.html | CalibrationObject | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3452.html | CalibrationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3453.html | CardiacVolumeMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3455.html | IndexMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3456.html | SubsegmentMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3458.html | ContourRealignment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3460.html | CircumferentialExtent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3461.html | RegionalExtent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3462.html | ChamberIdentification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3463.html | VentricleIdentification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3465.html | QAReferenceMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3466.html | PlaneIdentification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3467.html | EjectionFraction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3468.html | EDVolume | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3469.html | ESVolume | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3470.html | VesselLumenCrosssectionalAreaCalculationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3471.html | EstimatedVolume | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3472.html | CardiacContractionPhase | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3480.html | IVUSProcedurePhase | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3481.html | IVUSDistanceMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3482.html | IVUSAreaMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3483.html | IVUSLongitudinalMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3484.html | IVUSIndex/Ratio | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3485.html | IVUSVolumeMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3486.html | VascularMeasurementSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3487.html | IntravascularVolumetricRegion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3488.html | Min/Max/Mean | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3489.html | CalciumDistribution | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3491.html | IVUSLesionMorphology | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3492.html | VascularDissectionClassification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3493.html | IVUSRelativeStenosisSeverity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3494.html | IVUSNonMorphologicalFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3495.html | IVUSPlaqueComposition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3496.html | IVUSFiducialPoint | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3497.html | IVUSArterialMorphology | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3500.html | PressureUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3502.html | HemodynamicResistanceUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3503.html | IndexedHemodynamicResistanceUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3510.html | CatheterSizeUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3515.html | SpecimenCollection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3520.html | BloodSourceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3524.html | BloodGasPressure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3525.html | BloodGasContent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3526.html | BloodGasSaturation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3527.html | BloodBaseExcess | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3528.html | BloodpH | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3529.html | Arterial/VenousContent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3530.html | OxygenAdministrationAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3531.html | OxygenAdministration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3550.html | CirculatorySupportAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3551.html | VentilationAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3552.html | PacingAction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3553.html | CirculatorySupport | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3554.html | Ventilation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3555.html | Pacing | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3560.html | BloodPressureMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3600.html | RelativeTime | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3602.html | HemodynamicPatientState | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3604.html | ArterialLesionLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3606.html | ArterialSourceLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3607.html | VenousSourceLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3608.html | AtrialSourceLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3609.html | VentricularSourceLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3610.html | GradientSourceLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3611.html | PressureMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3612.html | BloodVelocityMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3613.html | HemodynamicTimeMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3614.html | NonmitralValveArea | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3615.html | ValveArea | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3616.html | HemodynamicPeriodMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3617.html | ValveFlow | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3618.html | HemodynamicFlow | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3619.html | HemodynamicResistanceMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3620.html | HemodynamicRatio | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3621.html | FractionalFlowReserve | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3627.html | MeasurementType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3628.html | CardiacOutputMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3629.html | ProcedureIntent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3630.html | CardiovascularAnatomicLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3640.html | Hypertension | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3641.html | HemodynamicAssessment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3642.html | DegreeFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3651.html | HemodynamicMeasurementPhase | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3663.html | BodySurfaceAreaEquation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3664.html | OxygenConsumptionEquation/Table | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3666.html | P50Equation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3667.html | FraminghamScore | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3668.html | FraminghamTable | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3670.html | ECGProcedureType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3671.html | ReasonforECGStudy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3676.html | LeadMeasurementTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3677.html | SummaryCodesECG | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3678.html | QTCorrectionAlgorithm | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3680.html | ECGLeadNoiseDescription | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3687.html | ElectrophysiologyWaveformDuration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3688.html | ElectrophysiologyWaveformVoltage | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3689.html | ECGGlobalWaveformDuration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3690.html | ECGControlNumericVariable | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3691.html | ECGControlTextVariable | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3700.html | CathDiagnosis | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3701.html | CardiacValve/Tract | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3703.html | WallMotion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3704.html | MyocardiumWallMorphologyFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3705.html | ChamberSize | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3706.html | OverallContractility | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3707.html | VSDDescription | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3710.html | CoronaryDominance | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3711.html | ValvularAbnormality | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3712.html | VesselDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3713.html | TIMIFlowCharacteristic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3714.html | Thrombus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3715.html | LesionMargin | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3716.html | Severity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3717.html | LeftVentricleMyocardialWall17SegmentModel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3718.html | MyocardialWallSegmentsinProjection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3719.html | CanadianClinicalClassification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3721.html | CardiovascularSurgery | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3722.html | DiabeticTherapy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3723.html | MIType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3724.html | SmokingHistory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3726.html | CoronaryInterventionIndication | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3727.html | CatheterizationIndication | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3728.html | CathFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3729.html | AdmissionStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3730.html | InsurancePayor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3733.html | PrimaryCauseofDeath | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3735.html | AcuteCoronarySyndromeTimePeriod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3736.html | NYHAClassification | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3737.html | IschemiaNoninvasiveTest | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3738.html | PreCathAnginaType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3739.html | CathProcedureType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3740.html | ThrombolyticAdministration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3741.html | LabVisitMedicationAdministration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3742.html | PCIMedicationAdministration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3743.html | Clopidogrel/TiclopidineAdministration | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3744.html | EFTestingMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3745.html | CalculationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3746.html | PercutaneousEntrySite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3747.html | PercutaneousClosure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3748.html | AngiographicEFTestingMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3749.html | PCIProcedureResult | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3750.html | PreviouslyDilatedLesion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3752.html | GuidewireCrossing | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3754.html | VascularComplication | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3755.html | CathComplication | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3756.html | CardiacPatientRiskFactor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3757.html | CardiacDiagnosticProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3758.html | CardiovascularFamilyHistory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3760.html | HypertensionTherapy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3761.html | AntilipemicAgent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3762.html | AntiarrhythmicAgent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3764.html | MyocardialInfarctionTherapy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3769.html | ConcernType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3770.html | ProblemStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3772.html | HealthStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3773.html | UseStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3774.html | SocialHistory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3777.html | CardiovascularImplant | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3778.html | Stage | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3779.html | ImplantedDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3781.html | LeftVentricleMyocardialWall18SegmentModel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3782.html | LeftVentricleBasalWall6Segments | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3783.html | LeftVentricleMidlevelWall6Segments | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3784.html | LeftVentricleApicalWall4Segments | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3785.html | LeftVentricleApicalWall6Segments | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3802.html | PlaqueStructure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3804.html | StenosisMeasurementMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3805.html | StenosisType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3806.html | StenosisShape | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3807.html | VolumeMeasurementMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3808.html | AneurysmType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3809.html | AssociatedCondition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3810.html | VascularMorphology | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3813.html | StentFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3814.html | StentComposition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3815.html | SourceofVascularFinding | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3817.html | VascularSclerosisType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3820.html | NoninvasiveVascularProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3821.html | PapillaryMuscleIncluded/Excluded | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3823.html | RespiratoryStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3826.html | HeartRhythm | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3827.html | VesselSegment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3829.html | PulmonaryArtery | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3831.html | StenosisLength | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3832.html | StenosisGrade | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3833.html | CardiacEjectionFraction | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3835.html | CardiacVolumeMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3836.html | TimebasedPerfusionMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3837.html | FiducialFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3838.html | DiameterDerivation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3839.html | CoronaryVein | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3840.html | PulmonaryVein | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3843.html | MyocardialSubsegment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_3850.html | ContrastBolusSubstance | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4.html | AnatomicRegion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_400.html | AuditEventID | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4005.html | PartialViewSectionforMammography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4009.html | DXAnatomyImaged | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_401.html | AuditEventTypeCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4010.html | DXView | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4011.html | DXViewModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4012.html | ProjectionEponymousName | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4013.html | AnatomicRegionforMammography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4014.html | ViewforMammography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4015.html | ViewModifierforMammography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4016.html | AnatomicRegionforIntraoralRadiography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4017.html | AnatomicRegionModifierforIntraoralRadiography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4018.html | PrimaryAnatomicStructureforIntraoralRadiography(PermanentDentitionDesignationofTeeth) | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4019.html | PrimaryAnatomicStructureforIntraoralRadiography(DeciduousDentitionDesignationofTeeth) | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_402.html | AuditActiveParticipantRoleIDCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4020.html | PETRadionuclide | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4021.html | PETRadiopharmaceutical | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4025.html | PrimaryAnatomicStructureforIntraoralRadiography(SupernumeraryDentitionDesignationofTeeth) | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4026.html | PrimaryAnatomicStructureforIntraoralandCraniofacialRadiographyTeeth | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4028.html | CraniofacialAnatomicRegion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4029.html | DermatologyAnatomicSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_403.html | SecurityAlertTypeCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4030.html | CT,MRandPETAnatomyImaged | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4031.html | CommonAnatomicRegion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4032.html | MRSpectroscopyMetabolite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4033.html | MRProtonSpectroscopyMetabolite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_404.html | AuditParticipantObjectIDTypeCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4040.html | EndoscopyAnatomicRegion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4042.html | XA/XRFAnatomyImaged | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_405.html | MediaTypeCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4050.html | DrugorContrastAgentCharacteristic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4051.html | GeneralDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4052.html | PhantomDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4053.html | CTDIPhantomDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4061.html | HeadandNeckPrimaryAnatomicStructure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4062.html | VLView | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4063.html | VLDentalView | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4064.html | VLViewModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4065.html | VLDentalViewModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4066.html | OrthognathicFunctionalCondition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4067.html | OrthodonticFindingbyInspection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4068.html | OrthodonticObservableEntity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4069.html | DentalOcclusion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4070.html | OrthodonticTreatmentProgress | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4071.html | GeneralPhotographyDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4072.html | DevicesforthePurposeofDentalPhotography | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4100.html | T1MeasurementMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4101.html | TracerKineticModel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4102.html | PerfusionMeasurementMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4103.html | ArterialInputFunctionMeasurementMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4104.html | BolusArrivalTimeDerivationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4105.html | PerfusionAnalysisMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4106.html | QuantitativeMethodUsedforPerfusionandTracerKineticModel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4107.html | TracerKineticModelParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4108.html | PerfusionModelParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4109.html | ModelIndependentDynamicContrastAnalysisParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4110.html | TracerKineticModelingCovariate | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4111.html | ContrastCharacteristic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_42.html | NumericValueQualifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4200.html | OphthalmicImagingAgent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4201.html | PatientEyeMovementCommand | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4202.html | OphthalmicPhotographyAcquisitionDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4203.html | OphthalmicPhotographyIllumination | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4204.html | OphthalmicFilter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4205.html | OphthalmicLens | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4206.html | OphthalmicChannelDescription | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4207.html | OphthalmicImagePosition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4208.html | MydriaticAgent | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4209.html | OphthalmicAnatomicStructureImaged | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4210.html | OphthalmicTomographyAcquisitionDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4211.html | OphthalmicOCTAnatomicStructureImaged | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4214.html | OphthalmicHorizontalDirection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4215.html | OphthalmicVerticalDirection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4216.html | OphthalmicVisualAcuityType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4220.html | VisualFixationQualityDuringAcquisition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4221.html | VisualFixationQualityProblem | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4222.html | OphthalmicMacularGridProblem | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4230.html | OphthalmicUltrasoundAxialMeasurementsType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4231.html | LensStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4232.html | VitreousStatus | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4233.html | OphthalmicAxialLengthMeasurementsSegmentName | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4234.html | RefractiveSurgeryType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4235.html | KeratometryDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4236.html | IOLCalculationFormula | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4237.html | LensConstantType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4238.html | RefractiveErrorType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4239.html | AnteriorChamberDepthDefinition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4240.html | OphthalmicMeasurementorCalculationDataSource | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4241.html | OphthalmicAxialLengthSelectionMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4242.html | CorneaMeasurementMethodDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4243.html | OphthalmicQualityMetricType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4244.html | OphthalmicAgentConcentrationUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4245.html | WideFieldOphthalmicPhotographyTransformationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4250.html | VisualFieldStaticPerimetryTestPattern | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4251.html | VisualFieldStaticPerimetryTestStrategy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4252.html | VisualFieldStaticPerimetryScreeningTestMode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4253.html | VisualFieldStaticPerimetryFixationStrategy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4254.html | VisualFieldStaticPerimetryTestAnalysisResult | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4255.html | VisualFieldIlluminationColor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4256.html | VisualFieldProcedureModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4257.html | VisualFieldGlobalIndexName | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4260.html | OphthalmicMappingUnitforRealWorldValueMapping | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4261.html | OphthalmicMappingAcquisitionMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4262.html | RetinalThicknessDefinition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4263.html | OphthalmicThicknessMapValueType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4264.html | OphthalmicMapPurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4265.html | OphthalmicThicknessDeviationCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4266.html | OphthalmicAnatomicStructureReferencePoint | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4267.html | CornealTopographyMappingUnitforRealWorldValueMapping | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4268.html | CornealTopographyMapValueType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_4270.html http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7158.html | ArtifactSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7159.html | LesionSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7160.html | PelvicOrganSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7161.html | PhysiologySegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7162.html | SurfaceProcessingAlgorithmFamily | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7163.html | BreastSegmentationTypes | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7165.html | AbstractSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7166.html | CommonTissueSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7167.html | PeripheralNervousSystemSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7168.html | BrainLesionSegmentationTypeWithNecrosis | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7169.html | BrainLesionSegmentationTypeWithoutNecrosis | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7170.html | CouinaudLiverSegment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7171.html | LiverSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7180.html | AbstractMultidimensionalImageModelComponentSemantic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7181.html | AbstractMultidimensionalImageModelComponentUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7182.html | AbstractMultidimensionalImageModelDimensionSemantic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7183.html | AbstractMultidimensionalImageModelDimensionUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7184.html | AbstractMultidimensionalImageModelAxisDirection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7185.html | AbstractMultidimensionalImageModelAxisOrientation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7186.html | AbstractMultidimensionalImageModelQualitativeDimensionSampleSemantic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7191.html | TissueSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7192.html | AnatomicalStructureSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7193.html | PhysicalObjectSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7194.html | MorphologicallyAbnormalStructureSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7195.html | FunctionSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7196.html | SpatialandRelationalConceptSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7197.html | BodySubstanceSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7198.html | SubstanceSegmentationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7199.html | AnatomicallyLocalizedLesionSegmentationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_72.html | ImagingAgentAdministrationStepType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7201.html | ReferencedImagePurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7202.html | SourceImagePurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7203.html | ImageDerivation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7205.html | PurposeofReferencetoAlternateRepresentation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7210.html | RelatedSeriesPurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7215.html | SpectroscopyPurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7220.html | RTDoseDerivation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7221.html | RTDosePurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7222.html | ParametricMapDerivationImagePurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7230.html | AutomationofMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7250.html | MultiFrameSubsetType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7260.html | DiffusionAcquisitionValueType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7261.html | DiffusionModelValueType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7262.html | DiffusionTractographyAlgorithmFamily | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7263.html | DiffusionTractographyMeasurementType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7270.html | MRDiffusionComponentSemantic | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7271.html | MRDiffusionAnisotropyIndex | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7272.html | MRDiffusionModelParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7273.html | MRDiffusionModel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7274.html | MRDiffusionModelFittingMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7275.html | MRDiffusionModelSpecificMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7276.html | MRDiffusionModelInput | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7277.html | DiffusionRateAreaOverTimeUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_73.html | BolusShapingCurve | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7300.html | ImplantMaterial | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7301.html | InterventionType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7302.html | ImplantTemplateViewOrientation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7303.html | ImplantTemplateModifiedViewOrientation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7304.html | ImplantTargetAnatomy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7305.html | ImplantPlanningLandmark | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7306.html | HumanHipImplantPlanningLandmark | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7307.html | ImplantComponentType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7308.html | HumanHipImplantComponentType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7309.html | HumanTraumaImplantComponentType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7310.html | ImplantFixationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7320.html | PlanningMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_74.html | ImagingAgentAdministrationConsumableCatheterType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7445.html | DeviceParticipatingRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7448.html | ThirdPersonPronounSet | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7449.html | ReaderSpecialty | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7450.html | PersonRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7451.html | FamilyMember | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7452.html | OrganizationalRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7453.html | PerformingRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7454.html | AnimalTaxonomicRankValue | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7455.html | Sex | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7456.html | AgeUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7457.html | SexMaleFemaleorBoth | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7458.html | PersonGenderIdentity | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7459.html | CategoryofSexParametersforClinicalUse | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7460.html | LinearMeasurementUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7461.html | AreaMeasurementUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7462.html | VolumeMeasurementUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7464.html | GeneralRegionofInterestMeasurementModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7465.html | MeasurementDerivedFromMultipleROIMeasurements | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7466.html | PETRegionofInterestMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7467.html | GrayLevelCooccurrenceMatrixMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7468.html | TextureMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7469.html | GenericIntensityandSizeMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7470.html | LinearMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7471.html | AreaMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7472.html | VolumeMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7473.html | GeneralAreaCalculationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7474.html | GeneralVolumeCalculationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7475.html | GrayLevelRunLengthBasedFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7476.html | GrayLevelSizeZoneBasedFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7477.html | GlobalShapeDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7478.html | IntensityHistogramFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7479.html | GreyLevelDistanceZoneBasedFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7480.html | Breed | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7481.html | BreedRegistry | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7482.html | DXAnatomyImagedforAnimal | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7483.html | CommonAnatomicRegionsforAnimal | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7484.html | DXViewforAnimal | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7486.html | MixedBreed | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7490.html | ResearchAnimalSourceRegistry | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_75.html | LowHighorEqual | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7500.html | NeighbourhoodGreyToneDifferenceBasedFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7501.html | NeighbouringGreyLevelDependenceBasedFeature | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7550.html | AngleMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7551.html | GenericPurposeofReferencetoImagesandCoordinatesinMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7552.html | GenericPurposeofReferencetoImagesinMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7553.html | GenericPurposeofReferencetoCoordinatesinMeasurement | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_76.html | PremedicationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7600.html | LymphNodeAnatomicSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7601.html | HeadandNeckCancerAnatomicSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7602.html | VertebralAnatomicStructure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7603.html | Vertebra | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7604.html | IntervertebralDisc | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7701.html | FiberTractInBrainstem | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7702.html | ProjectionandThalamicFiber | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7703.html | AssociationFiber | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7704.html | LimbicSystemTract | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7705.html | CommissuralFiber | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7706.html | CranialNerve | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7707.html | SpinalCordFiber | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7710.html | TractographyAnatomicSite | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8.html | AngiographicInterventionalDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_800.html | ProtocolAssertion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8101.html | ContainerType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8102.html | ContainerComponentType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8103.html | AnatomicPathologySpecimenType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8104.html | BreastTissueSpecimenType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8109.html | SpecimenCollectionProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8110.html | SpecimenSamplingProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8111.html | SpecimenPreparationProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8112.html | SpecimenStain | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8113.html | SpecimenPreparationStep | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8114.html | SpecimenFixative | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8115.html | SpecimenEmbeddingMedia | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8120.html | WholeSlideMicroscopyImageReferencedImagePurposeofReference | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8121.html | MicroscopyLensType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8122.html | MicroscopyIlluminatorandSensorColor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8123.html | MicroscopyIlluminationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8124.html | MicroscopyFilter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8125.html | MicroscopyIlluminatorType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8130.html | StainingProtocol | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8131.html | PathologyImagingProtocol | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8132.html | MagnificationSelection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8133.html | TissueSelection | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8134.html | AnatomicStructure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8135.html | MicroscopyAnnotationPropertyType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8136.html | MicroscopyMeasurementType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8201.html | SurfaceScanAcquisitionType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8202.html | SurfaceScanModeType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8203.html | SurfaceScanRegistrationMethodType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_83.html | RealWorldValueMappingUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8300.html | VisualEvaluationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8301.html | TestPatternCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8302.html | MeasurementPatternCode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_8303.html | DisplayDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_84.html | PETUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_85.html | SUVUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9.html | ImageGuidedTherapeuticProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9000.html | PhysicalQuantityDescriptor | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_91.html | FunctionalConditionPresentDuringAcquisition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_92.html | JointPositionDuringAcquisition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9231.html | WorkitemDefinition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9233.html | RequestedReportType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9241.html | RadiotherapyGeneralWorkitemDefinition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9242.html | RadiotherapyAcquisitionWorkitemDefinition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9243.html | RadiotherapyRegistrationWorkitemDefinition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9250.html | ScheduledProcessingParameterConceptCodesforRTTreatment | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9260.html | RadiotherapyAcquisitionWorkItemSubtasks | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9261.html | PatientPositionAcquisitionRadiationSourceLocations | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9262.html | EnergyDerivationTypes | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9263.html | KVImagingAcquisitionTechniques | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9264.html | MVImagingAcquisitionTechniques | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9265.html | PatientPositionAcquisitionProjectionTechniques | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9266.html | PatientPositionAcquisition–CTTechniques | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9267.html | PatientPositioningRelatedObjectPurposes | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9268.html | PatientPositionAcquisitionDevices | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9269.html | RTRadiationMetersetUnits | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9270.html | AcquisitionInitiationTypes | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9271.html | RTImagePatientPositionAcquisitionDevices | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9272.html | RTROIImageAcquisitionContext | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9273.html | PatientPositionAcquisition–MRTechniques | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_93.html | JointPositioningMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9300.html | ProcedureDiscontinuationReason | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9301.html | ModalityPPSDiscontinuationReason | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9302.html | MediaImportPPSDiscontinuationReason | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9303.html | InterpretationRequestDiscontinuationReason | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_94.html | PhysicalForceAppliedDuringAcquisition | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9401.html | IEC61217DevicePositionParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9402.html | IEC61217GantryPositionParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9403.html | IEC61217PatientSupportPositionParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9500.html | DosimetricObjectiveType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9501.html | PrescriptionAnatomyCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9502.html | RTSegmentAnnotationCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9503.html | RadiotherapyTherapeuticRoleCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9504.html | RTGeometricInformation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9505.html | FixationorPositioningDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9506.html | BrachytherapyDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9507.html | ExternalBodyModel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9508.html | NonspecificVolume | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9509.html | PurposeofReferenceforRTPhysicianIntentInput | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9510.html | PurposeofReferenceforRTTreatmentPlanningInput | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9511.html | GeneralExternalRadiotherapyProcedureTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9512.html | TomotherapeuticRadiotherapyProcedureTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9513.html | FixationDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9514.html | AnatomicalStructureforRadiotherapy | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9515.html | RTPatientSupportDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9516.html | RadiotherapyBolusDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9517.html | RadiotherapyBlockDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9518.html | RadiotherapyAccessoryNoSlotHolderDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9519.html | RadiotherapyAccessorySlotHolderDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9520.html | SegmentedRTAccessoryDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9521.html | RadiotherapyTreatmentEnergyUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9522.html | MultiSourceRadiotherapyProcedureTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9523.html | RoboticRadiotherapyProcedureTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9524.html | RadiotherapyProcedureTechnique | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9525.html | RadiationTherapyParticle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9526.html | IonTherapyParticle | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9527.html | TeletherapyIsotope | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9528.html | BrachytherapyIsotope | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9529.html | SingleDoseDosimetricObjective | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9530.html | PercentageandDoseDosimetricObjective | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9531.html | VolumeandDoseDosimetricObjective | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9532.html | NoParameterDosimetricObjective | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9533.html | DeliveryTimeStructure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9534.html | RadiotherapyTarget | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9535.html | RadiotherapyDoseCalculationRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9536.html | RadiotherapyPrescribingandSegmentingPersonRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9537.html | EffectiveDoseCalculationMethodCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9538.html | RadiationTransportBasedEffectiveDoseMethodModifier | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9539.html | FractionationBasedEffectiveDoseMethodModifer | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9540.html | MovableBeamLimitingDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9541.html | BeamLimitingDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9542.html | CompensatorDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9543.html | RadiotherapyTreatmentMachineMode | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9544.html | RadiotherapyDistanceReferenceLocation | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9545.html | FixedBeamLimitingDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9546.html | RadiotherapyWedgeType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9547.html | RTBeamLimitingDeviceOrientationLabel | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9548.html | GeneralAccessoryDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9549.html | RadiationGenerationModeType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9550.html | CArmPhotonElectronDeliveryRateUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9551.html | TreatmentDeliveryDeviceType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9552.html | CArmPhotonElectronDosimeterUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9553.html | TreatmentPoint | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9554.html | EquipmentReferencePoint | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9555.html | RadiotherapyTreatmentPlanningPersonRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9556.html | RadiotherapyRoboticNodeSet | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9557.html | TomotherapeuticDosimeterUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9558.html | TomotherapeuticDoseRateUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9559.html | RoboticDeliveryDeviceDosimeterUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9560.html | RoboticDeliveryDeviceDoseRateUnit | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9561.html | TreatmentTerminationReason | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9562.html | RadiotherapyTreatmentDeliveryPersonRole | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9563.html | RadiotherapyInterlockResolution | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9564.html | TreatmentSessionConfirmationAssertion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9565.html | TreatmentToleranceViolationCause | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9566.html | ClinicalToleranceViolationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9567.html | MachineToleranceViolationType | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9568.html | RadiotherapyTreatmentInterlock | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9569.html | IsocentricPatientSupportPositionParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9570.html | RTOverriddenTreatmentParameter | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9571.html | PatientTreatmentPreparationMethod | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9572.html | PatientShieldingDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9573.html | PatientTreatmentPreparationDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9574.html | PatientPositionDisplacementReferencePoint | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9575.html | PatientAlignmentDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9576.html | ReasonsforRTRadiationTreatmentOmission | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9577.html | PatientTreatmentPreparationProcedure | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9578.html | MotionManagementSetupDevice | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9579.html | RTSegmentMaterial | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9580.html | RTSegmentationPropertyCategory | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9581.html | RadiotherapyRegistrationMark | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9582.html | RadiotherapyDoseRegion | active | 2025-04 | hl7 |
| fhir.dicom | R4 | http://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_9583.html | RTPlanRadiotherapyProcedureTechnique | active | 2025-04 | hl7 |
| hl7.fhir.us.nhsn-med-admin | R4 | ImplementationGuide/hl7.fhir.us.nhsn-med-admin | NHSN Reporting: Inpatient Medication Administration | draft | 2021-03 | hl7 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Composition-inpatient-med-admin | Composition - Inpatient Medication Administration | active | 2021-10 | hl7 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Condition-lab-confirmed-covid | Condition - Lab Confirmed COVID-19 | active | 2021-10 | hl7 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Condition-suspected-covid | Condition - Suspected COVID-19 | active | 2021-10 | hl7 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/MedicationAdministration-inpatient-med-admin | Medication Administration - Inpatient Med Admin | active | 2021-10 | hl7 |
| hl7.fhir.us.nhsn-med-admin | R4 | StructureDefinition/Observation-lab-sars-cov | Observation Laboratory SARS COVID-19 | active | 2021-10 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | CapabilityStatement/rtpbc-requester | RTPBC Requester Capability Statement | active | 2019-12 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | CapabilityStatement/rtpbc-responder | RTPBC Responder Capability Statement | active | 2019-12 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | CodeSystem/rtpbc-benefit-restriction | RTPBC Benefit Restriction Code System | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | CodeSystem/rtpbc-event-type | RTPBC Event Type Code System | active | 2019-12 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | CodeSystem/rtpbc-patient-pay-type | RTPBC Patient Pay Type Code System | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ImplementationGuide/hl7.fhir.us.carin-rtpbc | Consumer Real-Time Pharmacy Benefit Check | draft | 2020-08 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | MessageDefinition/rtpbc-request | RTPBC Request Message Definition | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | MessageDefinition/rtpbc-response | RTPBC Response Message Definition | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-benefitRestriction | RTPBC benefitRestriction Extension | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-coverage | RTPBC Coverage | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-isAlternative | RTPBC isAlternative Extension | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-medicationrequest | RTPBC Medication Request | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-patient | RTPBC Patient | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-pharmacy-organization | RTPBC Pharmacy Organization | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-request-bundle | RTPBC Request Bundle | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-request-claim | RTPBC Request Using Claim | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-request-messageheader | RTPBC Request MessageHeader | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-response-bundle | RTPBC Response Bundle | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-response-claimresponse | RTPBC Response Using ClaimResponse | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | StructureDefinition/rtpbc-response-messageheader | RTPBC Response MessageHeader | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-benefit-restriction | RTPBC Benefit Restriction Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-billing-unit | RTPBC Billing Unit Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-country-code | RTPBC Country Code Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-error-code | RTPBC Error Code Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-event-type | RTPBC Event Type Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-patient-pay-type | RTPBC Patient Pay Type Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-pharmacy-type | RTPBC Pharmacy Type Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-prescribable-product-code | RTPBC Prescribable Product Code Value Set | active | 2020-05 | hl7 |
| hl7.fhir.us.carin-rtpbc | R4 | ValueSet/rtpbc-state-and-province-code | RTPBC Two Letter State and Province Code Value Set | active | 2020-05 | hl7 |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.1 | Facility Location NICU (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.10 | Seizure or Serious Neurologic Dysfunction (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.100 | Third Degree Perineal Laceration (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.101 | Fourth Degree Perineal Laceration (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.102 | Ruptured Uterus (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.103 | Unplanned Hysterectomy (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.104 | Facility Location OR (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.105 | Unplanned Operation (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.106 | Attempted Forceps Procedure (NCHS) | draft | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.107 | Attempted Vacuum Procedure (NCHS) | draft | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.108 | Fetal Presentation at Birth- Breech (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.109 | Fetal Presentation at Birth- Cephalic (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.11 | Newborn Given Surfactant Replacement (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.110 | Fetal Presentation at Birth- Other (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.111 | Route and Method of Delivery - Spontaneous (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.112 | Route and Method of Delivery - Forceps (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.113 | Route and Method of Delivery - Vacuum (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.114 | Route and Method of Delivery - Cesarean (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.115 | Route Method of Delivery - Trial of Labor (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.116 | Route and Method of Delivery - Scheduled C (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.117 | Measured Height (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.118 | Pre-Pregnancy Weight (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.119 | Problem Status Active (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.12 | 5 Min Apgar Score (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.120 | Mothers Delivery Weight (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.121 | Previous Other Pregnancy Outcomes (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.122 | Number of Previous Live Births Now Dead (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.123 | Number of Previous Live Births Now Living (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.124 | Obstetric Estimate of Gestation (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.125 | Cervical Cerclage (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.127 | External Cephalic Version (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.128 | Tocolysis (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.129 | Premature Rupture (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.13 | 10 Min Apgar Score (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.130 | Precipitous Labor (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.131 | Prolonged Labor (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.132 | Birth Plurality of Delivery (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.133 | First Prenatal Care Visit (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.135 | Number Prenatal Care Visits (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.136 | Prepregnancy Diabetes (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.137 | Gestational Diabetes (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.138 | Prepregnancy Hypertension (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.139 | Gestational Hypertension (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.14 | Delivery (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.140 | Eclampsia (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.141 | Preterm Birth (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.142 | Poor Pregnancy Outcome History (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.143 | Infertility Treatment (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.144 | Fertility Enhancing Drugs (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.145 | Artificial or Intrauterine Insemination (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.146 | Assistive Reproductive Technology (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.147 | Listeria (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.148 | Number of Previous Cesareans (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.149 | Neonatal Death (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.15 | Physician (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.150 | Hysterotomy Hysterectomy (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.151 | Fetus Weight (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.153 | Fetal Autopsy (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.154 | Karyotype Determination (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.155 | Education Level 8th (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.156 | Education Level - 9 - 12 No Diploma (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.157 | Education Level - High School (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.158 | Education Level Some College (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.159 | Education Level Associate (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.16 | Doctor of Osteopathic Medicine (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.160 | Education Level Baccalaureate (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.161 | Education Level Graduate Degree (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.164 | Number of Fetal Deaths This Delivery (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.166 | Group B Streptococcus (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.167 | Cytomegalovirus (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.168 | Parvovirus (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.169 | Toxoplasmosis (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.17 | Certified Midwife (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.170 | Married (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.171 | Never Married (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.172 | Previously Married (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.176 | Transferred for Maternal Medical or Fetal Indicat | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.177 | Transfer In (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.178 | Antibiotic Administration Procedure (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.179 | Stated Height (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.18 | Midwife (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.180 | Conception Date (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.184 | Birthplace Setting (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.185 | Time of Death (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.187 | Number of Preterm Births (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.188 | ICU Care (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.189 | Cleft Palate Alone (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.19 | U.S. Territories (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.190 | Transfer to Facility (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.191 | Institution Referred To (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.192 | Birth Place Hospital (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.193 | Birth Place Home Intended (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.194 | Birth Place Home Unintended (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.195 | Birth Place Home Unknown Intention (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.196 | Birth Place Freestanding Birthing Center (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.197 | Birth Place Clinic Office (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.198 | NICU Care (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.2 | Facility Location ICU (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.20 | Birth Weight (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.22 | Augmentation of Labor - Procedure (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.23 | Augmentation of Labor - Medication (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.24 | Chorioamnionitis During Labor (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.25 | Fever Greater Than 100.4 (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.26 | Epidural Anesthesia - Medication (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.27 | Epidural Anesthesia - Procedure (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.28 | Spinal Anesthesia - Medication (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.29 | Spinal Anesthesia - Procedure (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.3 | Antibiotics (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.30 | Fetal Intolerance of Labor (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.31 | In-utero Resuscitation (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.32 | Further Fetal Assessment (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.33 | Operative Delivery (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.34 | Induction of Labor (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.35 | Spontaneous Onset of Labor (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.36 | Meconium Staining (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.37 | Non-vertex presentation in active phase of (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.38 | Glucocortico Steroids (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.39 | Immature Fetus (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.4 | IV Medication Administration Route (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.40 | Inflammation Indication (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.41 | Breastfed Infant (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.42 | Male Gender (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.43 | Female Gender (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.5 | IM Medication Administration Route (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.53 | Anencephaly of the Newborn (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.54 | Cyanotic Congenital Heart Disease (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.55 | Congenital Diaphragmatic Hernia (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.56 | Karyotype Confirmed (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.57 | Suspected Chromosomal Disorder (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.58 | Cleft Lip with or without Cleft Palate (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.59 | Karyotype Result (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.6 | Neonatal Sepsis (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.60 | Cleft Lip without Cleft Palate (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.61 | Down Syndrome (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.62 | Gastroschisis of the Newborn (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.63 | Hypospadias (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.65 | Meningomyelocele/Spina Bifida - Newborn (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.66 | Omphalocele of the Newborn (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.67 | Date of Last Live Birth (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.68 | Number of Live Births (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.69 | Date of Last Menses (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.70 | Date of Last Other Pregnancy Outcome (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.71 | Number of Prior Pregnancies (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.72 | Hispanic Ethnicity - Mexican (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.73 | Hispanic Ethnicity - Puerto Rican (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.74 | Hispanic Ethnicity - Cuban (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.75 | Other Hispanic Ethnicity (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.76 | Not Hispanic Ethnicity (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.77 | Father (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.81 | Race - Asian Indian (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.9 | Significant Birth Injury (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.93 | Chlamydia (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.95 | Pregnant (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.96 | Hepatitis B (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.97 | Hepatitis C (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.98 | Syphilis (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.13.8.99 | Transfusion Whole Blood or Packed Red Bld (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.11 | JCIH-EHDI Hearing Loss Risk Factors | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.12 | JCIH-EHDI Hearing Loss Risk Factors - Procedures | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.13 | JCIH-EHDI NICU Service Delivery Location | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.14 | JCIH-EHDI Newborn Hearing Loss Diagnosis | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.15 | JCIH-EHDI Reason for no Hearing Loss Diagnosis | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.16 | JCIH-EHDI Newborn Hearing Loss Referrals | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.17 | JCIH-EHDI Newborn Hearing Procedure | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.2 | JCIH-EHDI Outpatient Encounter | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.20 | JCIH-EHDI Procedure Declined | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.7 | JCIH-EHDI Reason for no Follow-up - Patient Reason | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.8 | JCIH-EHDI Hearing Screen Left | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.15.2.9 | JCIH-EHDI Hearing Screen Right | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.1 | Autopsy Performed (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.13 | Family History (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.14 | Mother Breastfeeding (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.17 | Laboratory Tests (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.19 | Associated Conditions (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.2 | Autopsy Not Performed (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.4 | Discharge Death (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.6 | Death Certification (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7 | Interventions (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.8 | Dietary Behavior (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.19376.1.7.3.1.1.23.8.9 | Physical Activity Behavior (HW) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.75 | Joint Commission Medical Reason | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.11222.4.11.5025 | Original Specimen Type Modifier PHLIP | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 | Route of Administration | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.1 | Administrative Gender (HL7 V3) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10267 | Participation Function (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10416 | Financially Responsible Party Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.10637 | Postal Address Use (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12199 | Language Ability Proficiency (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12212 | Marital Status Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.12249 | LanguageAbilityMode Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.14914 | Race Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.15913 | Entity Name Use (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.159331 | Act Status | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16866 | Act Priority (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.16926 | Basic Confidentiality Kind (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.18877 | Coverage Role Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19185 | Religious Affiliation Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19563 | Personal Relationship Role Type Value Set | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19579 | Family Member Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19601 | x_ServiceEventPerformer (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.19717 | No Immunization Reason Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.20.2 | Advance Directive Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.1.11.78 | Observation Interpretation (HL7) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.1 | Amniotic Fluid Conditions (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.10 | Type of Twin (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.11 | Twin Placenta (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.12 | Umbilical Cord Complication (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.13 | Infant Fetal Complications (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.14 | Placental Measurement (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.2 | Cord Insertion Type (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.3 | Hospital Care-Setting (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.4 | Maternal Exposures (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.5 | Intended Newborn Feeding Type (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.6 | Placenta Type (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.7 | Placental Conditions (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.1.1.13.9 | Type of Recreational Drug (HL7) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.91 | Birth Defects Diagnostic Confirmation (HL7) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.14.93 | Birth Defects Laterality at Diagnosis (HL7) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.10 | eICR Processing Status Reason Detail Type (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.11 | eICR Initiation | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.3 | Determination of Reportability (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.4 | External Resource Type (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.5 | Reportability Priority (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.6 | Location Relevance (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.7 | eICR Processing Status Reason (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.10.20.15.2.5.8 | eICR Processing Status (eCR) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.19465 | Healthcare Provider Taxonomy Code (NUCC) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.12.1 | Personal And Legal Relationship Role Type (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.18 | MoodCodeEvnInt (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.20 | Telecom Use - US Realm Header (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.21 | AgePQ_UCUM | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.22 | Procedure Act Status Code (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.23 | Planned moodCode - Act/Encounter/Procedure (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.24 | Planned moodCode - SubstanceAdministration/Supply | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.25 | Planned moodCode - Observation (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.26 | Entity Person Name Part Qualifier (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.33 | Role Class Codes (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.34 | Patient Education | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.38 | Current Smoking Status (NAACCR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.41 | Tobacco Use | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.49 | Residence and Accommodation Type | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.11.20.9.60 | Priority Level (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.19 | Healthcare Service Location (NHSN) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.13.277 | Birth Defect Diagnosis | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.1 | Immunization Funding Source Excluding Nulls | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.2 | Pt Immunization Registry Status Excluding Nulls | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.3 | Race Category Excluding Nulls | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.2074.1.1.4 | Immunization Refusal Reason Excluding Nulls | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.5.20.1 | USDA Subject Descriptor | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.5.20.2 | USDA Subject Function | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.1 | NAACCR Laterality at Diagnosis | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.10 | NAACCR TNM Clinical Stage Descriptor | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.11 | NAACCR Cancer Status | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.12 | NAACCR Quality of Survival | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.13 | NAACCR Screening Result | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.14 | NAACCR Behavior Code | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.15 | NAACCR Grade | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.16 | NAACCR ICD-9-CM Cancer Reportability List | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.21 | TNM Pathologic Stage Descriptor (NAACCR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.22 | Laterality (NAACCR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.25 | Radiation Rx and Boost Radiation ICD10-PCS (NAACCR | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.26 | Radiation Rx and Boost Radiation SNOMEDCT (NAACCR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.27 | NAACCR TNM Pathologic Staged By (NAACCR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.29 | NAACCR SNOMEDCT Cancer Reportability List | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.3 | NAACCR Diagnostic Confirmation | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.4 | NAACCR TNM Clinical Staged By | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.520.4.5 | NAACCR TNM Edition Number | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.3.2 | Contact Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.4.2 | Provider Role Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.2 | Allergy/Adverse Event Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.6.8 | Problem Severity | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.2 | Problem Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.7.4 | Problem Value Set | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.11 | Medication Product Form Value Set | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.19 | Medication Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.7 | Medication Route FDA Value Set | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.3221.8.9 | Body Site Value Set | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.16 | Medication Brand Name Value Set | active | 2022-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.18 | Medication Drug Class Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.21 | Medication Vehicle Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.39 | Immunization Information Source | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.46 | Document Class Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.47 | Document Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.60 | Social History Type Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.62 | Vital Sign Result Value Set | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.64 | Medication Fill Status Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.65 | V3 Result Status Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.66 | Patient Class Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.113883.3.88.12.80.68 | Problem Status | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.2.11.7101 | VPD Reason for Study | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1000 | Identity Reliability Code (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1002 | Lab Test Result Name | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1003 | Observation Method | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1004 | Ordered Test | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1006 | Type of Long Term Care Facility | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1007 | Major Site of Disease (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1009 | Microorganism | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1011 | Data Subtype | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1012 | Type of Data | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1013 | Missing Lab Result Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1014 | Modifier or Qualifier | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1015 | Nationally Notifiable Disease Surveillance System (NNDSS) & Other Conditions of Public Health Importance | active | 2022-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1016 | Nationally Notifiable Infectious Disease reportable to the Nationally Notifiable Disease Surveillance System | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1017 | Nature of Abnormal Test (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1018 | Non Paint Lead Source | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1019 | Non-paint lead source - hobby related | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1021 | Number Of Lesions (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1023 | Response Flag (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1024 | Extended Priority Codes (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1025 | Order Status (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1026 | Pregnancy Trimester | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1027 | Previous Vaccine History | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1028 | Processing ID (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1029 | Processing Mode (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1031 | Public Health Case Record Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1036 | Referral Status (CRA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1037 | Risk Category | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1038 | Sex (MFU) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1039 | Specimen Appropriateness (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1040 | Specimen Child Role (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1041 | Specimen Collection Method (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1042 | Specimen Condition | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1043 | Specimen Quality (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1044 | Specimen Reject Reason (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1045 | Specimen Risk | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1046 | Specimen Role | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1047 | Specimen Treatment | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1048 | Strain Type (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1049 | Substance Administered (CRA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1050 | Batch Deactivation Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1053 | Volume Units | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1054 | Volume Mass Units | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1055 | Universal ID Type (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1057 | Vaccine Contraindications | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1058 | Vaccine Purchased With Funds | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1059 | Value Type (HL7) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1061 | PHIN Questions (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1062 | PHIN Questions (Varicella) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1063 | PHIN Questions (Lead Case) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1064 | PHIN Questions (Lead Laboratory Report) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1065 | PHIN Questions (Lead Environmental) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1066 | Healthcare Provider Taxonomy (HIPAA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1067 | Body Substance | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1068 | Event | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1069 | Material | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1071 | Drug Susceptibility Test Result Name | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1074 | Animal | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1075 | Physical Object | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1076 | Situation with Explicit Context | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1089 | Botulism-like Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1090 | Fever Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1091 | Gastrointestinal Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1092 | Hemorrhagic Illness Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1093 | Localized Cutaneous Lesion Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1094 | Lymphadenitis Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1095 | Neurological Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1096 | Rash Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1097 | Respiratory Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1098 | Severe Illness Or Death Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1099 | Specific Infection Syndrome (BT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1100 | Industry (NAICS) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1102 | Drug Active Ingredients | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1103 | Semantic Clinical Drug (Ingredient plus strength and dose form) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1104 | Semantic Clinical Drug Form (Ingredient plus dose form) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1105 | Drug Product (NDC) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1106 | Drug Manufacturers (NDC) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1107 | Notification Section Header | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1108 | Drug Classes (NDF-RT) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.1109 | Procedure by Site (SNOMED) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3000 | PHLIP Questions (Flu) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3014 | Source of Comment (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3015 | Ethnicity Group including Unknown | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3016 | Lab Test Order (PHLIP Flu) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3018 | Patient Location Status at Specimen Collection | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3019 | Resulted Lab Test Name (PHLIP Flu) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3020 | Specimen Source (PHLIP) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3021 | Preferred Method of Contact (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3022 | PHIN Questions (Hepatitis) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3023 | Immunization Body Site | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3025 | Case Confirmation Method | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3026 | Case Detection Method | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3027 | Case Transmission Mode | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3028 | Contact Type (Hepatitis A) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3029 | Contact Type (Hepatitis B and C) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3030 | Disease Acquired Jurisdiction | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3031 | Incarceration Type (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3032 | Notifiable Condition (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3034 | Outbreak Type (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3035 | Reason For Test (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3036 | Reporting Source Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3038 | Vaccine Dose Number (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3039 | Isolate Availability EIP Testing | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3040 | Isolate Not Available EIP Test Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3041 | Isolate Not Received Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3042 | Isolate Not Sent To NARMS Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3043 | Lab Test Result Name (Hepatitis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3044 | Microbiology strain | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3046 | Specimen Reshipment Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3047 | Specimen Shipped | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3048 | Lab Test Interpretation | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3049 | Lab Test Result Qualitative | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3050 | PHIN Questions (Animal Rabies) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3051 | PHIN Questions (ArboNet) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3052 | PHIN Questions (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3053 | PHIN Questions (Generic) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3054 | PHIN Questions (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3055 | ECOTOX Chemicals (EPA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3056 | STORET Chemicals (EPA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3057 | TRI Chemicals (EPA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3058 | Cancer Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3060 | Immunosuppressed Condition | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3061 | Public Private Lab | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3062 | Transplant Organ | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3063 | Virus Type (Arboviral Disease) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3064 | Yes No Unknown No Answer | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3065 | Age Category (Animal) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3066 | Bat Species (Animal Rabies) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3067 | Virus Variant Type (Animal Rabies) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3070 | Botulism Food Source Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3072 | Animal Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3074 | Case Traced to Carrier | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3079 | Day Care Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3080 | Eosin Units (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3083 | Food Cooking Method (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3084 | Food Processing Method (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3088 | Information Source | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3089 | Interview Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3093 | Non Pork Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3094 | Other Related Cases | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3096 | Pork Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3100 | Seafood Type (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3103 | Suspected Food Consumed (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3104 | Swimming Pool Type (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3105 | Tap Water Source (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3106 | Travel Destination Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3107 | Travel Mode | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3108 | Travel Purpose | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3109 | Travelers Health Info Source | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3112 | Underlying Conditions | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3114 | Well Water Treatment (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3115 | Wound History | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3116 | Notifiable Condition (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3117 | Body Site (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3118 | Medication Treatment (FDD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3122 | Birth Location (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3124 | Body Region (Tetanus) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3125 | Case Classification Exposure Source | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3126 | Genotype (Measles) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3127 | Genotype (Rubella) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3130 | Injury Type (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3131 | Lab Result (Pertussis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3132 | Lab Result (Rubella) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3133 | Live Birth Outcome (Rubella) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3135 | Non-Live Birth Outcome (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3136 | PCR Performed Lab Location (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3137 | Prenatal Care Provider (Rubella) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3138 | Relationship (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3139 | Serology Performed Lab Location (Pertussis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3142 | Test Method EIA IgM | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3147 | Medication Received (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3149 | Lab Test Method (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3150 | IgM Test Type (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3151 | IgG Test Type (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3152 | Whole Cell ELISA Manufacturer (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3153 | gp ELISA Manufacturer (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3154 | Vaccines Administered (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3155 | Vaccine Manufacturer (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3156 | Reporting Area (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3157 | RVCT Link Reason (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3158 | Case Count Status (TB) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3159 | Reporting Lab Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3160 | Microscopic Exam Type (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3162 | Risk Factors (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3163 | Immigration Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3166 | Cause of Death Related to TB | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3168 | Education Level | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3169 | Birth Country (TB) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3200 | Birth Country | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3201 | Geographical location history | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3203 | Treatment status | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3204 | Non-Laboratory Intervention and Procedure | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3205 | Lab Test Result Name (TB) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3206 | Lab Test Result Name (Acute Hepatitis B) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3207 | Lab Test Result Name (Anthrax) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3208 | Lab Test Result Name (Tularemia) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3209 | Exposure Location | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3210 | Contact Type (Hepatitis B) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3211 | Material exposure type | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3212 | Signs and Symptoms (Anthrax) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3213 | Signs and Symptoms (Acute Hepatitis B) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3214 | Signs and Symptoms (TB) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3215 | Signs and Symptoms (Tularemia) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3216 | Medication Treatment (Anthrax) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3217 | Medication Treatment (Tularemia) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3218 | Medication Treatment (TB) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3219 | Vaccine Administered (Hepatitis B) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3220 | Disease Type (Anthrax) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3221 | Disease Type (Acute Hepatitis B) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3222 | Disease Type (TB) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3223 | Disease Type (Tularemia) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3224 | Blood or body fluid exposure event | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3225 | Blood or body fluid exposure frequency | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3226 | Blood or body fluid exposure related procedure | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3227 | Location performing blood or body fluid exposure procedure | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3228 | Sociobehavioral risk factor | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3230 | Disease Type (Hepatitis) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3231 | Disease Type (STD) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3232 | HIV Status (PHCR) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3236 | National Reporting Jurisdiction | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3237 | PHIN Questions (Mumps) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3238 | PHIN Questions (Measles) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3239 | PHIN Questions (Summary) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3240 | Flu Signs and Symptoms | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3241 | Notifiable Event Condition (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3242 | Risk Factor (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3243 | Lab Test Finding (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3245 | Radiology Lab Test (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3246 | Specimen (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3250 | Vaccines Administered (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3251 | Lab Test Procedure (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3252 | Lab Test Interpretation (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3253 | Obesity Severity (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3254 | Employment Status (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3255 | Case Contact Signs and Symptoms (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3256 | Time Frame (Daily Weekly) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3257 | Surveillance Method (Novel Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3258 | Change Pattern | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3259 | Age Group (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3260 | Count Group Type (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3261 | Death Location (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3262 | Lab Test Procedure (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3263 | Lab Test Interpretation (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3265 | Positive Negative Unknown | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3270 | Therapy 7 Days Prior or After Illness Onset (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3271 | Therapy Prior Illness Onset (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3272 | Therapy After Illness Onset (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3273 | Vaccines Administered (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3274 | Timing Prior To Illness Onset | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3275 | Relationship (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3276 | PHIN Questions (Flu Summary) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3277 | PHIN Questions (Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3278 | PHIN Questions (Pediatric Flu) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3279 | H1N1 Vaccine Manufacturer | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3282 | Specimen Collection Method | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3285 | Anatomical Entity (Body Site) | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3286 | Country Subdivision (ISO 3166-2) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3287 | Immunization Funding Source (IIS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3288 | Vaccination Contraindication (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3289 | Vaccination Reaction and Adverse Event (IIS) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3290 | Vaccination Special Indication (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3291 | Immunization Profile Identifier (IIS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3292 | Immunization Schedule Identifier (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3293 | Evidence Of Immunity (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3294 | PHIN Questions (CRS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3295 | PHIN Questions (Malaria) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3298 | PHIN Questions (Rubella) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3299 | PHIN Questions (Strep Pneumo) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3300 | Lab Test Procedure (Rubella) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) | active | 2022-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3308 | Complications (Malaria) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3309 | Lab Test Procedure (Malaria) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3311 | Medication Prophylaxis (Malaria) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3313 | Species (Malaria) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3315 | Travel Reason (Malaria) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3316 | Antimicrobial Agent (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3317 | Antimicrobial Susceptibility Test Method (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3323 | Birth Outcome (Rubella) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) | draft | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3337 | Event Type (HL7) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3338 | Coding System HL7 2x Table 0396 | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3339 | Check Digit Scheme (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3340 | Specimen Action Code (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3341 | Message Type (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3342 | Version ID (HL7) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3343 | Abnormal Flag (HL7 27) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3344 | Accept Application Acknowledgment Conditions (HL7) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3345 | Type of Referenced Data (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3346 | Organizational Name Type (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3347 | Alternate Character Sets (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3348 | Visit Indicator (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3349 | Message Structure (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3350 | Alternate Character Set Handling Scheme (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3351 | Name Assembly Order (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3352 | Name Address Representation (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3353 | TQ Conjunction ID (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3354 | Order Type (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3355 | Authorization Mode (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3356 | Risk Codes (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3357 | Observation Result Handling (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3358 | Lab Test Name (NND) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3359 | Evaluation Finding | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3362 | Event Type (IIS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3363 | Patient Class (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3364 | Message Type (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3365 | Relationship (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3366 | Financial Class (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3367 | Version ID (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3368 | Order Control Code (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3369 | Route Of Administration (IIS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3370 | Administrative Site (IIS) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3371 | Name Type (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3372 | Identifier Type (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3373 | Organizational Name Type (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3374 | Query Response Status (IIS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3375 | Action Code (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3376 | Message Structure (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3377 | Immunization Registry Status (HL7) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3378 | Immunization Registry Status (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3379 | Query Name (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3380 | Substance Refusal Reason (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3381 | Observation Identifier (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3382 | Query Priority (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3383 | Quantity Limited Request (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3384 | Publicity Code (IIS) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3392 | Value Type (IIS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3401 | Facility / Visit Type (Syndromic Surveillance) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3402 | Age Unit (Syndromic Surveillance) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3403 | Gender (Syndromic Surveillance) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3404 | Patient Class (Syndromic Surveillance) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3405 | Race Category including Unknown | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3406 | Disease Acquired Jurisdiction (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3408 | Age Unit (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3411 | Body Region Tetanus (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3415 | Vaccines Administered (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3416 | Manufacturers Of Vaccines (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3423 | Antibiotic Treatment (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3424 | Hemodialysis Contact Type Hepatitis (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3428 | Result Status (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3434 | Antimicrobial Agent NETSS | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3435 | Serotype (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3501 | Bacterial Infectious Disease | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3502 | Infectious Disease | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3503 | Pneumonia Disease | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3587 | Flu Activity Code | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3588 | Method of Race and Ethnicity Data Collection | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3589 | Observation Identifier (Syndromic Surveillance) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3590 | Pulse Oximetry Unit | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3591 | Source of Payment Typology (PHDSC) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3593 | Cause of Death (ICD-10) | draft | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3594 | Campylobacter Organism | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3597 | Identifier Type (Syndromic Surveillance) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3598 | Wound Depth Tetanus (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3599 | Time Period Tetanus (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.3600 | Stay Period Hepatitis (NETSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4000 | Lab Result (Amebiasis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4001 | Lab Result (Anaplasma) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4002 | Lab Result (Anthrax) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4003 | Lab Result (Arbovirus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4004 | Lab Result (Arenavirus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4006 | Lab Result (Bartonellosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4007 | Lab Result (Blastomycosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4008 | Lab Result (Botulism) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4009 | Lab Result (Brucellosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4010 | Lab Result (California serogroup virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4011 | Lab Result (Campylobacteriosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4012 | Lab Result (Chagas) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4013 | Lab Result (Chancroid) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4014 | Lab Result (Chlamydia trachomatis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4015 | Lab Result (Cholera) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4016 | Lab Result (Clostridium perfringens) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4017 | Lab Result (Clostridium perfringens Epsilon Toxin) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4018 | Lab Result (Coccidioidomycosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4019 | Lab Result (Colorado Tick Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4020 | Lab Result (Creutzfeldt-Jakob disease) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4021 | Lab Result (Cryptococcosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4022 | Lab Result (Cryptosporidiosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4023 | Lab Result (Cyclosporiasis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4025 | Lab Result (Dengue) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4026 | Lab Result (Diphtheria) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4027 | Lab Result (Eastern equine encephalitis virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4028 | Lab Result (Ebolavirus) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4029 | Lab Result (E. coli STEC) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4030 | Lab Result (Ehrlichia chaffeensis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4031 | Lab Result (Ehrlichia ewingii) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4032 | Lab Result (Ehrlichiosis Anaplasmosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4033 | Lab Result (Genital Warts) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4034 | Lab Result (Giardiasis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4035 | Lab Result (Glanders) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4036 | Lab Result (Gonorrhea) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4037 | Lab Result (Granuloma Inguinale) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4038 | Lab Result (Haemophilus influenzae) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4039 | Lab Result (Hansen's Disease) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4040 | Lab Result (Hantavirus Pulmonary Syndrome) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4041 | Lab Result (Hendra virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4042 | Lab Result (Hepatitis A) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4043 | Lab Result (Hepatitis B) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4044 | Lab Result (Hepatitis C) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4045 | Lab Result (Hepatitis D) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4046 | Lab Result (Hepatitis E) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4047 | Lab Result (Herpes Simplex) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4048 | Lab Result (Histoplasmosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4049 | Lab Result (HIV) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4050 | Lab Result (Influenza A virus, H1N1 2009 strain) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4051 | Lab Result (Jamestown Canyon virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4052 | Lab Result (Legionellosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4053 | Lab Result (Leptospirosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4054 | Lab Result (Listeriosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4055 | Lab Result (Lyme disease) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4056 | Lab Result (Lymphogranuloma Venereum) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4057 | Lab Result (Malaria) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4058 | Lab Result (Marburgvirus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4059 | Lab Result (Measles) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4060 | Lab Result (Melioidosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4061 | Lab Result (Meningococcal Disease) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4062 | Lab Result (Monkeypox Orthopox) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4063 | Lab Result (MRSA) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4064 | Lab Result (Mumps) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4065 | Lab Result (Nipah Virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4066 | Lab Result (Nongonococcal Urethritis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4068 | Lab Result (Norovirus) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4069 | Lab Result RCMT (Pertussis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4070 | Lab Result (Plague) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4071 | Lab Result (Polio) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4072 | Lab Result (Powassan virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4073 | Lab Result (Prion Disease) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4074 | Lab Result (Psittacosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4075 | Lab Result (Q Fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4076 | Lab Result (Rabies) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4077 | Lab Result (Relapsing Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4078 | Lab Result (Respiratory Syncytial Virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4079 | Lab Result (Rickettsial infection, other) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4080 | Lab Result (Rift Valley Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4081 | Lab Result (Rotavirus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4082 | Lab Result RCMT (Rubella) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4083 | Lab Result (Salmonellosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4084 | Lab Result (SARS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4085 | Lab Result (Shigella) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4086 | Lab Result (Smallpox) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4087 | Lab Result (Spotted fever rickettsiosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4088 | Lab Result (Staphylococcus aureus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4089 | Lab Result (Staphylococcus aureus enterotoxin B) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4090 | Lab Result (Staphylococcus aureus food poisoning) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4091 | Lab Result (Staphylococcal TSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4092 | Lab Result (St. Louis encephalitis virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4093 | Lab Result (Streptococcus pneumoniae) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4094 | Lab Result (Streptococcal TSS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4095 | Lab Result (Streptococcus, group A) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4096 | Lab Result (Streptococcus, group B) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4097 | Lab Result (Syphilis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4098 | Lab Result (Tetanus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4099 | Lab Result (Toxoplasmosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4100 | Lab Result (Trichinellosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4101 | Lab Result (Tuberculosis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4102 | Lab Result (Tularemia) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4103 | Lab Result (Typhoid Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4104 | Lab Result (Typhus group rickettsiosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4105 | Lab Result (Vaccinia) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4106 | Lab Result (Vancomycin resistant Enterococcus) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4107 | Lab Result (Varicella) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4108 | Lab Result (Vesicular Stomatitis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4109 | Lab Result (Vibriosis, non-cholera) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4110 | Lab Result (Viral Hemorrhagic Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4111 | Lab Result (VISA) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4112 | Lab Result (VRSA) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4113 | Lab Result (Western equine encephalitis virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4114 | Lab Result (West Nile virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4115 | Lab Result (Yellow Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4116 | Lab Result (Yersiniosis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4117 | Lab Test Name (Amebiasis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4118 | Lab Test Name (Anaplasma) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4119 | Lab Test Name (Anthrax) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4120 | Lab Test Name (Arbovirus) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4122 | Lab Test Name (Babesiosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4123 | Lab Test Name (Bartonellosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4124 | Lab Test Name (Blastomycosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4125 | Lab Test Name (Botulism) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4126 | Lab Test Name (Brucellosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4127 | Lab Test Name (California serogroup virus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4128 | Lab Test Name (Campylobacteriosis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4129 | Lab Test Name (Chagas) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4130 | Lab Test Name (Chancroid) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4131 | Lab Test Name (Chlamydia trachomatis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4132 | Lab Test Name (Cholera) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4133 | Lab Test Name (Clostridium perfringens) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4134 | Lab Test Name (Coccidioidomycosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4135 | Lab Test Name (Colorado Tick Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4137 | Lab Test Name (Cryptococcosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4138 | Lab Test Name (Cryptosporidiosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4139 | Lab Test Name (Cyclosporiasis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4140 | Lab Test Name (Cysticercosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4141 | Lab Test Name (Dengue) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4142 | Lab Test Name (Diphtheria) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4143 | Lab Test Name (Eastern equine encephalitis virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4145 | Lab Test Name (E. coli STEC) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4146 | Lab Test Name (Ehrlichia chaffeensis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4147 | Lab Test Name (Ehrlichia ewingii) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4148 | Lab Test Name (Ehrlichiosis Anaplasmosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4149 | Lab Test Name (Giardiasis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4150 | Lab Test Name (Glanders) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4151 | Lab Test Name (Gonorrhea) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4152 | Lab Test Name (Granuloma Inguinale) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4153 | Lab Test Name (Haemophilus influenzae) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4155 | Lab Test Name (Hantavirus Pulmonary Syndrome) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4157 | Lab Test Name (Hepatitis A) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4158 | Lab Test Name (Hepatitis B) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4159 | Lab Test Name (Hepatitis C) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4160 | Lab Test Name (Hepatitis D) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4161 | Lab Test Name (Hepatitis E) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4162 | Lab Test Name (Herpes Simplex) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4163 | Lab Test Name (Histoplasmosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4164 | Lab Test Name (HIV) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4165 | Lab Test Name (Influenza A virus, H1N1 2009 strain) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4166 | Lab Test Name (Jamestown Canyon virus) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4167 | Lab Test Name (Legionellosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4168 | Lab Test Name (Leptospirosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4169 | Lab Test Name (Listeriosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4170 | Lab Test Name (Lyme disease) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4171 | Lab Test Name (Lymphogranuloma Venereum) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4172 | Lab Test Name (Malaria) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4174 | Lab Test Name (Measles) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4175 | Lab Test Name (Melioidosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4176 | Lab Test Name (Meningococcal Disease) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4177 | Lab Test Name (Monkeypox Orthopox) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4178 | Lab Test Name (MRSA) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4179 | Lab Test Name (Mumps) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4181 | Lab Test Name (Nongonococcal Urethritis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4182 | Lab Test Name (Nontuberculous Mycobacteria) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4183 | Lab Test Name (Norovirus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4184 | Lab Test Name (Pertussis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4185 | Lab Test Name (Plague) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4186 | Lab Test Name (Polio) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4187 | Lab Test Name (Powassan virus) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4188 | Lab Test Name (Prion Disease) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4189 | Lab Test Name (Psittacosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4190 | Lab Test Name (Q Fever) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4191 | Lab Test Name (Rabies) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4192 | Lab Test Name (Relapsing Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4193 | Lab Test Name (Respiratory Syncytial Virus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4194 | Lab Test Name (Rickettsial infection, other) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4195 | Lab Test Name (Rift Valley Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4196 | Lab Test Name (Rotavirus) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4197 | Lab Test Name (Rubella) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4198 | Lab Test Name (Salmonellosis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4199 | Lab Test Name (SARS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4200 | Lab Test Name (Shigella) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4201 | Lab Test Name (Smallpox) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4202 | Lab Test Name (Spotted fever rickettsiosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4203 | Lab Test Name (Staphylococcus aureus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4204 | Lab Test Name (Staphylococcus aureus enterotoxin B) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4205 | Lab Test Name (Staphylococcus aureus food poisoning) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4206 | Lab Test Name (Staphylococcal TSS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4207 | Lab Test Name (St. Louis encephalitis virus) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4208 | Lab Test Name (Streptococcus pneumoniae) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4210 | Lab Test Name (Streptococcus, group A) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4211 | Lab Test Name (Streptococcus, group B) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4212 | Lab Test Name (Syphilis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4213 | Lab Test Name (Tetanus) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4214 | Lab Test Name (Toxoplasmosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4215 | Lab Test Name (Trichinellosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4216 | Lab Test Name (Tuberculosis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4217 | Lab Test Name (Tularemia) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4218 | Lab Test Name (Typhoid Fever) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4219 | Lab Test Name (Typhus group rickettsiosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4220 | Lab Test Name (Vaccinia) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4221 | Lab Test Name (Vancomycin resistant Enterococcus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4222 | Lab Test Name (Varicella) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4223 | Lab Test Name (Vesicular Stomatitis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4224 | Lab Test Name (Non-Cholera Vibrio) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4225 | Lab Test Name (Viral Hemorrhagic Fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4228 | Lab Test Name (Western equine encephalitis virus) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4229 | Lab Test Name (West Nile virus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4230 | Lab Test Name (Yellow Fever) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4231 | Lab Test Name (Yersiniosis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4239 | Lab Test Name (Diabetes, hemoglobin A1c) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4240 | Lab Test Name (Asbestosis) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4241 | Lab Test Name (Berylliosis) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4242 | Lab Test Name (Ricin poisoning) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4243 | Lab Test Name (Mushroom poisoning) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4244 | Lab Test Name (Carbon monoxide poisoning) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4245 | Lab Test Name (Pesticide poisoning) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4246 | Lab Test Name (Arsenic poisoning) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4247 | Lab Test Name (Cadmium poisoning) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4248 | Lab Test Name (Lead poisoning) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4249 | Lab Test Name (Mercury poisoning) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4250 | Lab Test Name (Acid fast stain) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4251 | Lab Test Name (Bacteria) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4252 | Lab Test Name (Fungus) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4253 | Lab Test Name (Microorganism) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4254 | Lab Test Name (Mycobacteria) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4255 | Lab Test Name (Parasite) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4256 | Lab Test Name (Virus) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4257 | Lab Test Name (Antimicrobial susceptibility tests) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4258 | Lab Test Name (TB Antimicrobial susceptibility test) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5000 | Universal Identifier (HL7) (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5001 | Specimen Type PHLIP | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5002 | Order Control Codes (HL7) (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5004 | Specimen Reject Reason (SCT) (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5005 | Lab Test Order (PHLIP Sal) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5006 | Value Type (HL7) (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5007 | Specimen Related Observations (PHLIP Sal) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5013 | Suspected Agent (PHLIP Sal) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5014 | Observation Result Status (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5015 | Role (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5016 | Organization Unit (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5017 | Resulted Lab Test Name PHLIP Salmonella | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5020 | Acknowledgment Code (HL7) (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5021 | Original Specimen Source Site PHLIP (PLT212) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5022 | Original Specimen Source Site Modifier PHLIP | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5023 | Original Specimen Collection Method PHLIP | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5024 | Original Specimen Type PHLIP | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5026 | Lab Test Result PHLIP Salmonella | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5027 | Identifier Type (HL7) (PHLIP for PID3.5) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.5028 | Method Detail (PHLIP) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6000 | Problem Goal Action Code (HL7) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6002 | Manner of Death (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6003 | Pregnancy Status (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6006 | Legacy Reporting Jurisdiction (CDS) | active | 2011-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6013 | Lab Test Type (Hepatitis) | active | 2022-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6014 | Lab Test Type Enzymes (Hepatitis) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6027 | Smoking Status (PI) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6036 | Occupation (Census) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6037 | Industry (Census) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6038 | Morphology of Neoplasms ICD-9-CM | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6039 | Funding Eligibility Observation Method (IIS) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6040 | VIS Vaccines (IIS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6041 | VIS Bar Codes (IIS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6046 | Specimen Type (HL7) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6047 | Message Structure (Syndromic Surveillance) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6048 | Event Type (Syndromic Surveillance) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6049 | Message Type (Syndromic Surveillance) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6050 | Universal ID Type (Syndromic Surveillance) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6053 | Lab Test Name (Reportable Conditions) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6054 | Lab Test Result (Reportable Conditions) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6055 | Lab Test Name (HEDIS) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6056 | Name Type (Syndromic Surveillance) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6057 | Value Type (Syndromic Surveillance) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6062 | Observation Result Status Interpretation Codes | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6063 | Universal ID Type (IIS) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6064 | Value Type (ELR) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6065 | Race (HL7) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6066 | Ethnic Group (HL7) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6067 | Universal ID Type (ELR) | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6069 | NAACCR ICD-10-CM Cancer Reportability List | active | 2012-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6071 | Gonorrhea (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.6072 | Trachoma (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7055 | Antituberculosis Drugs (TB) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7102 | VPD Lab Test Identifiers | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7104 | VPD Specimen Type | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7105 | VPD Specimen Collection Method | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7106 | VPD Specimen Source Body Site | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7107 | VPD Specimen Role | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7108 | VPD Specimen Condition | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7109 | VPD Lab Order Identifier | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7110 | VPD Specimen Reject Reason | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7115 | Karyotype Suspected Chromosomal Disorder (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7116 | Karyotype Down Syndrome (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7117 | Labor and Delivery Characteristics (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7118 | Delivery Routes (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7119 | Maternal Morbidities (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7121 | Newborn Abnormal Conditions (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7122 | Newborn Congenital Anomalies (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7123 | Onset Labor (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7126 | Pregnancy Risk Factors (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7129 | Employment Status (ODH) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7130 | Work Schedule (ODH) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7136 | Obstetric Procedures (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7137 | Autopsy Examination (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7138 | Histological Placental Examination (NCHS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7140 | Autopsy Planned (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7142 | Non-Vertex Presentation (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7143 | Steroids For Fetal Lung Maturation (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7144 | Assisted Ventilation Minutes After Birth (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7145 | Assisted Ventilation More Than Six Hours (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7153 | Estimated Time of Death No Labor Ongoing (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7154 | Fetal Presentation at Birth- Unknown (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7155 | Height (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7156 | Assisted Ventilation (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7157 | Binational Reporting Criteria | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7158 | State or Province of Exposure | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7159 | Mexican Health Jurisdictions (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7162 | Country (GEC) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7163 | Birth and Fetal Death Financial Class (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7164 | Birth and Fetal Death Report Event Reason (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7165 | Previous Cesarean (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7166 | Binational Reporting Criteria (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7168 | Notifiable Event Disease Condition (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7169 | US Mexico States (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7172 | Shigella Serogroup (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7173 | Campylobacter Species (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7175 | E. coli Culture Isolate Id Serotype (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7176 | STEC Nonculture Test Type (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7183 | Listeria Culture Species (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7184 | Occupation CDC Census 2002 | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7185 | Industry CDC Census 2002 | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7186 | Occupation CDC Census 2010 | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7187 | Industry CDC Census 2010 | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7188 | Travel Reason (Hepatitis A) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7189 | Specimen Source (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7190 | Current Sex (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7191 | Syphilis Neurologic Involvement (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7192 | HIV Status (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7193 | YNRD (CDC) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7194 | Drugs Used (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7196 | Non Treponemal Serologic Test (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7197 | Treponemal Serologic Test (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7198 | Transmission Category (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7199 | Detection Method (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7200 | Lab Results (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7201 | Lab Tests (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7202 | Country Imported From (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7204 | Race Category including Refused | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7205 | Race Category including Null Flavor | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7208 | Newborn Vital Signs (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7209 | Maternal Vital Signs (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7210 | Apgar Assessments (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7211 | Influenza Transmission Zones (PHLIP) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7213 | PHIN Questions (BIDS) | active | 2013-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7221 | Syphilis Treatment Mother (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7222 | Serologic Response (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7223 | Birth Status (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7226 | X-Ray Result (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7231 | Result Status (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7234 | Qual Lab Result Positive (Reportable Conditions) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7235 | Qual Lab Result Negative (Reportable Conditions) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7236 | Qual Lab Result Inconc (Reportable Conditions) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7243 | Lab Test Name (Ebolavirus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7244 | History of Disease as Evidence Of Immunity (IIS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7245 | Serological Evidence Of Immunity (IIS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7246 | Vital Signs (Syndromic Surveillance) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7248 | Countries Widespread Transmission (EVD) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7249 | Exposure Risk (EVD) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7250 | Observation Identifiers (EVD Triage) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7256 | Morphologic Abnormalities of Neoplasms | draft | | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7257 | Abdominal Pain (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7258 | Weakness (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7259 | Fever (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7260 | Headache (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7261 | Hemorrhage (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7262 | Muscle Pain (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7263 | Vomiting (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7264 | Diarrhea (CDS - EHR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7265 | Duration Unit | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7267 | Death Report Observation Identifier (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7268 | Data Elements (NND Gen V2) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7271 | Case Notification Specification Version (NND) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7272 | Case Notification MMG Version (NND) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7273 | Death Pronouncement Finding (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7274 | Death Pronouncement Procedure (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7275 | Nationally Notifiable Event Code (Hepatitis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7276 | Nationally Notifiable Event Code (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7277 | Transport Mode to Hospital (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7278 | Lab Test Performed Modifier (CS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7279 | Non-Treponemal Test Result (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7282 | Complications (Mumps) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7285 | Complications (Pertussis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7328 | 1 Min Apgar Score (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7330 | Performing Laboratory Type (VPD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7331 | Vaccine Administered (MMR) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7332 | Setting of Further Spread | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7335 | Vaccine Administered (Pertussis) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7336 | Lab Test Type (Mumps) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7337 | Lab Test Type (Pertussis) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7339 | Lab Test Name (Chikungunya virus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7340 | Lab Test Name (Junin Hemorrhagic fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7341 | Lab Test Name (Lassa fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7342 | Lab Test Name (Marburgvirus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7343 | Lab Result (Chikungunya virus) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7344 | Lab Result (Crimean-Congo hemorrhagic fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7345 | Lab Result (Guanarito hemorrhagic fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7346 | Lab Result (Junin hemorrhagic fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7347 | Lab Result (Lassa fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7348 | Lab Result (Lujo virus) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7349 | Lab Result (Machupo hemorrhagic fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7350 | Lab Result (Sabia virus hemorrhagic fever) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7351 | Lab Test Performed Modifier (NND) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7352 | No Prenatal Care Visit (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7354 | Part/line Number | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7356 | Diagnosis (ICD-10 CM) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7357 | Hysterectomy (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7358 | Hysterotomy (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7360 | Discharge Disposition IP (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7363 | Specialty Unit Type (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7364 | Type of clinic/location (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7366 | Relationship (NND) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7367 | Exposure Time Frame (NND) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7370 | Activity Type (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7371 | Procedure (ICD-10 PCS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7372 | Time Units (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7373 | Race (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7374 | Place of Injury (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7375 | Ethnicity Group (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7376 | Ethnicity Detail (NCHS) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7377 | Bridged Race (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7378 | Death Reporting Name Type Code (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7380 | Marital Status (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7382 | Death Reporting Identifier Type (HL70203) (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7383 | Death Reporting Event Reason (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7385 | Decedent Education Level (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7386 | Death Reporting Profiles (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7387 | Edit Flags (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7388 | Education Level Edit Flags (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7389 | Intentional Reject Edit Flags (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7390 | Marital Status Edit Flags (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7391 | Pregnancy Edit Flags (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7392 | Race Coding Flag (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7393 | Source Flags (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7395 | System Reject Codes (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7396 | Transax Conversion Flag (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7397 | Void Flags (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7398 | Nationally Notifiable Event Code (Syphilis) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7401 | Triage System (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7402 | Patient Residence (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7403 | Injury or Poisoning (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7404 | Major reason for visit (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7405 | Co-morbid Conditions (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7419 | Provider ED (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7421 | Body Weight (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7423 | Pregnancy Resulting From Fertility Enhancing Drugs | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7426 | Estimated Time Of Fetal Death (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7430 | Histological Placental Exam Performed (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7431 | Surfactant Replacement Therapy (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7432 | Asthma (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7433 | Condition Control (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7436 | Disposition (NCHS) | active | 2014-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7438 | Application Error Code (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7439 | Episode of Care (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7440 | Hospital Discharge Status (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7442 | Death Reporting Event Type (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7443 | Death Reporting Message Structure (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7444 | Death Reporting Message Type (NCHS) | active | 2015-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7446 | States Territories Provinces (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7447 | Nationally Notifiable Event Code (Generic) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7448 | Vaccine Type (NND) | active | 2022-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7449 | Qualitative Lab Result (RCMT) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7452 | Age Unit (NND) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7454 | Character of Lesions | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7456 | Lab Test Type (Varicella) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7457 | Zika-affected areas | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7458 | Transmission Mode (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7459 | Signs Symptoms (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7460 | Signs Symptoms (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7462 | Prenatal Diagnostic Procedures | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7463 | Specimen Type (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7464 | Insect Repellant | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7465 | Vector (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7466 | Complications (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7467 | Drug Disease Interaction (Dengue) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7469 | Microcephaly Causes | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7470 | Head Circumference Findings | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7472 | Lab Test Type (Arbovirus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7475 | Epidural/Spinal Anesthesia - Medication (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7476 | Positive Negative Equivocal Not Done | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7477 | Positive Negative 4 Fold Rise Not Done | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7478 | Serotype (Dengue) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7479 | Lab Result (Zika virus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7480 | Lab Test Name (Zika virus) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7481 | Signs Symptoms (Dengue) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7482 | Signs Symptoms (Chikungunya) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7483 | Signs Symptoms Dengue ICD-10 CM | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7484 | Signs Symptoms Chikungunya ICD-10 CM | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7485 | Signs Symptoms Zika ICD-10 CM | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7486 | Yes No Not Applicable (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7488 | Specimen Type (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7489 | Transmission Mode (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7491 | Pregnancy Complications (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7492 | Newborn Complications (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7493 | Performing Lab Type (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7494 | Pregnancy Outcome | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7496 | Death Reporting Observation Result Status (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7497 | Death Reporting Value Type (NCHS) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7512 | City Places (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7513 | Message Error Condition Codes (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7515 | Data Elements (NND Hep Core) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7516 | Data Elements (NND Hep A Acute) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7517 | Data Elements (NND Hep B Acute) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7518 | Data Elements (NND Hep B Perinatal) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7519 | Data Elements (NND Hep B Chronic) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7520 | Data Elements (NND Hep C Acute) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7521 | Data Elements (NND Hep C Chronic) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7522 | Data Elements (NND Mumps) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7523 | Data Elements (NND Pertussis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7524 | Data Elements (NND STD) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7525 | Data Elements (NND CS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7526 | Method of Delivery VaginalSpon Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7527 | Method of Delivery Cesarean Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7528 | Method of Delivery Vaginal Forceps Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7529 | Method of Delivery Vaginal Vacuum Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7530 | Scheduled Cesarean Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7531 | Induction of Labor Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7532 | Augmentation of Labor Finding (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7536 | Height Unit (CDC) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7537 | Duration Unit (1) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7539 | Medication Treatment (Babesiosis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7540 | Blood Product | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7542 | Lab Test Name (Hantavirus Infection) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7543 | Lab Result (Hantavirus Infection) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7544 | Outdoor Activities | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7545 | Lab Test Type (Babesiosis) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7546 | NAT Tests (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7547 | IgM Ab Tests (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7548 | Neutralizing Ab Tests (Zika) | active | 2016-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7549 | Test Type (Syphilis) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7550 | Lab Test Type (STD) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7552 | Organism Identified AST (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7555 | Susceptibility Test Type (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7556 | Susceptibility Test Method (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7557 | Susceptibility Test Interpretation (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7558 | Susceptibility Test Result Units (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7559 | Susceptibility Test Result Quantitative (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.756 | Gender Identity | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7563 | Sexual Orientation | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7564 | Birth Reporting Address Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7565 | Birthdate Edit Flags (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7566 | Pregnancy Report Edit Flags (NCHS) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7567 | Estimate Of Gestation Edit Flags (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7568 | Number Of Previous Cesareans Edit Flags (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7569 | Birth Reporting Associated Party Relation (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7570 | Birth Reporting Event Reason (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7571 | Birth Reporting Event Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7572 | Birth Reporting Message Structure (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7573 | Birth Reporting Message Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7574 | Birth Reporting Value Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7575 | Birth Reporting Observation Result Status (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7576 | Birth Weight Edit Flags (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7577 | Plurality Edit Flags (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7578 | Consolidated Ethinicity (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7579 | Weight Of Fetus Edit Flag (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7580 | Informant Relationship to Mother (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7581 | Birth Reporting Associated Party ID Type (NCHS) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7582 | Vital Records Education Level (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7583 | Birth Reporting Observation Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7584 | CCOFDI Observation Type (NCHS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7586 | JFDI Observation Type (NCHS) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7587 | JLBI Observation Type (NCHS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7588 | PSFDI Observation Type (NCHS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7589 | PSFFDI Observation Type (NCHS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7590 | PSFLBI Observation Type (NCHS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7591 | PSLBI Observation Type (NCHS) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7592 | PSMFDI Observation Type (NCHS) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7593 | Consolidated Race (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7594 | PSMLBI Observation Type (NCHS) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7596 | Adverse Event Severity (Malaria) | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7597 | Work Classification (ODH) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7598 | Baby Or Fetus Weight Unit Of Measure (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7599 | Birth Reporting Mother's NameType (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7600 | Birth Reporting Related Party Address Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7601 | Jurisdiction Certificate ID Type (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7603 | Fetal Death Reporting Associated Party Relation (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7604 | Route Method of Delivery SpontaneousProcedure (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7605 | Tobacco Use Unit Of Measure (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7606 | Live Birth Reporting Associated Party Relation (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7607 | Type of Testing at CDC | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7610 | Gender Identity (STD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7611 | Clinical Manifestations (STD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7613 | Job Supervisory Level or Pay Grade (ODH) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7614 | Case Appraisal (CRS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7617 | Organism (FDD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7618 | Yes No Unknown Refused (NND) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7619 | Antibiotics (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7620 | Antacids (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7622 | Positive Negative Not Done | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7623 | Test Method (FDD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7624 | Performing Lab Type (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7625 | Test Type (FDD) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7626 | Test Result (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7628 | Yes No Unknown Maybe (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7629 | Yes No Don't Know Maybe (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7630 | Drinking Water (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7631 | Recreational H2O Treatment (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7632 | Raw Unpasteurized Products (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7634 | Sexual Contact (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7635 | Medication Administered (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7636 | Medical History (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7637 | Seafood Preparation (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7638 | Seafood Source (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7639 | Shellfish Distributed (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7640 | Improper Handling Storage (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7641 | Harvest Region (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7642 | Harvest Classification (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7643 | Vibrio Species (FDD) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7646 | Vaccine Received (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7647 | Typhoid Paratyphoid Serotype (FDD) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7648 | Yes No Not Tested (NND) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7652 | Mailing Address Indicator (NCHS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.7655 us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.923 | Order Control Code (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.925 | Pharmacy Order Type (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.927 | Administrative Sex (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.928 | True False (TF) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.930 | Chest XRay Result | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason | active | 2021-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.934 | Vaccines administered (CVX) | active | 2022-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.941 | Susceptibility Result | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.945 | Industry (SIC) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.946 | Specimen | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.950 | Passed Failed Unknown | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.954 | BioSense Observations | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.957 | Abnormal Chest X-Ray Finding (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.958 | Acknowledgment Code (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.960 | Specimen Additive or Preservative (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.961 | Address Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.962 | Procedure (ICD-9 CM) | active | 2010-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.963 | Consequence of Adverse Event | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.964 | Adverse Event Previously Reported | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.965 | Amplification and Extraction Kit | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.967 | Body site | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.968 | Case Classification Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.969 | Case investigation closure reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.970 | Case Investigation Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.972 | Case Verification (TB) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.973 | City | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.974 | Message Error Condition Codes (HL7) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.975 | Comment Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.976 | Confidentiality Code (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.977 | Contact Role | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.979 | Type of Correctional Facility | active | 2019-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.980 | Diagnosed by (VZ) | active | 2017-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.983 | Sites of Directly Observed Therapy (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.984 | Dwelling Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.985 | Employment Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.986 | Encoding Type (HL7) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.989 | Countermeasure Encounter Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.990 | Specimen Handling Code | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.991 | Environmental Investigation Reason | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.992 | Epilinked Case Type (VZ) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.993 | Error Severity (HL7) | active | 2018-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.994 | General Condition Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.996 | History Source (CRA) | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.998 | HIV Status | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.11.999 | Identifier Type | active | 2008-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) | active | 2020-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/2.16.840.1.114222.4.5.301 | Immunization Service Funding Eligibility Value Set | active | 2009-01 | |
| us.cdc.phinvads | R4 | http://phinvads.cdc.gov/fhir/ValueSet/6.1.4.1.19376.1.7.3.1.1.13.8.64 | Limb Reduction Defect (NCHS) | active | 2014-01 | |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/qualification | Qualification | active | 2022-04 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/region | SignalRegion | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceReferred | SignalServiceReferred | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestAuthorizedAmount | SignalServiceRequestAuthorizedAmount | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestDateOfReferral | SignalServiceRequestDateOfReferral | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestGuardian | SignalServiceRequestGuardian | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestNoOfUnits | SignalServiceRequestNoOfUnits | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFee | SignalServiceRequestParentFee | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestParentFlatRate | SignalServiceRequestParentFlatRate | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestPatient | SignalServiceRequestPatient | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestProvider | SignalServiceRequestProvider | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestReferringOrg | SignalServiceRequestReferringOrg | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsClientID | SignalServiceRequestTrailsClientID | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsCountyHouseholdID | SignalServiceRequestTrailsCountyHouseholdID | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalServiceRequestTrailsID | SignalServiceRequestTrailsID | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/StateActivityStatus | SurveyStateActivityStatus | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/StructureDefinition/patient-adoptionInfo | Patient Adoption Info | draft | 2023-06 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/StructureDefinition/no-fixed-address | Patient No Fixed Address | draft | 2023-05 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/documentreference | DocumentReference Profile | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/account | Account Profile | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/encounter | Encounter Profile | active | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/episodeofcare | EpisodeOfCare Profile | active | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/healthcareservice | HealthcareService Profile | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/invoice | Invoice | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/location | Location Profile | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/organization | Organization Profile | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/patient | Patient Profile | draft | 2023-06 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/practitionerrole | PractitionerRole Profile | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/SignalQuestionnaireResponse | SignalQuestionnaireResponse | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/StructureDefinition/servicerequest | ServiceRequest Profile | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/omb-race-category | OMB Race Categories | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/contact-attempt-results | Contact Attempt Results | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-category | Signal Healthcare Service Category | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-program | Signal Program | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-healthcare-service-type | Signal Healthcare Service Type | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-organization-license | Signal Organization License | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/CodeSystem/signal-organization-type | Signal Organization Type | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/place-of-service | Place Of Service | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/progress-made-towards-goals | Progress Made Towards Goals | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/provider-taxonomy-na | Provider Taxonomy NA | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-activity-involvement-rating | Questionnaire CCARS Overall Activity Involvement Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-aggression-danger-to-others-rating | Questionnaire CCARS Aggression Danger To Others Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-alcohol-use-rating | Questionnaire CCARS Alcohol Use Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-cognition-rating | Questionnaire CCARS Cognition Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-considerations-for-providers | Questionnaire CCARS Considerations For Providers | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-issues | Questionnaire CCARS Current Issues | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-non-prescription-substance-use | Questionnaire CCARS Current Non-Prescription Substance Use | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-current-primary-role | Questionnaire CCARS Current Primary Role | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-depressive-issues-rating | Questionnaire CCARS Depressive Issues Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-disabilities | Questionnaire CCARS Disabilities | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-drug-use-rating | Questionnaire CCARS Drug Use Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-empowerment-rating | Questionnaire CCARS Empowerment Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-enrollment-payer | Questionnaire CCARS Enrollment Payer | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-ethnicity | Questionnaire CCARS Ethnicity | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-family-rating | Questionnaire CCARS Family Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-gender | Questionnaire CCARS Gender | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-highest-education-level | Questionnaire CCARS Highest Education Level | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-current-victimization | Questionnaire CCARS History Current Victimization | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-issues | Questionnaire CCARS History Of Issues | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-hope-rating | Questionnaire CCARS Hope Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-interpersonal-rating | Questionnaire CCARS Interpersonal Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-rating | Questionnaire CCARS Legal Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-multiple-issues-rating | Questionnaire CCARS Multiple Issues Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-level-of-functioning-rating | Questionnaire CCARS Overall Level Of Functioning Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-recovery-rating | Questionnaire CCARS Overall Recovery Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-overall-symptom-severity-rating | Questionnaire CCARS Overall Symptom Severity Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-physical-health-rating | Questionnaire CCARS Physical Health Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-psychosis-rating | Questionnaire CCARS Psychosis Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-race | Questionnaire CCARS Race | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-role-performance-rating | Questionnaire CCARS Role Performance Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-development | Questionnaire CCARS School Development | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-school-problems | Questionnaire CCARS School Problems | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-security-supervision-rating | Questionnaire CCARS Security Supervision Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-self-care-basic-needs-rating | Questionnaire CCARS Self Care Basic Needs Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-sexual-orientation | Questionnaire CCARS Sexual Orientation | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-social-support-rating | Questionnaire CCARS Social Support Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-socialization-rating | Questionnaire CCARS Socialization Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-suicide-danger-to-self-rating | Questionnaire CCARS Suicide Danger To Others Rating | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-tobacco-use | Questionnaire CCARS Tobacco Use | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-discharge | Questionnaire CCARS Type Of Discharge | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-type-of-update | Questionnaire CCARS Type Of Update | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-na | Questionnaire CCARS Yes No NA | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no-unable-to-assess | Questionnaire CCARS Yes No Unable To Assess | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-ccars-yes-no | Questionnaire CCARS Yes No | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-admission-route-of-administration | Questionnaire DACODS Admission Route Of Administration | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-client-disability | Questionnaire DACODS Client Disability | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-clinician-diagnostic-impression | Questionnaire DACODS Clinician Diagnostic Impression | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals | Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-route-of-administration | Questionnaire DACODS Discharge Route Of Administration | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-discharge-status | Questionnaire DACODS Discharge Status | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-drug-type-code | Questionnaire DACODS Drug Type Code | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-education-employment-problems | Questionnaire DACODS Education Employment Problems | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-employment-status | Questionnaire DACODS Employment Status | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-family-issues-and-problems | Questionnaire DACODS Family Issues And Problems | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-health-insurance-status | Questionnaire DACODS Health Insurance Status | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-living-situation | Questionnaire DACODS Living Situation | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-marital-status | Questionnaire DACODS Marital Status | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-medical-physical-problems | Questionnaire DACODS Medical Physical Problems | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-reason-for-discharge | Questionnaire Dacods Reason For Discharge | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-secondary-tertiary-drug-type-code | Questionnaire DACODS Secondary Tertiary Drug Type Code | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-sexual-orientation | Questionnaire DACODS Sexual Orientation | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-socialization-problems | Questionnaire DACODS Socialization Problems | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-illicit-drugs | Questionnaire DACODS Source Of Illicit Drugs | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-income | Questionnaire DACODS Source Of Income | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-source-of-payment-for-treatment | Questionnaire DACODS Source Of Payment For Treatment | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-statutory-commitment | Questionnaire DACODS Statutory Commitment | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-tobacco-use | Questionnaire DACODS Tobacco Use | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-transfer-referral-source | Questionnaire DACODS Transfer Referral Source | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-na | Questionnaire DACODS Yes No NA | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unable-to-assess | Questionnaire DACODS Yes No Unable To Assess | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no-unknown | Questionnaire DACODS Yes No Unknown | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/questionnaire-dacods-yes-no | Questionnaire DACODS Yes No | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/reason-for-discharge | Reason For Discharge | draft | 2023-08 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-classification | Signal FileRepo Classification | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://signalbhn.org/fhir/us/core/CodeSystem/signal-filerepo-docreviewstatus | Signal FileRepo Doc Review DocStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/CodeSystem/signal-region | Signal Region | active | 2023-09 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/CodeSystem/signal-state-activity-status | Signal State Activity Status | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-observation-category | US Core Screening Assessment Observation Category | active | 2023-03 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/account-status | AccountStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/account-type | Account Types | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/fips-county-co | CO FIPS Counties | draft | 2023-06 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/address-type | AddressType | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/address-use | AddressUse | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/birthsex | Birth Sex | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/chargeitem-status | ChargeItemStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/composition-status | CompositionStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-clinical | Condition Clinical Status Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-severity | Condition/Diagnosis Severity | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/condition-ver-status | ConditionVerificationStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/contact-attempt-results | Contact Attempt Results | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-class | Coverage Class Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-copay-type | Coverage Copay Type Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/coverage-financial-exception | Example Coverage Financial Exception Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/data-absent-reason | DataAbsentReason | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/days-of-week | DaysOfWeek | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/detailed-ethnicity | Detailed ethnicity | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/detailed-race | Detailed Race | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/device-action | Procedure Device Action Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/device-kind | FHIR Device Types | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/diagnosis-role | DiagnosisRole | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-classcodes | Document Class Value Set | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-reference-status | DocumentReferenceStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/document-relationship-type | DocumentRelationshipType | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-admit-source | Admit source | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-diet | Diet | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-location-status | EncounterLocationStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-participant-type | Participant type | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-special-arrangements | Special arrangements | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-special-courtesy | Special courtesy | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/encounter-status | EncounterStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/episode-of-care-status | EpisodeOfCareStatus | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/episodeofcare-type | Episode of care type | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/event-status | EventStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/c80-facilitycodes | Facility Type Code Value Set | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/fm-status | Financial Resource Status Codes | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/formatcodes | DocumentReference Format Code Set | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.32 | Gender Identity | active | 2022-03 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-category | Signal Healthcare Service Category | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/healthcare-service-procedure-code-cpt | HealthCare Service Procedure Code CPT | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-program | Signal Program | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-healthcare-service-type | Signal Healthcare Service Type | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/identifier-use | IdentifierUse | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/invoice-priceComponentType | InvoicePriceComponentType | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/invoice-status | InvoiceStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/languages | Common Languages | draft | 2016-08 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-mode | LocationMode | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-physical-type | Location type | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/location-status | LocationStatus | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/observation-category | Observation Category Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/observation-status | ObservationStatus | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/omb-ethnicity-category | OMB Ethnicity Categories | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/organization-role | Organization Affiliation Role | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-organization-license | Signal Organization License | draft | 2023-07 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-organization-type | Signal Organization Type | draft | 2023-07 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/performer-role | Procedure Performer Role Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/place-of-service | Place Of Service | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-category | Procedure Category Codes (SNOMED CT) | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-followup | Procedure Follow up Codes (SNOMED CT) | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-not-performed-reason | Procedure Not Performed Reason (SNOMED-CT) | active | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/procedure-outcome | Procedure Outcome Codes (SNOMED CT) | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/progress-made-towards-goals | Progress Made Towards Goals | draft | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/provider-taxonomy | Provider Taxonomy Codes | draft | 2023-03 | hl7 |
| signal.core.r4 | R4 | http://terminology.hl7.org/ValueSet/v2-2.7-0360 | v2 table 0360, Version 2.7 | active | | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/questionnaire-answers-status | QuestionnaireResponseStatus | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-action-types | Questionnaire CCARS Action Types | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-activity-involvement-rating | Questionnaire CCARS Overall Activity Involvement Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-aggression-danger-to-others-rating | Questionnaire CCARS Aggression Danger To Others Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-alcohol-use-rating | Questionnaire CCARS Alcohol Use Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-cognition-rating | Questionnaire CCARS Cognition Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-considerations-for-providers | Questionnaire CCARS Considerations For Providers | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-issues | Questionnaire CCARS Current Issues | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-non-prescription-substance-use | Questionnaire CCARS Current Non-Prescription Substance Use | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-current-primary-role | Questionnaire CCARS Current Primary Role | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-depressive-issues-rating | Questionnaire CCARS Depressive Issues Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-disabilities | Questionnaire CCARS Disabilities | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-drug-use-rating | Questionnaire CCARS Drug Use Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-empowerment-rating | Questionnaire CCARS Empowerment Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-enrollment-payer | Questionnaire CCARS Enrollment Payer | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-ethnicity | Questionnaire CCARS Ethnicity | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-existence-presenting-problem | Questionnaire CCARS Existence Presenting Problem | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-family-rating | Questionnaire CCARS Family Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-gender | Questionnaire CCARS Gender | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-highest-education-level | Questionnaire CCARS Highest Education Level | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-current-victimization | Questionnaire CCARS History Current Victimization | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-issues | Questionnaire CCARS History Of Issues | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-history-of-mental-health-services | Questionnaire CCARS History Of Mental Health Services | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-hope-rating | Questionnaire CCARS Hope Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-interpersonal-rating | Questionnaire CCARS Interpersonal Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-rating | Questionnaire CCARS Legal Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-marital-status | Questionnaire CCARS Marital Status | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-medication-psychiatric-service | Questionnaire CCARS Medication Psychiatric Service | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-mental-health-services-program | Questionnaire CCARS Mental Health Services Program | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-multiple-issues-rating | Questionnaire CCARS Multiple Issues Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-level-of-functioning-rating | Questionnaire CCARS Overall Level Of Functioning Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-recovery-rating | Questionnaire CCARS Overall Recovery Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-overall-symptom-severity-rating | Questionnaire CCARS Overall Symptom Severity Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-physical-health-rating | Questionnaire CCARS Physical Health Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-place-of-residence | Questionnaire CCARS Place Of Residence | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-previous-concurrent-services | Questionnaire CCARS Previous Concurrent Services | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-psychosis-rating | Questionnaire CCARS Psychosis Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-race | Questionnaire CCARS Race | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-rae-aso-identification-codes | Questionnaire CCARS RAE ASO Identification Codes | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-role-performance-rating | Questionnaire CCARS Role Performance Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-development | Questionnaire CCARS School Development | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-school-problems | Questionnaire CCARS School Problems | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-security-supervision-rating | Questionnaire CCARS Security Supervision Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-self-care-basic-needs-rating | Questionnaire CCARS Self Care Basic Needs Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-sexual-orientation | Questionnaire CCARS Sexual Orientation | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-social-support-rating | Questionnaire CCARS Social Support Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-socialization-rating | Questionnaire CCARS Socialization Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-suicide-danger-to-self-rating | Questionnaire CCARS Suicide Danger To Others Rating | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-tobacco-use | Questionnaire CCARS Tobacco Use | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-discharge | Questionnaire CCARS Type Of Discharge | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-type-of-update | Questionnaire CCARS Type Of Update | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-na | Questionnaire CCARS Yes No NA | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no-unable-to-assess | Questionnaire CCARS Yes No Unable To Assess | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-ccars-yes-no | Questionnaire CCARS Yes No | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-admission-route-of-administration | Questionnaire DACODS Admission Route Of Administration | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-client-disability | Questionnaire DACODS Client Disability | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-clinician-diagnostic-impression | Questionnaire DACODS Clinician Diagnostic Impression | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-progress-towards-measurable-treatment-goals | Questionnaire DACODS Discharge Progress Towards Measurable Treatment Goals | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-route-of-administration | Questionnaire DACODS Discharge Route Of Administration | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-discharge-status | Questionnaire DACODS Discharge Status | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-drug-type-code | Questionnaire DACODS Drug Type Code | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-education-employment-problems | Questionnaire DACODS Education Employment Problems | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-employment-status | Questionnaire DACODS Employment Status | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-family-issues-and-problems | Questionnaire DACODS Family Issues And Problems | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-health-insurance-status | Questionnaire DACODS Health Insurance Status | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-living-situation | Questionnaire DACODS Living Situation | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-marital-status | Questionnaire DACODS Marital Status | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-medical-physical-problems | Questionnaire DACODS Medical Physical Problems | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-reason-for-discharge | Questionnaire Dacods Reason For Discharge | draft | 2023-09 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-secondary-tertiary-drug-type-code | Questionnaire DACODS Secondary Tertiary Drug Type Code | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-sexual-orientation | Questionnaire DACODS Sexual Orientation | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-socialization-problems | Questionnaire DACODS Socialization Problems | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-illicit-drugs | Questionnaire DACODS Source Of Illicit Drugs | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-income | Questionnaire DACODS Source Of Income | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-source-of-payment-for-treatment | Questionnaire DACODS Source Of Payment For Treatment | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-statutory-commitment | Questionnaire DACODS Statutory Commitment | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-tobacco-use | Questionnaire DACODS Tobacco Use | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-transfer-referral-source | Questionnaire DACODS Transfer Referral Source | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-na | Questionnaire DACODS Yes No NA | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unable-to-assess | Questionnaire DACODS Yes No Unable To Assess | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no-unknown | Questionnaire DACODS Yes No Unknown | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/questionnaire-dacods-yes-no | Questionnaire DACODS Yes No | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/reason-for-discharge | Reason For Discharge | active | 2023-06 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/referencerange-appliesto | Observation Reference Range Applies To Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/referencerange-meaning | Observation Reference Range Meaning Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/service-provision-conditions | ServiceProvisionConditions | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/service-referral-method | ReferralMethod | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/request-intent | RequestIntent | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/servicerequest-orderdetail | Service Request Order Details Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/request-priority | RequestPriority | draft | 2016-07 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/request-status | RequestStatus | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/service-type | Service type | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-classification | Signal FileRepo Classification | draft | 2023-09 | hl7 |
| signal.core.r4 | R4 | http://signalbhn.org/fhir/us/core/ValueSet/signal-filerepo-docreviewstatus | Signal FileRepo DocStatus | draft | 2023-09 | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-organization-qualification | Signal Organization Qualification | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/ValueSet/signal-region | Signal Region | draft | | hl7 |
| signal.core.r4 | R4 | https://signalbhn.org/fhir/us/core/ValueSet/signal-state-activity-status | Signal State Activity Status | draft | 2023-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/subscriber-relationship | SubscriberPolicyholder Relationship Codes | draft | 2019-11 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/contact-point-system | ContactPointSystem | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/ValueSet/contact-point-use | ContactPointUse | draft | 2019-10 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-discharge-disposition | US Core Discharge Disposition | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-encounter-type | US Core Encounter Type | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-problem-or-health-concern | US Core Problem or Health Concern | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-screening-assessment-condition-category | US Core Screening Assessment Condition Category | active | 2023-04 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-servicerequest-category | US Core ServiceRequest Category Codes | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-simple-observation-category | US Core Simple Observation Category | active | 2022-09 | hl7 |
| signal.core.r4 | R4 | http://hl7.org/fhir/us/core/ValueSet/us-core-usps-state | USPS Two Letter Alphabetic Codes | active | 2022-09 | hl7 |
| tiga.health.clinical | R4 | http://tigahealth.com/SearchParameter/tiga-allergyintolerance-encounter | TigaAllergyIntoleranceEncounter | active | 2022-09 | |
| tiga.health.clinical | R4 | http://tigahealth.com/SearchParameter/tiga-immunization-encounter | TigaImmunizationEncounter | active | 2022-10 | |
| tiga.health.clinical | R4 | https://www.ama-assn.org/cdt | CDT, The Code on Dental Procedures and Nomenclature, produced by American Dental Association (ADA) | active | | |
| tiga.health.clinical | R4 | http://www2a.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx | HL7 Table 0292, Vaccine Administered (CVX) is a product of the National Center of Immunization and Respiratory Diseases (NCIRD). NCIRD is part of the Centers for Disease Control and Prevention (CDC). | active | | |
| tiga.health.clinical | R4 | http://dicom.nema.org/ | DICOM defines how to format images and image quality requirements that aid the exchange of images for clinical use. | active | | |
| tiga.health.clinical | R4 | http://tigahealth.com/fhir/ConceptMap/cpt-hcpcs | | active | | |
| tiga.health.clinical | R4 | http://tigahealth.com/fhir/ConceptMap/dicom-loinc | | active | | |
| tiga.health.clinical | R4 | http://tigahealth.com/fhir/ConceptMap/hcpcs-cpt | | active | | |
| tiga.health.clinical | R4 | http://tigahealth.com/fhir/ConceptMap/loinc-dicom | | active | | |
| tiga.health.clinical | R4 | http://tigahealth.com/fhir/ConceptMap/snomed-dicom | | active | | |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/CapabilityStatement/client | Argonaut Provider Directory Client | draft | 2016-11 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/CapabilityStatement/server | Argonaut Provider Directory Server | draft | 2017-04 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/ImplementationGuide/ig | Argonaut Provider Directory Implementation Guide | draft | | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-endpoint | Argonaut Provider Directory Endpoint | draft | 2016-11 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-location | Argonaut Provider Directory Location | draft | 2016-11 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-organization | Argonaut Provider Directory Organization | draft | 2016-11 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-practitioner | Argonaut Provider Directory Practitioner | draft | 2016-11 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/StructureDefinition/argo-practitionerrole | Argonaut Provider Directory PractitionerRole | draft | 2016-11 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/ValueSet/provider-role | Argonaut Provider Directory Provider Role (NUCC) | draft | 2016-08 | hl7 |
| fhir.argonaut.pd | R3 | http://fhir.org/guides/argonaut-pd/ValueSet/provider-specialty | Argonaut Provider Directory Provider Speciality (NUCC) | draft | 2016-08 | hl7 |
| hl7.fhir.us.patient-reported-outcomes | R4 | CapabilityStatement/server | Server | draft | 2017-03 | hl7 |
| hl7.fhir.us.patient-reported-outcomes | R4 | ImplementationGuide/ig | Patient Reported Outcomes | draft | | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ConceptMap/ndc-cvx | Argonaut NDC to CVX Code Mapping | active | 2016-06 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ImplementationGuide/ig | Implementation Guide Template | draft | | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/OperationDefinition/docref | Argonaut Get DocumentReferences | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/SearchParameter/ethnicity | ArgonautEthnicity | draft | 2016-12 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/SearchParameter/race | ArgonautRace | draft | 2016-12 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-allergyintolerance | Argonaut AllergyIntolerance Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-birthsex | Sex of patient assigned at birth | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-careplan | Argonaut CarePlan Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-careteam | Argonaut CareTeam Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-condition | Argonaut Condition Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-device | Argonaut Device Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-diagnosticreport | Argonaut DiagnosticReport Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-documentreference | Argonaut DocumentReference Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-ethnicity | Argonaut ethnicity Extension | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-goal | Argonaut Goal Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-immunization | Argonaut Immunization Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-medication | Argonaut Medication Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-medicationorder | Argonaut MedicationOrder Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-medicationstatement | Argonaut MedicationStatement Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-observationresults | Argonaut Observation Results Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-patient | Argonaut Patient Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-procedure | Argonaut Procedure Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-profile-link | Profile-Resource Association | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-race | Argonaut Race Extension | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-resource-documentation | Resource level Documentation | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-smokingstatus | Argonaut Smoking Status Observation Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/StructureDefinition/argo-vitalsigns | Argonaut Vital Signs Observation Profile | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/argo-codesystem | Argonaut Extension Codes | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/condition-category | Argonaut Condition Category Codes | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/detailed-ethnicity | US-Core Detailed ethnicity | draft | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/detailed-race | US-Core Detailed Race | draft | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/device-kind | Argonaut Device Types | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/languages | All Languages | draft | 2016-11 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/medication-codes | Medication Clinical Drug (RxNorm) | draft | 2016-05 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/narrative-status | Narrative Status | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/ndc-vaccine-codes | Vaccine National Drug Code (NDC) | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/observation-ccdasmokingstatus | Smoking Status | active | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/observation-ccdavitalsignresult | Argonaut Vital Sign Codes | active | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/observation-value-codes | Observation Value Codes (SNOMED-CT) | draft | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/omb-ethnicity | OMB Ethnicity Categories | draft | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/omb-race | OMB Race Categories | active | 2016-05 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/procedure-icd10pcs | Argonaut Procedure Type ICD-10-PCS Codes | draft | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/procedure-type | Argonaut ProcedureType | draft | 2016-05 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/provider-role | Care Team Provider Roles | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance-ndfrt | DAF Substance ND-FRT codes | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance-rxnorm | DAF Substance RxNorm Codes | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance-sct | DAF SNOMED CT Substances Other Than Clinical Drugs | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/substance | Argonaut Substance-Reactant for Intolerance and Negation Codes | draft | 2016-10 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/ucum-vitals-common | Argonaut Vital Signs Units | draft | 2016-05 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/ucum | UCUM units | draft | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/usrealm-birthsex | USRealm Birth Sex Value Set | active | 2016-08 | hl7 |
| fhir.argonaut.r2 | R2 | http://fhir.org/guides/argonaut/ValueSet/vacc-status | Argonaut Immunization Status | draft | 2016-10 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-datamart | Data Mart | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-datasource | Data Source | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-research-queryrequester | Research Query Requester | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/CapabilityStatement/daf-research-queryresponder | Research Query Responder | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/CodeSystem/daf-research-data-models | DAF Research Data Models | draft | 2017-04 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/CodeSystem/daf-research-query-formats | DAF Research Query Formats | draft | 2017-04 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/ImplementationGuide/ig | Implementation Guide Template | draft | | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-execute-query | Execute Query | draft | 2016-07 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-extract | Extract Data | draft | 2016-07 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/OperationDefinition/daf-load | Load Data | draft | 2016-07 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-capabilitystatement | U.S. Data Access Framework (DAF) Capability Statement Profile | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-data-model | Data Models | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-operationdefinition | U.S. Data Access Framework (DAF) OperationDefinition Profile | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-provenance | U.S. Data Access Framework (DAF) Provenance | draft | 2014-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-query-format | Query Formats | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-queryresults | U.S. Data Access Framework (DAF) Query Results | draft | 2014-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/StructureDefinition/daf-task | U.S. Data Access Framework (DAF) Task Profile | draft | 2016-08 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-data-models | DAF Research Data Models | active | 2016-07 | hl7 |
| hl7.fhir.us.daf | R3 | http://hl7.org/fhir/us/daf-research/ValueSet/daf-research-query-formats | DAF Research Query Formats | active | 2016-07 | hl7 |
| fhir.tx.support.r4 | R4 | urn:oid:2.16.840.1.113883.3.1937.98.5.8 | TemplateStatusCode LifeCycle | active | 2013-12 | hl7 |
| fhir.tx.support.r4 | R4 | https://www.humanservices.gov.au/organisations/health-professionals/enablers/air-vaccine-code-formats | Australian Immunisation Register Vaccine | active | 2021-03 | hl7 |
| fhir.tx.support.r4 | R4 | http://cap.org/eCP | College of American Pathologists Electronic Cancer Protocol (eCP) Codes | active | 2023-03 | hl7 |
| fhir.tx.support.r4 | R4 | http://terminology.hl7.org/CodeSystem/ICHContextOfUse | ICH Context of Use | active | 2025-05 | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/CodeSystem/MDC-concept-status | MDC Concept Status | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/CodeSystem/MDC-designation-use | MDC Designation Use | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://standardterms.edqm.eu | EDQM Standard Terms | active | 2019-03 | hl7 |
| fhir.tx.support.r4 | R4 | http://terminology.hl7.org/CodeSystem/hl7-document-format-codes | HL7 Document Format Codes | active | 2019-07 | hl7 |
| fhir.tx.support.r4 | R4 | urn:oid:2.16.840.1.113883.2.9.6.2.7 | International Standard Classification of Occupations (ISCO) | active | 2007-12 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/spdx-license | SPDXLicense | draft | 2021-01 | hl7 |
| fhir.tx.support.r4 | R4 | https://www.usps.com/ | US State Codes | active | 2013-12 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/resource-names-r2-r3 | Resource Names R2 to R3 | active | 2019-01 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/resource-names-r2-r4 | Resource Names R2 to R4 | active | 2019-01 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/resource-names-r3-r2 | Resource Names R3 to R2 | active | 2019-01 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/resource-names-r3-r4 | Resource Names R3 to R4 | active | 2019-01 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/resource-names-r4-r2 | Resource Names R4 to R2 | active | 2019-01 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/resource-names-r4-r3 | Resource Names R4 to R3 | active | 2019-01 | hl7 |
| fhir.tx.support.r4 | R4 | http://fhir.org/packages/fhir.tx.support.r4/ImplementationGuide/fhir.tx.support.r4 | FHIR Terminology Support Package | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/ValueSet/MDC-dimension | MDC Unit of Measurement | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/ValueSet/MDC-metric | MDC Metric nomenclature | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/ValueSet/MDC-object | MDC Object infrastructure and Device nomenclature | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/ValueSet/MDC-partition | MDC Partition codes | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://devices.fhir.org/ValueSet/MDC | MDC Nomenclature | active | | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-gps-uv-ips | Allergy-intolerance substance-product - GPS - IPS | active | 2021-05 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/uv/ips/ValueSet/allergy-intolerance-substance-product-snomed-extended-uv-ips | Allergy intolerance substance product - SNOMED CT extended - IPS | active | 2021-05 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/ValueSet/covid-19-cond | COVID-19 related Condition codes | draft | 2020-03 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/ValueSet/covid-19-obs | COVID-19 related Observation codes | draft | 2020-03 | hl7 |
| fhir.tx.support.r4 | R4 | http://hl7.org/fhir/ValueSet/jurisdiction-common | Common Jurisdiction Codes | active | 2020-09 | hl7 |
| fhir.tx.support.r4 | R4 | http://terminology.hl7.org/ValueSet/snomed-intl-ips | SNOMED CT® International Patient Set (IPS) | active | 2022-06 | hl7 |
| fhir.tx.support.r4 | R4 | https://www.iana.org/time-zones | IANA Timezones | draft | 2021-01 | hl7 |
| hl7.fhir.us.sdcde | R3 | CapabilityStatement/sdc-de-curator | SDC Data Element Curator | draft | 2014-07 | hl7 |
| hl7.fhir.us.sdcde | R3 | CapabilityStatement/sdc-de-registry | SDC Data Element Manager | draft | 2014-07 | hl7 |
| hl7.fhir.us.sdcde | R3 | ImplementationGuide/sdcde | Structured Data Capture - Data Element Exchange | draft | | hl7 |
| hl7.fhir.us.sdcde | R3 | StructureDefinition/sdcde-codesystem | Structured Data Capture Code System | draft | 2014-07 | hl7 |
| hl7.fhir.us.sdcde | R3 | StructureDefinition/sdcde-dataelement | Structured Data Capture Data Element Exchange | draft | 2014-04 | hl7 |
| hl7.fhir.us.sdcde | R3 | StructureDefinition/sdcde-valueset | Structured Data Capture Data Element Exchange Value Set | draft | 2014-07 | hl7 |
| hl7.fhir.us.sdcde | R3 | ValueSet/dataelement-sdccode | DataElement SDC Concept | draft | 2017-04 | hl7 |
| hl7.fhir.us.immds | R4 | CodeSystem/ForecastReason | Forecast Reason | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | CodeSystem/ForecastStatus | Forecast Status | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | CodeSystem/StatusReason | Evaluation Status Reason | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | ImplementationGuide/hl7.fhir.us.immds | Immunization Decision Support Forecast (ImmDS) Implementation Guide | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | OperationDefinition/ImmDSForecastOperation | Immunization Decision Support Forecast | draft | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | StructureDefinition/immds-immunization | ImmDS Immunization | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | StructureDefinition/immds-immunizationevaluation | ImmDS Immunization Evaluation | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | StructureDefinition/immds-immunizationrecommendation | ImmDS Immunization Recommendation | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | StructureDefinition/immds-patient | ImmDS Patient | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | ValueSet/ForecastReason | Forecast Reason | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | ValueSet/ForecastStatus | Forecast Status | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | ValueSet/StatusReason | Evaluation Status Reason | active | 2021-06 | hl7 |
| hl7.fhir.us.immds | R4 | ValueSet/targetDisease | Vaccine Target Disease | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | ImplementationGuide/us.nlm.vsac | US VSAC Package | active | | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.1280649 | Sneezing and Itching Grouping | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.15972546 | Conditions Indicating Appropriate Sinonasal Imaging | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16432390 | Cerumen Impaction | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.16929355 | Allergic Rhinitis Grouping | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.18316962 | Severe Asthma | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.19613338 | Immunoglobulin G Testing Grouping | active | 2022-03 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.23618223 | Hearing Aids Grouping | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.24927846 | Specific IgE testing | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.26050446 | Ear Surgery Affecting the Tympanic Membrane | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.26878039 | Specific IgE Testing | active | 2022-03 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.29996863 | Immunoglobulin G testing | active | 2017-06 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.13925.17760.4352590 | Benign Prostatic Hyperplasia | active | 2017-08 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.2.91.8867.26816.649902 | Office or Outpatient Encounter | active | 2017-07 | |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.33895.1.3.0.45 | Comfort Measures | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.15.1.999.1 | Selected non pharmaceutical therapies for moderate to severe chronic pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.1.999.3 | selected first line medications for pain control | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.11.1.999.3 | selected muscle relaxants for pain control | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.16.1.12.1.999.3 | Selected topical agents for pain control | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.1.999.2 | selected non opioids for moderate to severe pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.13.1.17.1.11.1.999.2 | Selected opioids for moderate to severe pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.13.18.1.1.11.1.999.1 | pain medication action plan | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.2.1.1.999.1 | Selected urine drug screens for opioids indicating testing is complete | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.15.7.1.1.11.1.999.1 | selected follow up visit intervals for opioid monitoring | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.2 | Selected urine screening for patients receiving opioid therapy | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.1 | Opioids used for pain control | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.3.2 | All prescribable opioids used for pain control including Inactive Medications | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.1 | malignant neoplasms and cancer pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.2 | malignant neoplasms and cancer pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.7 | malignant neoplasms and cancer pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.234.999.4.9 | malignancy or cancer related pain | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.150 | Cerumen on Otoscopy | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.151 | Cerumen on Otoscopy | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31172.1.1.999.152 | Cerumen on Otoscopy | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.172 | Hearing Loss | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.173 | Hearing Loss | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.12.1.999.174 | Hearing Loss | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.175 | Tinnitus | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.176 | Tinnitus | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.13.1.999.177 | Tinnitus | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.14.1.999.178 | Ear Congestion | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.15.1.999.179 | Ear Pruritus | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.180 | Otalgia | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.181 | Otalgia | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31182.1.16.1.999.182 | Otalgia | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31441.1.2.999.96 | Initial Encounter with Otolaryngologist or undefined clinician | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.204 | Hearing Aids | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.205 | Hearing Aids | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.13.31471.1.11.1.999.206 | Hearing Aids | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.81 | Cerumen Impaction | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31212.1.1.999.82 | Cerumen Impaction | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.188 | Radiotherapy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.189 | Radiotherapy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.1.999.190 | Radiotherapy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.191 | Head and Neck Anatomic Locations | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.192 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31305.1.11.2.999.193 | Conditions Associated with Head and Neck Radiotherapy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.194 | Ear Canal Stenosis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.195 | Ear Canal Stenosis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31317.1.1.999.196 | Ear Canal Stenosis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.197 | Exostoses | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.198 | Exostoses | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31329.1.1.999.199 | Exostoses | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.200 | Non intact Tympanic Membrane | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.201 | Non Intact Tympanic Membrane | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31341.1.1.999.202 | Non Intact Tympanic Membrane | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.246 | Hearing Aids | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.11.1.999.250 | DO NOT USE | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.251 | Cerumenolytics | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.252 | Irrigation | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31481.1.12.1.999.253 | Irrigation | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31593.1.12.1.999.288 | Otoscopy performed on exam | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.15.31663.1.1.999.291 | Otolaryngologist as a Clinician or Service | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.8.31102.1.1.999.123 | Cerumen Impaction | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31104.1.1.999.275 | Dermatologic Diseases of the Ear | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31108.1.1.999.20 | Keratoses Obturans | active | 2017-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.221 | Tympanoplasty | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.11.1.999.222 | Tympanoplasty | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.223 | Myringoplasty | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.12.1.999.224 | Myringoplasty | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.225 | Mastoidectomy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.13.1.999.229 | Mastoidectomy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.227 | Ear Surgery, Other | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.265.9.31112.1.14.1.999.228 | Ear Surgery, Other | active | 2018-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.334 | Sleep Apnea | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.335 | Sleep Apnea | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.12.31833.1.1.999.336 | Sleep Apnea | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.237 | Allergic Rhinitis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.238 | Allergic Rhinitis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34853.1.1.999.239 | Allergic Rhinitis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.263 | Uncontrolled or severe asthma | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.264 | Uncontrolled or severe asthma | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.34951.1.11.1.999.265 | Uncontrolled or severe asthma | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.300 | Rhinosinusitis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.301 | Rhinosinusitis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.11.1.999.302 | Rhinosinusitis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.303 | Nasal Polyposis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.304 | Nasal Polyposis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.12.1.999.305 | Nasal Polyposis | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.306 | Suspected Nasal Neoplasm | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.307 | Suspected Nasal Neoplasm | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.13.1.999.308 | Suspected Nasal Neoplasm | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.309 | Other sinus conditions potentially requiring imaging | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35031.1.14.1.999.310 | Other sinus conditions potentially requiring imaging | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.11.1.999.319 | Intranasal Antihistamines | active | 2017-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.12.1.999.320 | Mast Cell Stabilizers | active | 2017-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35211.1.13.1.999.321 | Ophthalmic Antihistamines | active | 2017-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.215 | Sneezing as a finding | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.11.1.999.216 | Sneezing as a Clinical Condition | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.217 | Pruritus Unspecified or Other Location | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.13.35282.1.12.1.999.218 | Pruritus Unspecified or Other Location | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.11.1.999.272 | Specific IgE Testing for Allergies | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.12.1.999.273 | Immunoglobulin G Testing | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34907.1.13.1.999.274 | Total IgE Testing | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.34920.1.1.999.290 | Clinicians who perform allergy testing | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35043.1.1.999.279 | Radiography of face, head or neck | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.11.1.999.315 | Intranasal Corticosteroids | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.316 | Eustachian Tube Dysfunction | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.317 | Eustachian Tube Dysfunction | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35221.1.13.1.999.318 | Eustachian Tube Dysfunction | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35292.1.1.999.287 | Oral Second Generation and Less Sedating Antihistamines | active | 2017-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35464.1.1.999.266 | Leukotriene antagonist | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.11.1.999.267 | Immunotherapy that is not Identified as Subcutaneous | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.268.15.35607.1.14.1.999.268 | Immunotherapy | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37641.1.1.999.653 | Fidaxomicin | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.12.37696.1.1.999.654 | Proton Pump Inhibitors not including for H. pylori treatment | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.655 | Clostridium difficile infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.656 | Clostridium difficile infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.37752.1.1.999.657 | Clostridium difficile infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38167.1.1.999.594 | Complete Blood Count (with Diff) | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38256.1.1.999.662 | Metronidazole Systemic | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38266.1.1.999.663 | Vancomycin non injectable | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38343.1.1.999.665 | Creatinine | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.722 | Ileus due to infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.723 | Ileus due to infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.11.1.999.724 | Ileus due to infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.725 | Vomiting potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.726 | Vomiting potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.12.1.999.727 | Vomiting potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.728 | Toxic Megacolon in adults | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.729 | Toxic Megacolon in adults | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.13.1.999.730 | Toxic Megacolon in adults | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.731 | Abdominal Distension | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38398.1.14.1.999.732 | Abdominal Distension | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.688 | Septic Shock due to C. Diff | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.689 | Septic Shock due to C. Diff | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.13.38493.1.1.999.690 | Septic Shock due to C. Diff | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.658 | Antiperistaltic agents to avoid in C. diff | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37872.1.1.999.734 | Systemic Antimicrobial Medications not used for CDI | active | 2019-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.11.1.999.659 | Recurrent Clostridium difficile infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.37937.1.13.2.999.660 | History of CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38112.1.1.999.661 | Consult Infectious Disease | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38827.1.1.999.691 | Abdominal Xrays for CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38839.1.1.999.692 | CT of abdomen with contrast for fulminant CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.38904.1.1.999.693 | Surgical consult for CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.15.39406.1.1.999.694 | Fecal microbiota transplantation | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.4.37623.1.1.999.645 | Hospitalist | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.697 | Positive result indicator | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37627.1.1.999.698 | Clostridium Difficile Test | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.646 | Body Temperature | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.11.1.999.647 | Body Temperature | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.648 | Diarrhea Potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.649 | Diarrhea Potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.12.1.999.650 | Diarrhea Potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.8.37631.1.13.1.999.651 | Leukocyte count | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/1.3.6.1.4.1.6997.4.1.2.271.9.37637.1.1.999.652 | Inpatient Setting | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1 | ONC Administrative Sex | active | 2015-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.1 | Substance Reactant for Intolerance | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.2 | Clinical Substance | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.4 | Medication Clinical Drug | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.5 | Medication Clinical Brand specific Drug | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.6 | CVX Vaccines Administered Vaccine Set | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.7 | Clinical Drug Ingredient | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.8 | Vaccine Clinical Drug | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1010.9 | Substance Other Than Clinical Drug | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.240 | SNOMED CT CORE Problem List | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1018.98 | Route of Administration | active | 2019-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.101 | Gender Identity USCDI core | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.102 | Unknown or did not answer | active | 2021-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.103 | Other or unknown or refused to answer | active | 2021-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.12 | Low Molecular Weight Heparin for VTE prophylaxis ingredient specific | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.120 | Patient Sex for Quality Measurement | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.121 | Federal Administrative Sex | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.14 | Published test VS | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.24 | Birth Sex | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.30 | AdministrationUnitDoseForm | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.33 | Sexual Orientation | active | 2021-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.40 | MDP Test Intensional | active | 2019-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.41 | MDP Test HL7 Intensional | active | 2019-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.46 | Device Magnetic resonance (MR) Safety | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.47 | Device Latex Safety | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.48 | Implantable Device Status | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.56 | Medical Reason Not Done SCT | active | 2019-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.119 | Phototherapy | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.120 | Phototherapy | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.121 | Phototherapy | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.122 | Neonatal Jaundice | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.123 | Neonatal Jaundice | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.124 | Neonatal Jaundice | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.125 | Maternal Drug Use | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.126 | Maternal Drug Use | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.127 | Maternal Drug Use | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.128 | Fetal Conditions | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.129 | Fetal Conditions | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.130 | Fetal Conditions | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.131 | Congenital Malformations | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.132 | Congenital Malformations | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.133 | Congenital Malformations | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.134 | Social Indications | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.135 | Social Indications | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.136 | Social Indications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.137 | Neonatal Severe Birth Trauma | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.138 | Neonatal Severe Birth Trauma | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.139 | Neonatal Severe Birth Trauma | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.140 | Neonatal Severe Hypoxia or Asphyxia | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.141 | Neonatal Severe Hypoxia or Asphyxia | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.142 | Neonatal Severe Hypoxia or Asphyxia | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.143 | Neonatal Severe Shock and Resuscitation | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.144 | Neonatal Severe Shock and Resuscitation | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.145 | Neonatal Severe Shock and Resuscitation | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.146 | Neonatal Severe Respiratory Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.147 | Neonatal Severe Respiratory Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.148 | Neonatal Severe Respiratory Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.149 | Neonatal Severe Infection | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.150 | Neonatal Severe Infection | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.151 | Neonatal Severe Infection | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.152 | Neonatal Severe Neurological Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.153 | Neonatal Severe Neurological Complications | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.154 | Neonatal Severe Neurological Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.155 | Neonatal Severe Shock and Resuscitation Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.156 | Neonatal Severe Shock and Resuscitation Procedures | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.157 | Neonatal Severe Shock and Resuscitation Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.158 | Neonatal Severe Respiratory Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.159 | Neonatal Severe Respiratory Procedures | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.160 | Neonatal Severe Respiratory Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.161 | Neonatal Severe Neurological Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.162 | Neonatal Severe Neurological Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.163 | Neonatal Severe Neurological Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.164 | Neonatal Severe Septicemia | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.165 | Neonatal Severe Septicemia | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.166 | Neonatal Severe Septicemia | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.167 | Neonatal Moderate Birth Trauma | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.168 | Neonatal Moderate Birth Trauma | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.169 | Neonatal Moderate Birth Trauma | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.170 | Neonatal Moderate Respiratory Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.171 | Neonatal Moderate Respiratory Complications | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.172 | Neonatal Moderate Respiratory Complications | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.173 | Neonatal Moderate Respiratory Complications Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.174 | Neonatal Moderate Respiratory Complications Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.175 | Neonatal Moderate Respiratory Complications Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.176 | Neonatal Moderate Birth Trauma with LOS | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.177 | Neonatal Moderate Birth Trauma with LOS | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.178 | Neonatal Moderate Birth Trauma with LOS | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.179 | Neonatal Moderate Respiratory Complications with LOS | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.180 | Neonatal Moderate Respiratory Complications with LOS | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.181 | Neonatal Moderate Respiratory Complications with LOS | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.182 | Moderate Neurological Complications with LOS Procedures | active | 2019-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.183 | Neonatal Moderate Neurological Complications with LOS Procedures | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.184 | Neonatal Moderate Neurological Complications with LOS Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.185 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.186 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.187 | Neonatal Moderate Respiratory complications with LOS Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.188 | Single Liveborn Newborn Vaginal | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.189 | Single Liveborn Newborn Vaginal | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.190 | Single Liveborn Newborn Vaginal | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.191 | Single Liveborn Newborn Cesarean | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.192 | Single Liveborn Newborn Cesarean | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.193 | Single Liveborn Newborn Cesarean | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.194 | Birth Weight | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.195 | Neonatal Moderate Infection with LOS | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.196 | Neonatal Moderate Infection with LOS | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.197 | Neonatal Moderate Infection with LOS | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.203 | Neonatal Intensive Care Unit | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.204 | Intensive Care Unit | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.205 | Neonatal Intensive Care Unit | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.206 | Intensive Care Unit | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.208 | Blood Transfusion Administration | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.209 | Blood Transfusion Administration | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.213 | Blood Transfusion | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.214 | Acute Respiratory Distress Syndrome | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.217 | Amniotic Fluid Embolism | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.219 | Aortic Aneurysm | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.220 | Aortic Aneurysm | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.221 | Cardiac Arrest Ventricular Fibrillation | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.223 | Disseminated Intravascular Coagulation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.225 | Eclampsia | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.227 | Heart Failure Cardiac Arrest Related to Procedure or Surgery | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.228 | Heart Failure Cardiac Arrest Related to Procedure or Surgery | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.229 | Puerperal Cerebrovascular Disorder | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.231 | Pulmonary Edema | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.233 | Acute Heart Failure | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.235 | Severe Anesthesia Complications | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.237 | Sepsis | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.239 | Shock | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.24 | Blood Transfusion Administration | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.241 | Sickle Cell Disease with Crisis | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.243 | Air and Thrombotic Embolism | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.245 | Blood Transfusion | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.246 | Blood Transfusion | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.247 | Conversion of Cardiac Rhythm | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.248 | Conversion of Cardiac Rhythm | active | 2021-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.249 | Hysterectomy | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.250 | Hysterectomy | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.251 | Tracheostomy | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.252 | Tracheostomy | active | 2021-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.253 | Ventilation | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.254 | Ventilation | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.255 | Severe Maternal Morbidity Diagnoses | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.256 | Severe Maternal Morbidity Procedures | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.267 | Gestational Diabetes | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.269 | Gestational Diabetes | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.271 | HIV in Pregnancy Childbirth and Puerperium | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.272 | HIV in Pregnancy Childbirth and Puerperium | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.274 | Preexisting Diabetes | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.275 | Preexisting Diabetes | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.277 | Previous Cesarean | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.278 | Previous Cesarean | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.279 | Pulmonary Hypertension | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.281 | Pulmonary Hypertension | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.282 | Multiple Pregnancy | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.284 | Multiple Pregnancy | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.286 | Bleeding Disorder | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.287 | Bleeding Disorder | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.289 | Morbid or Severe Obesity | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.290 | Morbid or Severe Obesity | active | 2022-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.291 | Economic Housing Instability | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.292 | Economic Housing Instability | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.295 | Thyrotoxicosis | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.296 | Thyrotoxicosis | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.297 | Preterm Birth | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.299 | Preterm Birth | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.300 | Placenta Accreta | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.302 | Placenta Accreta | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.303 | Placental Abruption | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.305 | Placental Abruption | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.306 | Neuromuscular Disease | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.308 | Neuromuscular Disease | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.309 | Autoimmune Disease | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.311 | Autoimmune Disease | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.312 | Mental Health Disorder | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.314 | Mental Health Disorder | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.315 | Bariatric Surgery | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.317 | Bariatric Surgery | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.318 | Substance Abuse | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.320 | Substance Abuse | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.321 | Anemia | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.323 | Anemia | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.324 | Severe Preeclampsia | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.326 | Mild or Moderate Preeclampsia | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.327 | Severe Preeclampsia | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.329 | Mild or Moderate Preeclampsia | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.330 | Hypertension | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.332 | Hypertension | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.333 | Renal Disease | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.335 | Renal Disease | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.336 | Gastrointestinal Disease | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.338 | Gastrointestinal Disease | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.339 | Cardiac Disease | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.341 | Cardiac Disease | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.344 | Aortic Aneurysm | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.357 | Conversion of Cardiac Rhythm | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.358 | Hysterectomy | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.359 | Tracheostomy | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.360 | Ventilation | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.361 | Venous Thromboembolism in Pregnancy | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.363 | Venous Thromboembolism in Pregnancy | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.364 | Long Term Anticoagulant Use | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.366 | Long Term Anticoagulant Use | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.368 | Preadmission Observation Undelivered Mother | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.369 | ED Visit and OB Triage | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.370 | Present on Admission is No or Unable To Determine | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.371 | COVID 19 Confirmed | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.372 | COVID 19 Confirmed | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.373 | COVID 19 Confirmed | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.374 | Respiratory Conditions Related to COVID 19 | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.375 | Respiratory Conditions Related to COVID 19 | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.376 | Respiratory Conditions Related to COVID 19 | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.377 | Respiratory Support Procedures | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.378 | Respiratory Support Procedures | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.379 | Respiratory Support Procedures Related to COVID 19 | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.387 | Placenta Increta or Percreta | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.388 | Placenta Increta or Percreta | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.67 | Other Health Care Facility | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.10 | Non essential Hypertension SNOMEDCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.102 | Suicide Attempt | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.11 | Cirrhosis ICD9CM | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.12 | Cirrhosis ICD10CM | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.14 | Cirrhosis | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.151 | Polycystic Ovary Syndrome | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.16 | Low Intensity Statin Therapy/Branded | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.17 | Moderate Intensity Statin Therapy/Branded | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.18 | High Intensity Statin Therapy/Branded | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.21 | ALT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.230 | Gestational Diabetes SNOMED CT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.231 | Gestational Diabetes ICD10CM | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.233 | All Results of High Risk HPV Test | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.234 | High Risk HPV Positive Results | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.26 | Nonopioid pain medications | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.263 | High Risk Positive HPV Results Without HPV16 or HPV18 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.265 | CDS Pregnancy Intensional | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.267 | CDS Rhabdomyolysis | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.268 | HPV Negative Results | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.27 | Non pharmacologic treatments for chronic pain ICD10PCS | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.28 | Urine drug screen for pain management | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.29 | Non pharmacologic treatments for chronic pain SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.292 | Non pharmacologic treatments for chronic pain NCI | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.296 | SCT Findings 202209 | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.298 | Cervical Cytology Test | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.299 | HPV 16 Tests | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.300 | HPV 18 Tests | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.303 | Statin Combinations | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.305 | Counseling for Physical Activity CPT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.306 | Counseling for Physical Activity ICD10CM | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.307 | Counseling for Physical Activity CDS | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.309 | SCT Findings 202309 | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.311 | SCT Procedures 202209 | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.312 | SCT Procedures 202309 | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.313 | Statin Allergen Grouping | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.319 | Steward Transfer Test | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.320 | Opioids ATCPROD N02A | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.322 | Test 123 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.34 | Opioid pain medications | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.36 | Non pharmacologic treatments for chronic pain | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.40 | Suicide attempt | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.42 | Naloxone and Nalmefene medications | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.43 | Benzodiazepine medications | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.44 | Stool softeners and laxatives | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.47 | Anxiety | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.48 | Anxiety | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.50 | Sleep disordered breathing | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.51 | Sleep disordered breathing | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.52 | Anxiety | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.53 | Sleep disordered breathing | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.54 | Adjuvant pain medications | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.55 | Risk assessments relevant to pain management | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.6 | Non essential Hypertension ICD9CM | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.7 | Non essential Hypertension ICD10CM | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.79 | Behavioral Counseling for Nutrition and Activity Referral | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.85 | Impaired Glucose Tolerance | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.87 | Fasting Plasma Glucose | active | 2023-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.88 | Waist Circumference | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.9 | Hypertension | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.90 | Gestational Diabetes | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.92 | First Degree Family Member | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.94 | Glucose Tolerance Test Results | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1032.99 | Gestational Diabetes | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.460 | Cluster Headache (ICD10CM) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.461 | Cluster Headache (ICD9CM) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.464 | Cluster Headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.467 | Medication Therapy for Cluster Headache (RXNORM) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.555 | Patient Declines Treatment for Cluster Headache (SNOMEDCT) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.558 | Acute Cluster Headache Medication (RXNORM) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.559 | Long Term Preventive Medication for Cluster Headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.561 | Oral Steroid for Cluster Headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.569 | Migraine Preventive Medication | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.601 | Acute Migraine Attack Medication | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.605 | NSAID OTC Migraine Attack Medication | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.606 | NSAID Prescribable Migraine Attack Medication | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.640 | Neurologic Disorders | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.641 | Neuromodulation for migraine | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.642 | No pain with headache | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.643 | Antiplatelets | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.644 | Anticoagulants | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.645 | Statin Medications | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.646 | Anxiety Disorders (ICD10 and SNOMED) | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.648 | Depression Diagnosis (ICD10 and SNOMED) | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.649 | Psychosis (ICD10 and SNOMED) | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.650 | Cluster Headache (SNOMED) | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.651 | Galcanezumab (RxNorm) | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.652 | Lithium (RxNorm) | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.653 | Verapamil | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.654 | Long term preventive medications for cluster headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.655 | Short term preventive medication for cluster headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.656 | Zolmitriptan | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.657 | Sumatriptan | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.658 | Dihydroergotamine | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.659 | Acute cluster headache medication | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.660 | Acute cluster headache treatment | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.661 | Short term preventive treatment for cluster headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.662 | Long term preventive treatment for cluster headache | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.663 | Migraine diagnosis (ICD) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.664 | Prescribable NSAIDs and Acute Migraine Attack Medication | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.103 | Abnormal Presentation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.105 | Abnormal Presentation | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.114 | Hematocrit Lab Test | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.117 | Potassium Lab Test | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.119 | Sodium Lab Test | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.127 | Platelet Count Lab Test | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.129 | White Blood Cells Count Lab Test | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.130 | Respiratory Rate | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.134 | Glucose Lab Test | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.139 | Bicarbonate Lab Test | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.15 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.151 | Oxygen Saturation by Pulse Oximetry | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.152 | Body Temperature | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.159 | Body Weight | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.16 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.163 | Systolic Blood Pressure | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.171 | Abnormal Presentation | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.173 | Delivery of Singleton | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.26 | Estimated Gestational Age at Delivery | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.27 | Cornual Ectopic Pregnancy | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.38 | General Or Neuraxial Anesthesia | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.39 | Low Dose Unfractionated Heparin for VTE Prophylaxis | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.41 | Glycoprotein IIb IIIa Inhibitors | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.55 | Oxytocin | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.56 | Dinoprostone | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.58 | Delivery Procedures | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.59 | Delivery Procedures | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.66 | PCI | active | 2017-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.67 | PCI | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.68 | Endotracheal Intubation | active | 2018-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.69 | Endotracheal Intubation | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.98 | Delivery of Singleton | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.99 | Delivery of Singleton | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.225 | Opioid Medication Assisted Treatment (MAT) SNOMED | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.241 | Schedule II, III and IV Opioid Medications | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.242 | Opioid Use Disorder | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.243 | Opioid Use Disorder | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.265 | Inpatient, Emergency, and Observation Locations | active | 2022-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.269 | Medications for Opioid Use Disorder (MOUD) | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.274 | NHSN Inpatient Encounter Class Codes | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.277 | Emergency Department Location | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.278 | Emergency Department Treatment Location | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.279 | Triage | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.283 | Emergency Department Location | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.284 | Emergency Department Location | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.285 | Mental Health Diagnosis without Substance Use Disorders | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.286 | Decision to Transfer | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1046.35 | Healthcare Agent or Proxy Choices | active | 2022-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.10 | Breastfeeding | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.100 | Familial Hypercholesterolemia | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.102 | Rhabdomyolysis | active | 2017-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.107 | Low Intensity Statin Therapy | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.12 | Liver Disease | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.13 | Rhabdomyolysis | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.19 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.20 | Atherosclerosis and Peripheral Arterial Disease | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.21 | Atherosclerosis and Peripheral Arterial Disease | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.22 | Liver Disease ICD9 | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.37 | Stable and Unstable Angina | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.39 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.41 | Ischemic Heart Disease or Related Diagnoses | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.42 | Liver Disease | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.43 | Liver Disease | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.44 | Cerebrovascular Disease Stroke or TIA | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.46 | Ischemic Heart Disease or Related Diagnoses | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.47 | Stable and Unstable Angina | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.501 | Overweight or Obese | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.502 | Overweight or Obese | active | 2018-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.512 | Elevated Blood Pressure Reading | active | 2019-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.513 | Elevated Blood Pressure Reading | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.514 | Finding of Elevated Blood Pressure or Hypertension | active | 2019-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.515 | Bariatric Procedures | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.517 | Age related macular degeneration intermediate dry | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.518 | Ophthalmologist visit | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.519 | Posterior vitreous detachment (PVD) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.521 | Ophthalmoscopic exam | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.523 | Opthalmoscopic exams with Scleral Depression | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.525 | Referral (ophthalmology) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.526 | Retina Ultrasound | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.527 | Retina visualization inadequate | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.528 | Refusal or Noncompliance with treatment | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.529 | Vitreous hemorrhage | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.530 | Vitreous hemorrhage | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.536 | Macula examination | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.539 | Fluorescein angiography | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.541 | Optical coherence tomography (OCT) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.542 | Intravitreal injection | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.543 | Bevacizumab injection | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.544 | Ranibizumab injection | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.545 | Aflibercept injection | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.552 | Uveitis | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.553 | Uveitis | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.554 | Post Cataract Surgery Cystoid Macular Edema AND Idiopathic Macular Edema | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.555 | Macular edema | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.556 | Corticosteroids for Injection | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.557 | Corticosteroids for Injection | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.560 | Tonometry | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.561 | Intraocular pressure | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.571 | Retinal Vein Occlusion Related Macular Edema | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.576 | Vitreous hemorrhage | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.580 | Intravitreal and Periocular Injections | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.581 | Intravitreal and Periocular Injections | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.582 | Corticosteroids for Injection | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.583 | Endophthalmitis in the Right Eye | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.584 | Endophthalmitis in the Left Eye | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.585 | Panophthalmitis in the Right Eye | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.586 | Panophthalmitis in the Left Eye | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.587 | Lost to follow up | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.588 | Uveitis | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.610 | Scleral depressed exam | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.611 | 3 Mirror Goldmann exam | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.612 | Scleral depressed exam | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.615 | Physical Disability | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.616 | Financial difficulty | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.617 | Vitreous exam findings | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.619 | Scleral depressed exam | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.629 | Post operative follow up | active | 2020-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.67 | Breastfeeding | active | 2017-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.69 | Stable and Unstable Angina | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.70 | Ischemic Heart Disease or Related Diagnoses | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.71 | Cerebrovascular Disease Stroke or TIA | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.73 | Breastfeeding | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.85 | Familial Hypercholesterolemia | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.89 | Rhabdomyolysis | active | 2017-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.9 | Outpatient Encounters for Preventive Care | active | 2019-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.91 | Familial Hypercholesterolemia | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.93 | Hypercholesterolemia ICD 9 | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.97 | High Intensity Statin Therapy | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.98 | Moderate Intensity Statin Therapy | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.50 | HIV Lab Tests | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.51 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.52 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.53 | Indicators of Human Immunodeficiency Virus (HIV) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1056.71 | Human Immunodeficiency Virus (HIV) Viral Load | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.10 | ARBs (Angiotensin Receptor Blockers) | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1000 | OIA_V2_GLP1s_RxNorms | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1001 | OIA_V2_PCSK9s_RxNorms | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1002 | OIA_RFs_Secondary_Prevention_ICD10 | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1003 | OIA_RFs_Secondary_Prevention_SNOMED | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1004 | OIA_RFs_Secondary_Prevention_CPT | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1005 | OIA_RFs_Secondary_Prevention_ICD_SM_CPT | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1006 | OIA_Asthma_COPD_Combo_Meds | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1007 | OIA_Asthma_COPD_Combo_Meds_SABA_SAMA | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1008 | OIA_Asthma_COPD_Combo_Meds_LABA_LAMA_ICS | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1009 | PAE_Patient_Conditions | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1012 | PAE Conditions Short | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1016 | OIA_TEST_VS | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1017 | Triptan Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1018 | NSAID Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1019 | Statin Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1021 | Penicillin Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1022 | Macrolide Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1023 | Quinolone Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1025 | Beta blocker Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1026 | ACE inhibitor Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1027 | ARB Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1028 | Sulfonylurea Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1030 | DPP4i Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1031 | GLP1RA Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1032 | Beta blocker allergy intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1033 | SGLT2i Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1034 | MRA Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1036 | Meglitinide Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1037 | Alpha glucosidase inhibitor Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1038 | TZD Allergy NDFRT | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1041 | Hemoglobin | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1042 | Hematocrit | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1043 | Anemia for Erythropoesis Simulating Agents I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1044 | Anemia for Erythropoesis Simulating Agents SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1045 | Anemia for Erythropoesis Simulating Agents | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1046 | AZT Meds | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1047 | Ferritin | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1048 | Knee pain I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1049 | Knee pain SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.105 | conditions_heartfailure | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1050 | Knee pain | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1051 | Knee decreased ROM SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1052 | Knee effusion I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1054 | Knee effusion | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1055 | Knee crepitus SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1056 | OIA_Antiemetics | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1057 | OIA_PDE5is | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1058 | OIA_Vitamins | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1059 | OIA_Plavix | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1061 | OIA_Oral_Contraceptives | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1063 | OIA_Topical_Steroids | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1064 | OIA_Cough_Cold_Meds | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1065 | Antiperspirant aluminum salts | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1066 | Antiperspirant anticholinergics | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1067 | Antieplieptic medications | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1068 | Antidepressant medications | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1069 | Urinary incontinence SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1070 | Urinary incontinence I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1071 | Urinary incontinence | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1073 | Hemifacial spasm SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1074 | Hemifacial spasm I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1075 | Hemifacial spasm | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1076 | Spasmodic dysphonia SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1077 | Physical therapy procedure SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1078 | Occupational therapy SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1079 | Hyperhidrosis SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1080 | Hyperhidrosis I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1081 | Hyperhidrosis | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1082 | Tic disorder I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1083 | Tic disorder SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1084 | Tic disorder | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1085 | Esophageal achalasia SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1086 | Esophageal achalasia I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1087 | Esophageal achalasia | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1088 | ET propanolol or primidone | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1089 | ET topiramate alprazolam or gabapentin | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.109 | CKD stage4above I10 | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1090 | Blephraospasm SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1091 | Blepharospasm I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1092 | Blepharospasm | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1093 | Strabismus SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1094 | Strabismus I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1095 | Strabismus | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1096 | Overactive bladder SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1097 | Overactive bladder I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1098 | Overactive bladder | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1099 | Movement disorders SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.110 | CKD stage4above SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1100 | Movement disorders I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1101 | Movement disorders | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1102 | Lateral epicondylitis SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1103 | Lateral epicondyltisis I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1104 | Lateral epicondylitis | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1105 | Plantar fasciitis SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1106 | Plantar fasciitis I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1107 | Plantar fasciitits | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1108 | Cardiac CT SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1109 | Cardiac CT CPT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.111 | CKD stage4above | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1111 | Cardiac CT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1112 | Cardiac MRI SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1113 | Cardiac MRI CPT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1114 | Cardiac MRI | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1115 | CT Angiography of Coronary Artery SCT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1116 | CT Angiography of Coronary Artery CPT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.1117 | CT Angiography of Coronary Artery | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.112 | Chronic kidney disease I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.113 | Chronic kidney disease SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.116 | DigTx Cognitive Impairment I10 | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.117 | DigTx Cognitive Impairment SCT | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.120 | Diabetic ketoacidosis SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.121 | Diabetic ketoacidosis | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.124 | DKD | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.146 | Long Acting Muscarinic Antagonists (LAMA) | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.147 | HFrEF SCT | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.148 | HFrEF I10 | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.15 | Kidney tansplant | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.150 | History of Hypoglycemia I10 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.151 | History of Hypoglycemia SCD | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.153 | Hyperlipidemia | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.159 | conditions_COPD I10 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.168 | medications_COPD | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.17 | Atrial fibrillation | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.173 | Asthma I10 | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.175 | Asthma | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.184 | DigTx Virtual Reality Contraindications Visual Impairment | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.186 | Beta blockers GDMT for heart failure | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.188 | medications_heart failure | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.189 | SGLT2i | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.193 | relatedconditions_COPD I10 | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.197 | Blood (Serum and Plasma) Potassium | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.202 | Serum Creatinine | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.21 | Thoracic aorta disease | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.214 | Type 1 Diabetes Mellitus SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.224 | Systolic Heart Failure I10 | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.226 | Systolic Heart Failure | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.238 | MRA mineralocorticoid receptor antagonists | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.244 | MRA Mineralocorticoid Receptor Antagonist Allergy | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.252 | relatedconditions_Heart failure I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.260 | UACR SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.263 | Pregnancy I10 | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.281 | Statins Allergy SCT | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.282 | Statin Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.292 | Metabolic syndrome I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.3 | Delivery I10 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.314 | relatedconditions_hyperlipidemia I10 | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.322 | Angina I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.325 | Tachyarrhythmia I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.337 | Migraine I10 | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.34 | Blood pressure panel | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.35 | Systolic Blood Pressure | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.350 | Coronary artery disease I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.367 | Trandolapril | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.369 | Candesartan | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.37 | relatedconditions_hypertension SCT | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.377 | Valsartan | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.38 | relatedconditions_hypertension I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.397 | eGFR | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.409 | Hypertension I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.412 | Statin Moderate Intensity | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.415 | LDL Cholesterol | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.43 | Urinalysis | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.434 | Insulin | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.437 | TZD Thiazolidinediones | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.438 | medications_T2DM | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.439 | relatedconditions_T2DM I10 | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.440 | relatedconditions_T2DM SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.442 | Blood Glucose | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.45 | ACE inhibitor allergy RXNORM | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.455 | Metabolic acidosis I10 | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.459 | Liver cancer | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.47 | ACE inhibitor allergy SCT | active | 2022-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.473 | Tetanus toxoid, diphtheria (Td) Vaccine | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.474 | Allergy to Tdap Vaccine | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.475 | Allergy to Td Vaccine | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.478 | Allergy to HPV Vaccine | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.481 | medications_hypertension | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.492 | Inhaled Corticosteroids Allergy | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.498 | Metformin AllergyIntolerance SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.5 | Delivery - Procedure | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.508 | Abdominal aortic imaging CPT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.516 | Allergy to Herpes Zoster Vaccine SCT | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.517 | Hemoglobin A1c | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.518 | Drug hypersensitivity I10 | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.521 | Diabetic Kidney Disease I10 | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.523 | Diabetic kidney disease | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.527 | OCS_Prednisone | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.528 | High Dose Non Combo ICS Adult | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.529 | Medium Dose Non Combo Asthma ICS Adult | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.530 | Low Dose Non Combo ICS | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.531 | Anti IgE Medications | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.532 | IL5 Antagonists | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.533 | Mast cell stabilizers for asthma | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.534 | Vasospastic disease I10 | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.536 | Vasospastic disease | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.537 | Hemiplegic and basilar migraine I10 | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.540 | Peptic ulcer disease I10 | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.544 | Bleeding disorder I10 | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.549 | Bleeding disorder | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.551 | Heart Rate | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.552 | Triptans | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.553 | CGRP receptor antagonists | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.554 | Ditans | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.555 | Ergots | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.556 | Migraine specific NSAIDs | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.557 | OTC migraine analgesics | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.558 | Butalbital analgesics | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.559 | medications_migraine_acute | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.560 | relatedconditions_migraine I10 | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.561 | conditions_migraine | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.567 | Ischemic bowel disease I10 | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.569 | Allergen Immunotherapy | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.570 | Allergy to house dust mites SCT | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.571 | Allergy to house dust mites I10 | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.572 | Allergy to house dust mites | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.573 | conditions_hyperlipidemia I10 | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.578 | PIM_Schedule V | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.580 | PIM_Acarbose | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.581 | PIM_Avandamet | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.582 | PIM_Dulaglutide | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.583 | PIM_Glimepiride | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.585 | PIM_Glucophage | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.587 | PIM_Glucovance | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.588 | Glyburide PIM | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.590 | Alpha glucosidase inhibitors | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.592 | Azotemia | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.595 | ICS Low | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.596 | ICS Medium | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.597 | ICS High | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.598 | Low Dose ICS Formoterol | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.599 | PIM_Vitamin B12 Level_LOINC_CPT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.600 | PIM_Vitamin B12 Level_LOINC | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.601 | PIM_Vitamin B12 Level_CPT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.604 | PIM_Glyburide | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.605 | PIM_Pioglitazone | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.606 | PIM_Semaglutide | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.607 | PIM_Linagliptin | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.609 | Macrolide_Azithromycin | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.61 | Secondary antihypertensives | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.610 | Long Acting Beta Agonists (LABA) Non_Formoterol | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.611 | relatedconditions_Asthma I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.613 | Wolff Parkinson White I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.615 | medications_Asthma | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.617 | HighICS_LABA_NonFormoterol | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.618 | relatedconditions_Asthma SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.619 | ICS_LABA_LAMA | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.620 | Low Dose ICS_LABA_Non Formoterol | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.621 | Medium ICS_LABA Non Formoterol | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.622 | relatedconditions_Asthma | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.629 | PIM_Refill_Request_Antilipemics_LFTs | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.638 | TZD Allergy SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.642 | T2DM_Medications Allergy RXNORM | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.667 | Herpes Zoster Vaccine Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.672 | LABA(Formoterol only) | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.674 | PIM_Tirzepatide | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.676 | PIM_Diabetes_Testing_Supplies | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.677 | PIM_H2_Antagonists | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.678 | SGLT2i DM CKD | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.679 | SGLT2i DM ASCVD | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.680 | GLP1RA DM ASCVD | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.683 | OIA_Gout_Medications | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.684 | GlumetzaSubstitution | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.685 | MetforminER500mg | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.686 | PIM_Metformin | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.687 | PIM_Glipizide | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.689 | PIM_Glipizide_Glyburide_Glimepiride | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.690 | PIM_Insulin_Meglitinides | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.691 | PIM_Glyxambi | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.692 | PIM_Farxiga | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.693 | PIM_Invokana | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.694 | PIM_Jardiance | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695 | PIM_Invokana_Jardiance | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.696 | Reclast | active | 2023-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.697 | LAMA_LABA Combination 1 Inhaler | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.698 | PIM_Contraceptives | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.699 | Selected Oral Antiemetics for Migraine | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.702 | PIM_SSRIs | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.703 | PIM_SNRIs | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.704 | PIM_NRIs | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.705 | PIM_TCAs | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.706 | PIM_Citalopram | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.707 | PIM_Hydroxyzine | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.708 | PIM_Buspirone | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.709 | PIM_Bupropion | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.710 | PIM_Mirtazapine | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.711 | PIM_Trazodone | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.712 | PIM_IHD_CHD_CAD_ICD10 | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.714 | PIM_Gabapentin | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.715 | PIM_Allergy_Nasal_Sprays | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.716 | PIM_Allergy_Oral_Meds | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.717 | PIM_Allergy_Nasal_Oral | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.719 | OCS_Prednisolone | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.72 | Inhaled corticosteroids (IC) | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.720 | COPD_Ofloxacin | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.721 | COPD_Ciprofloxacin | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.722 | COPD_Doxycycline | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.731 | Penicillin Allergy RXNORM | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.734 | PIM_Metformin_Single_Ingredient_Only | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.735 | PIM_Metformin_Combo_Ingredient_Only | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.736 | Pneumonia I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.738 | Pneumonia | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.739 | Pulmonary Embolism I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.744 | Influenza I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.745 | Influenza SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.747 | Influenza | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.748 | COVID 19 I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.749 | COVID19 SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.750 | COVID19 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.752 | RSV I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.753 | RSV SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.754 | RSV | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.757 | Respiratory Rate | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.758 | Acute Respiratory Failure I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.762 | Dyspnea I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.763 | Dyspnea | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.764 | Confusion I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.765 | Confusion SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.766 | Confusion | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.768 | Drowsiness I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.769 | Drowsiness | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.770 | Cyanosis I10 | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.772 | Cyanosis | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.779 | PIM_Potassium_Supplements | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.780 | PIM_PPIs | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.781 | PIM_Migraine_Medications_Abortive | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.782 | PIM_Migraine_Medications_Preventive | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.783 | PIM_Bisphosphonates | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.784 | PIM_BPH_Medications | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.785 | PIM_Thyroid_Replacement_Medications | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.786 | PIM_Overactive_Bladder_Medications | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.787 | PIM_Topical_Acne_Medications | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.788 | PIM_Antidepressant_Anxiolytic_Medications | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.789 | Simple Knee Pain I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.794 | Simple Right Knee Pain I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.795 | Simple Left Knee Pain I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.798 | Knee joint surgery CPT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.800 | Knee joint surgery | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.801 | Knee Osteoarthritis I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.806 | Osteoarthritis of right knee I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.807 | Osteoarthritis of left knee I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.811 | Hip Osteoarthritis I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.813 | Hip joint surgery CPT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.815 | Hip joint surgery | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.816 | Osteoarthritis of right hip I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.817 | Osteoarthritis of left hip I10 | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.822 | DigTx RelieVR inclusions I10 | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.823 | Aminoglycosides | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.824 | Carbapenems | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.826 | Monobactams | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.827 | Penicillins | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.828 | Antimycobacterials | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.829 | Beta_lactamase | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.830 | Cyclic lipopeptides | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.831 | Lincosamides | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.832 | Macrolides | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.833 | Amphenicol | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.834 | Oxazolidinones | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.835 | Fluoroquinolones | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.836 | Sulfonamides | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.837 | Tetracyclines | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.838 | Phosphonics | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.839 | Pleuromutilin | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.840 | Streptogramins | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.841 | Lipoglycopeptides | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.842 | Nitroimidazoles | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.843 | PIM_Hyd_Bus_Mir_Tra | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.844 | Nitrofurans | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.845 | Rifamycins | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.846 | Glycylcycline | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.847 | Pyrimidines | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.849 | Antibiotics oral and parenteral | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.85 | PCSK9i | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.850 | Medications_hyperkalemia | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.852 | Hyperkalemia_ICD10 | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.855 | Medications_Chronic Hyperkalemia | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.858 | PIM_Alpha_Blockers_2 | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.860 | PIM_Ambulatory_Visits_CPTs | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.869 | PIM_Migraine_Medications | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.870 | PIM_Triptans | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.871 | ICS_SABA Reliever | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.873 | PIM_Asthma_COPD_Meds | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.874 | PIM_Lipid_Panel_CPTs | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.875 | PIM_Hepatic_Function_Panel_CPTs | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.877 | Inflammatory bowel disease I10 | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.88 | DEPRECATED Diabetes | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.881 | Gastrointestinal obstruction I10 | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.883 | DPP4i Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.885 | Multiple endocrine neoplasia type 2 (MEN II) I10 | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.888 | Gastroparesis I10 | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.889 | Gastroparesis | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.890 | Meglitinide Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.891 | Sulfonylurea Allergy Intolerance | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.892 | Peripheral edema I10 | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.894 | Peripheral edema | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.895 | TZD Allergy Intolerance | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.896 | PIM_Beta_Blockers | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.897 | PIM_CCB_DHPs | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.898 | PIM_Loop_Diuretics | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.899 | PIM_Inhaled_Corticosteroids_(ICS) | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.9 | ACE inhibitors | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.90 | ASCVD I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.900 | PIM_Leukotrienes | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.901 | OIA_Asthma_COPD_Meds_Inhalers | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.902 | OIA_Asthma_COPD_Meds_Nebulizers | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.903 | OIA_Asthma_COPD_Meds_Oral | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.904 | OIA_GLP1_Injectables | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.905 | OIA_Insulin_Injectables | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.906 | OIA_Oral_Hypoglycemics | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.907 | OIA_DM1_DM2_Meds | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.908 | Medium Dose ICS Formoterol | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.909 | High Dose ICS Formoterol | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.910 | CKD stage5OrESRD I10 | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.914 | Anxiety_I10 | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.916 | Anxiety | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.918 | Stress_SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.919 | Stress_I10 | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.92 | ASCVD | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.920 | Stress | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.925 | PIM_CMP_CPTs | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.926 | Canagliflozin meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.927 | Empagliflozin meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.928 | Dapagliflozin meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.929 | Ertugliflozin meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.93 | Albuminuria I10 | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.930 | Dulaglutide meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931 | Liraglutide meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.932 | Semaglutide SC meds | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933 | T2DM meds benefitting ASCVD | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934 | T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935 | T2DM meds benefitting CKD stage 5 | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.936 | T2DM meds benefitting HF with eGFR >= 20 mL/min | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.939 | Crohn disease I10 | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.94 | Albuminuria SCT | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.940 | Crohn disease | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.942 | Celiac disease I10 | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.943 | Celiac disease | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.944 | OIA_Bisoprolol | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.945 | OIA_PVD_ICD10 | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.946 | Vibration Controlled Transient Elastography (VCTE) | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.947 | OIA_Antihypertensive_Medications | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.95 | Albuminuria | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.950 | OIA_CAD_ICD10 | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.951 | OIA_DM_ICD10 | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.959 | ACEi for HFrEF | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.96 | AlcoholicLiverDisease I10 | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.960 | ARB for HFrEF | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.961 | OIA_AntiHTN_Meds_Inclusion_List | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.962 | OIA_Thiazide_Diuretics | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.963 | OIA_RFs_ACS_ICD10 | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.966 | OIA_Aortic_Calcifications_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT | active | 2023-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.971 | Pioglitazone | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.972 | MASLD I10 | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.973 | MASLD SCT | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.974 | MASLD | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.975 | OIA_Sulfonylureas | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.976 | Ensifentrine | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.977 | Dupilumab | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.978 | OIA_RFs_ASCVD_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.98 | BMI LOINC | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.981 | OIA_TIA_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.984 | OIA_Angina_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.988 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.989 | OIA_Ischemic_Hemorrhagic_Stroke_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.99 | BMI SCT | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.990 | OIA_Ischemic_Hemorrhagic_Stroke_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.991 | OIA_Myocardial_Infarction_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.992 | OIA_Myocardial_Infarction_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.993 | OIA_Myocardial_Infarction_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.995 | OIA_PAD_ICD10 | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.996 | OIA_PAD_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.997 | OIA_PAD_ICD10_SNOMED | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.998 | OIA_Coronary_Arterial_Revascularization | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.5 | Contact or Office Visit | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.6 | Contact or Office Visit | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1080.7 | Contact or Office Visit | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.10 | Nutrition Diagnosis SNOMED CT | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.101 | Hospice Status | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.14 | Vitamin Mineral Supplement and Bioactive Substance Management SNOMED CT | active | 2020-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.17 | Pediatric Enteral Formulas SNOMED CT | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.18 | Modified Amino Acid Formulas SNOMED CT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.19 | Nutrition Counseling Approach and Strategies SNOMED CT | active | 2020-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.20 | Enteral Nutrition Management SNOMED CT | active | 2020-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.21 | Nutrition Assessment | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.24 | Malnutrition Assessment | active | 2015-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.25 | Nutritional Status Severely Malnourished | active | 2016-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.29 | Malnutrition Assessment | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.30 | Malnutrition Risk Screening | active | 2015-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.31 | Malnutrition At Risk | active | 2015-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.32 | Malnutrition Risk Screening | active | 2016-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.33 | Nutrition Assessment Procedure | active | 2015-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.34 | Malnutrition Screening Finding of Not At Risk Result | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.35 | Malnutrition Screening Not at Risk | active | 2015-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.38 | Malnutrition Screening Finding of At Risk Result | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.39 | Malnutrition Risk Screening | active | 2016-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.40 | Malnutrition Risk Screening | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.41 | Nutritional Status Severely Malnourished | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.42 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.43 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.44 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.45 | Nutritional Status Moderately Malnourished | active | 2015-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.46 | Nutritional Status Moderately Malnourished | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.47 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.48 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.49 | Nutrition Focused Physical Findings Grouping | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.5 | Adult Enteral Formulas SNOMED CT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.50 | Enteral Nutrition Composition SNOMED CT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.51 | Enteral Nutrition Composition Grouping | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.52 | Parenteral Nutrition Management SNOMED CT | active | 2020-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.53 | Malnutrition Diagnosis | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.54 | Malnutrition Diagnosis | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.55 | Malnutrition Diagnosis | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.56 | Malnutrition Diagnosis | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.58 | Nutrition Order Item Grouping | active | 2018-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.59 | Diet Item Grouping | active | 2018-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.60 | Edible Substances | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.61 | Feeding Device SNOMED CT | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.65 | Nutrition Recommendation Grouping | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.7 | Modular Nutrition Formulas SNOMED CT | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT | active | 2020-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.71 | Coordination of Care by a Nutrition Professional SNOMED CT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.73 | Nutrition Anthropometric Measurement SNOMED CT | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.74 | Nutrition Anthropometric Measure Panel LOINC | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.75 | Nutrition Anthropometric Measurements Grouping | active | 2018-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.76 | Manage Feeding Environment | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.77 | Special Food Items and Regime/Therapy for Special Food Items SNOMED CT | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.78 | Food and Nutrition Related History LOINC | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.79 | Nutrition Encounter Individual and Group CPT | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.80 | Nutrition Encounters HCPCS | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.81 | Nutrition Encounter Codes Grouping | active | 2018-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.84 | Food and Nutrition Related History SNOMED CT | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.87 | Feeding Device Grouping | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.88 | Nutrition Intervention Care Planning | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.89 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.90 | Medical Nutrition Therapy Procedures | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.91 | Dietitian Referral | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.92 | Malnutrition Risk Screening | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.93 | Nutrition Care Plan | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.94 | Malnutrition Screening Finding of At Risk Result | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.95 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.96 | Nutrition Assessment Status Finding of Well Nourished or Not Malnourished or Mildly Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.97 | Nutrition Assessment Status Finding of Severely Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.98 | Nutrition Assessment Status Finding of Moderately Malnourished | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1095.99 | Nutrition Diagnosis SNOMED CT (2) | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.1 | Findings Related to Medication Management, Referral Source | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.100 | Recommendations Related to Medication Regimen | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.101 | Interventions Related to Medication Regimen, Initiate Medication | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.102 | Interventions Related to Medication Regimen, Change Medication | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.103 | Interventions Related to Medication Regimen, Change Medication Dose | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.104 | Interventions Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.105 | Interventions Related to Medication Regimen, Change Medication Course | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.106 | Interventions Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.107 | Interventions Related to Medication Regimen, Discontinue Medication | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.109 | Interventions Related to Medication Regimen | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.11 | Interventions Related to Medication Management, Medication Reconciliation | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.110 | Interventions Related to Education, Medications | active | 2020-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.111 | Interventions Related to Education, Medical Equiptment and Devices | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.112 | Interventions Related to Medication Management, Notifications | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.113 | Interventions Related to Medication Management, Refill Synchronization | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.114 | Status of Patient Condition | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.115 | Interventions Related to Education, Diseases and Disorders | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.116 | Interventions Related to Education | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.118 | Interventions Related to Medication Management | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.119 | Interventions Related to Medication Management, Targeted Medication Review | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.120 | Interventions Related to Medication Management, Discussion | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.121 | Reasons for Interventions Related to Medication Management, Cost | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.122 | Interventions Related to Education, Immunizations | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.123 | Status of Recommendations | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.124 | Interventions Related to Medication Management, Provision of Documents | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.125 | Status of Compliance Ability | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.126 | Status of Interventions | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.127 | Status of Disease Control | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.128 | Status of Compliance | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.129 | Occupations of Providers | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.130 | Environments of Care | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.131 | Findings Related to Medication Management, Body Mass Index | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.132 | Findings Related to Medication Management, Alcohol Use | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.133 | Findings Related to Medication Management, Caffeine Use | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.134 | Interventions Related to Education, Diet | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.136 | Findings Related to Medication Management, Exercise | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.137 | Interventions Related to Education, Behavior | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.138 | Findings Related to Medication Management, Diet | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.139 | Status of Care Goal | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.140 | Findings Related to Medication Management, Illicit Drug Use | active | 2020-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.141 | Interventions Related to Administration, Immunizations | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.142 | Interventions Related to Care Coordination, Communication Needs | active | 2020-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.144 | Findings Related to Medication Management, Life Event | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.145 | Interventions Related to Medication Management, Device or Equipment Fitting | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.146 | Findings Related to Medication Management, Immunizations | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.148 | Findings Related to Medication Management, Cultural Beliefs | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.149 | Findings Related to Medication Management, Tobacco Use | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.150 | Interventions Related to Medication Regimen, Continue Medication | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.151 | Encounter Type | active | 2020-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.152 | Encounter Class | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.156 | Allergy/Intolerance Severity | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.16 | Reasons for Interventions Related to Medication Management | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.160 | Allergy/Intolerance Manifestation | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.162 | Allergy/Intolerance Substance & Negation | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.163 | Allergy/Intolerance Negation | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.165 | Interventions Related to Care Coordination, Benefit Management | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.166 | Interventions Related to Administration | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.167 | Interventions Related to Administration, Medications | active | 2020-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.168 | Findings Related to Medication Management, Eating Habits | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.169 | Findings Related to Medication Management, Tobacco Exposure | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.170 | Interventions Related to Care Coordination | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.176 | Interventions Related to Medication Management, Information Gathering | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.177 | Interventions Related to Medication Management, Care Planning | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.178 | Interventions Related to Medication Management, Documentation | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.179 | Allergy/Intolerance Substance, Food | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.180 | Allergy/Intolerance Substance, Environmental | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.182 | Encounter Reason | active | 2020-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.183 | Findings Related to Medication Management, Medication related | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.211 | PharmacyAllergyIntoleranceType | active | 2018-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.214 | PharmacyEducation | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.218 | Reasons for Interventions Related to Medication Management, Discontinue Medication | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.224 | Social Determinants of Health Problem Observation | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.225 | Laboratory results that are used in medication management | active | 2020-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.229 | COVID19 Related Disease, Test, or Exposure | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.230 | Maternity Health Interventions Value Set | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.231 | Social Determinants of Health Interventions | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.232 | Maternity Health Findings | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.233 | Reason Medication Discontinued Lack of Indication | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.234 | Reason Medication Discontinued Lack of Effectiveness | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.235 | Reason Medication Discontinued Safety Issue Occurred | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.236 | Reason Medication Discontinued Compliance Issue other than cost | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.237 | Recommendation to Resolve Medication Therapy Problem | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.239 | Reason Medication Discontinued Patient Unable to Afford | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.240 | Medication Lists | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.3 | Findings Related to Medication Management, Transitions Between Health Care Settings | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.35 | Interventions Related to Medication Management, Comprehensive Medication Review | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.5 | Reasons for Interventions Related to Medication Management, Unnecessary Therapy | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.53 | Reasons for Interventions Related to Medication Management, Adverse Events | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.55 | Reasons for Interventions Related to Medication Management, Adherence | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.56 | Findings Related to Medication Management, Multiple Providers | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.6 | Reasons for Interventions Related to Medication Management, New or Additional Therapy Required | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.60 | Findings Related to Medication Management, Health Literacy | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.61 | Findings Related to Medication Management | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.7 | Reasons for Interventions Related to Medication Management, Ineffective Therapy | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.8 | Reasons for Interventions Related to Medication Management, Dose Too Low | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.83 | Assessments Related to Medication Management, General Assessments | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.84 | Assessments Related to Medication Management | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.85 | Assessments Related to Medication Management, Assessments Using Assessment Scales | active | 2020-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.86 | Interventions Related to Medication Regimen, Monitoring | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.87 | Interventions Related to Care Coordination, Consultations | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.88 | Interventions Related to Care Coordination, Referrals to Other Providers | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.89 | Interventions Related to Care Coordination, Referrals for Specific Services | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.9 | Reasons for Interventions Related to Medication Management, Dose Too High | active | 2019-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.90 | Recommendations Related to Medication Regimen, Continue Medication | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.91 | Recommendations Related to Medication Regimen, Initiate Medication | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.92 | Recommendations Related to Medication Regimen, Change Medication | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.93 | Recommendations Related to Medication Regimen, Change Medication Dose | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.94 | Recommendations Related to Medication Regimen, Change Medication Dosage Form | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.95 | Recommendations Related to Medication Regimen, Change Medication Course | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.97 | Recommendations Related to Medication Regimen, Change Medication Dosing Interval | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.98 | Recommendations Related to Medication Regimen, Discontinue Medication | active | 2017-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1096.99 | Recommendations Related to Medication Regimen, Monitoring | active | 2021-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.10 | Care Plan Document Type | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.11 | Medication Status | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.12 | Medication Route | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.24 | Extended Pregnancy Status | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.29 | Allergy Clinical Status | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.30 | Care Team Member Function | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.33 | External Cause of Injury/Morbidity | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.35 | Arthritis Feedback Types (SNOMED) | active | 2019-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.36 | Arthritis Feedback Types (LOINC) | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.4 | DIRSectionTypeCodes LOINC | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.45 | Bidirectional Services eReferral Type | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.46 | Bidirectional Services eReferral Reason | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.49 | Disability Status Assessment | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.50 | Transport vehicle type | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.53 | Sex | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.54 | Specimen type | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.55 | At Home In Vitro Patient Questions | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.57 | Advance Directives Content Type | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.58 | Acute COVID 19 Diagnosis | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.1 | Case Management for Behavioral Health | active | 2021-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.63 | Case Management for Behavioral Health | active | 2021-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1102.64 | Case Management for Behavioral Health | active | 2021-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.10 | Medicare FFS Payer | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1104.12 | Medicare Advantage Payer | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.101 | Myocardial Infarction | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.124 | Follow Up Within 6 Months | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.125 | Follow Up Within 6 Months | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.126 | Bone Scan | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.127 | Bone Scan | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.15 | Hospice Care Ambulatory | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.175 | Office and Wellness Visits for General Screening | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.176 | Office and Wellness Visits for General Screening | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.177 | Office and Wellness Visits for General Screening | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.178 | Office and Wellness Visits for General Screening | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.179 | Hypertensive disorders in pregnancy | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.180 | Outpatient Prenatal Visit | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.182 | Eclampsia | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.183 | Gestational Hypertension | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.184 | Preexisting Hypertension in Pregnancy | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.185 | Postpartum Encounter | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.186 | Postpartum Encounter | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.187 | Postpartum Encounter | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.188 | Preexisting Hypertension in Pregnancy | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.189 | Spontaneous or Elective Abortion | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.190 | Spontaneous or Elective Abortion | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.191 | Preeclampsia or Eclampsia | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.192 | Spontaneous or Elective Abortion Procedure | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.193 | Spontaneous or Elective Abortion | active | 2024-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.28 | Non Acute Encounter Codes CPT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.29 | Non Acute Encounter Codes HCPCS | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.31 | Bleeding Event Diagnosis Codes ICD9 | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.78 | Statin Associated Muscle Symptoms | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.84 | Statin Associated Muscle Symptoms | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.85 | Statin Associated Muscle Symptoms | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1108.99 | Underweight | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.11 | Cornual Ectopic Pregnancy | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.12 | Cornual Ectopic Pregnancy | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.13 | Perforation of Uterus | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.14 | Perforation of Uterus | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.15 | Uterine Rupture | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.16 | Uterine Rupture | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.17 | Transabdominal Cerclage | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.18 | Transabdominal Cerclage | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.2 | Transabdominal Cerclage | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.21 | Intravenous or Intraarterial Thrombolytic tPA Therapy Prior to Arrival | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.23 | Intensive Care Unit | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.24 | Uterine Horn | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.25 | Metroplasty | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.3 | Medical Induction of Labor | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.35 | Placenta Previa | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.36 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.37 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.38 | Outpatient Surgery Service | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.41 | Statin Allergen | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.42 | Statin Allergen | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.50 | Rivaroxaban for VTE Prophylaxis | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.51 | Prasugrel | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.52 | Pharmacological Contraindications For Antithrombotic Therapy | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.53 | Acute Renal Failure | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.54 | Total Parenteral Nutrition | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.55 | Intravenous Thrombolytic tPA Therapy | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.56 | Intraarterial Thrombolytic tPA Therapy | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.57 | Ischemic Stroke Thrombosis | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.58 | Ischemic Stroke Thrombosis | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.59 | Ischemic Stroke Other | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.60 | Ischemic Stroke Other | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61 | Antithrombotic Therapy Antiplatelet | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.62 | Antithrombotic Therapy for Ischemic Stroke | active | 2021-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.63 | Present On Admission is Yes or Exempt | active | 2022-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.64 | Application of Venous Foot Pumps | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.65 | Application of Intermittent Pneumatic Compression Devices | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.66 | Application of Graduated Compression Stockings | active | 2022-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.67 | 20 to 42 Plus Weeks Gestation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.68 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.69 | 37 to 38 Weeks Gestation | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.70 | 20 to 42 Plus Weeks Gestation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.71 | 20 to 42 Plus Weeks Gestation | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.72 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.73 | 37 to 42 Plus Weeks Gestation | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.74 | 37 to 38 Weeks Gestation | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.75 | 37 to 38 Weeks Gestation | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.76 | History of Atrial Ablation | active | 2022-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.77 | Placenta Accreta Spectrum Previa or Vasa Previa | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.78 | Placenta Previa | active | 2023-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.126 | Hospital Settings | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.143 | Observation Services | active | 2021-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.146 | Buprenorphine | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.159 | All Primary and Secondary Cancer | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.161 | All Primary and Secondary Cancer | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.163 | Emergency Department Evaluation | active | 2020-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.164 | Admit Inpatient | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.166 | Codeine Schedule II and III | active | 2023-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.167 | Alfentanil | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.168 | Remifentanil | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.169 | Sufentanil | active | 2021-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.171 | Opioid Use Disorder | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.173 | Sickle Cell Disease with and without Crisis SNOMED | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.174 | Sickle Cell Disease with and without Crisis ICD | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.175 | Sickle Cell Disease with and without Crisis | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.176 | Opioid Medication Assisted Treatment (MAT) HCPCS | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.177 | Opioid Medication Assisted Treatment (MAT) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.178 | Cancer Related Pain ICD 10 | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.179 | Cancer Related Pain SNOMED | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1111.180 | Cancer Related Pain | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.10 | Care Experience Preferences at End of Life LOINC | active | 2024-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.11 | Care Experience Preferences Grouping | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.12 | Healthcare Agent Ordinality | active | 2020-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.14 | ADIClauseTypeVS | active | 2022-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.15 | Upon Death Preferences | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.17 | Preconditions for Treatment Preferences | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.18 | Treatment Intervention Preferences at End of Life Ordinal LOINC | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.19 | Obligation or Prohibition Instruction Type Grouping | active | 2023-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.2 | InstructionActStatus | active | 2017-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.20 | Advance Healthcare Directive Witness roleCode | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.21 | Witness Categories | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.22 | Advance Directive Document Types | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.23 | AD Conditions and Prognosis Scenarios | active | 2023-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.26 | Healthcare Agent or Advisor Indicator | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.27 | Initial Treatment portable medical order options | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.28 | Cardiopulmonary Resuscitation Order Options | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.30 | Cardiopulmonary Resuscitation Order Procedures | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.31 | Cardiopulmonary Resuscitation Procedures Grouping | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.32 | Additional Portable Medical Order Procedures | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.33 | Initial Treatment Portable Medical Order Procedures Grouping | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.34 | Additional portable medical order Procedures Grouping | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.35 | Medically Assisted Nutrition Order Options | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.36 | Medically Assisted Nutrition Portable Medical Order Procedures Grouping | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.37 | Healthcare Agent Powers | active | 2024-11 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.38 | Personal Health Goal Options LOINC | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.39 | Personal Health Goal Options Grouping | active | 2025-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.40 | Portable Medical Order Document Types | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.41 | Advance Healthcare Directive Document Types Grouper | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.5 | Advance Directive Content Type SCT | active | 2022-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.8 | Treatment Intervention Preferences at End of Life LOINC | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1115.9 | Treatment Intervention Preferences Grouping | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.1 | Rituximab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.100 | Pathological M Stage M1c | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.101 | Pathological N Stage N3 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.102 | N Stage pN1a | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.103 | N Stage pN1b | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.105 | Pathological N Stage pN1mi | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.106 | Pathological N Stage N2b | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.107 | Pathological N Stage N2a | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.108 | Pathological N Stage N2 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.109 | Pathological N Stage N1b | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.110 | Pathological N Stage N1a | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.112 | Pathological N Stage N0 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.114 | Pathological T Stage T4d | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.115 | Pathological T Stage T4c | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.116 | Pathological T Stage T4b | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.117 | Pathological T Stage T4a | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.118 | Pathological T Stage T4 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.120 | N Stage N2C | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.121 | T Stage T3c | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.122 | T Stage T3b | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.123 | T Stage T3a | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.124 | Pathological T Stage T3 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.125 | T Stage T2c | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.126 | T Stage T2b | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.127 | T Stage T2a | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.128 | Pathological T Stage T2 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.129 | Pathological T Stage T1c | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.132 | Pathological T Stage T1b | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.135 | Pathological T Stage T1a | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.136 | Pathological T Stage T1 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.137 | Pathological T Stage T1mic | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.139 | Pathological T Stage T0 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.142 | Cancer Stage III | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.143 | Cancer Stage IIIA | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.144 | Cancer Stage IIIB | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.145 | Cancer Stage IIIC | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.146 | Cancer Stage IV | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.147 | Cancer Stage IVA | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.148 | Cancer Stage IVB | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.149 | Cancer Stage IVC | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.151 | Cisplatin Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.153 | Vinorelbine Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.154 | Gemcitabine Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.155 | Docetaxel | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.156 | Pemetrexed Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.158 | Vinblastine Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.160 | ECOG Performance Status | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.161 | ECOG Performance Status | active | 2020-10 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.162 | ECOG Performance Status | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.164 | Karnofsky Performance Status | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.165 | Carboplatin Injectable | active | 2020-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.166 | Paclitaxel | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.168 | Doxorubicin Injectable | active | 2022-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.169 | Irinotecan Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.179 | Bevacizumab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.181 | Methotrexate | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.184 | Breast Cancer | active | 2022-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.185 | Breast Cancer | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.191 | Cancer Stage II | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.192 | Cancer Stage IIA | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.193 | Cancer Stage IIB | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.194 | Pertuzumab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.196 | Ixabepilone Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.197 | Goserelin | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.200 | Epirubicin Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.202 | Ramucirumab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.204 | Letrozole | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.206 | Exemestane | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.209 | Fluorouracil | active | 2024-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.210 | Capecitabine Oral | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.222 | Aprepitant Oral | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.223 | Fosaprepitant Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.255 | Colorectal Cancer | active | 2021-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.256 | Colorectal Cancer | active | 2021-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.257 | Colorectal Cancer Chemotherapy | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.280 | Cancer Stage IA | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.281 | Cancer Stage IB | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.286 | Cancer Stage IIC | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.291 | Positive Result | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.292 | Negative Result | active | 2015-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.300 | Pathological N Stage N1C | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.332 | Daunorubicin Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.336 | Palonosetron Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.341 | External Beam Radiotherapy | active | 2024-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.349 | Metastatic Cancer | active | 2023-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission | active | 2025-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.439 | T Category | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.440 | N Category | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.441 | M Category | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.442 | TNM Stage Group | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.449 | Opioids | active | 2024-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.492 | Pharmacological interventions for depression | active | 2024-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.535 | Ovarian Cancer | active | 2023-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.536 | Ovarian Cancer | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.537 | Fallopian Tube Cancer | active | 2022-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.539 | Fallopian Tube Cancer | active | 2022-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.541 | Peritoneal Cancer | active | 2022-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.542 | Peritoneal Cancer | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.547 | Cancer Stage 1C | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.555 | Gender Female | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.556 | Gender Male | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.557 | Pathological N Stage N3a | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.558 | Pathological N Stage N3b | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.560 | Rolapitant Oral | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.599 | Obinutuzumab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.600 | Ofatumumab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.602 | Neurokinin 1 Receptor Antagonist | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.604 | Serotonin Receptor Antagonist | active | 2025-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.61 | Cetuximab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.63 | Panitumumab Injectable | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.81 | Palonosetron Oral | active | 2024-12 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.88 | Lung Cancer | active | 2015-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.89 | Lung Cancer | active | 2023-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.95 | M Stage M0 | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.97 | Pathological M Stage M1 | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.98 | Pathological M Stage M1a | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.99 | Pathological M Stage M1b | active | 2024-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.5 | Most/Moderately Effective Contraceptive Procedures | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1121.6 | Most/Moderately Effective Contraceptive SNOMED Findings | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.1 | Schedule IV Benzodiazepines | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1125.7 | PROMIS Depression Assessment | active | 2023-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.11 | Sleep Apnea | active | 2018-05 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.12 | Toxic Megacolon in adults | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.13 | Septic Shock due to C. Diff | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.15 | Body Temperature | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.16 | Diarrhea Potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.17 | Abdominal Distension | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.18 | Vomiting potentially due to CDI | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.19 | Ileus due to infection | active | 2019-04 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.20 | Clostridium difficile infection | active | 2019-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.3 | Radiation Therapy Indicators from CPT | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.4 | Diagnostic Radiology Surrounding Face and Sinus | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.5 | Ear Surgery Affecting the Tympanic Membrane | active | 2017-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.6 | Allergic Rhinitis Immunotherapy | active | 2017-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.8 | Radiology to Head and Sinus | active | 2017-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1130.9 | Immunotherapy For Allergic Rhinitis | active | 2022-03 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1136.63 | Aortic Dissection or Ruptured Aortic Aneurysm | active | 2024-07 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.564 | CABG or PCI Procedure | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.565 | CABG or PCI Procedure | active | 2025-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1138.566 | CABG or PCI Procedure | active | 2018-08 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.1 | C2S Alcohol Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.11 | C2S Amphetamine Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.12 | C2S Cannabis Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.13 | C2S Cannabis Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.14 | C2S Cannabis Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.15 | C2S Cannabis Use DIsorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.16 | C2S Cocaine Use Disorder | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.17 | C2S Cocaine Use Disorder | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.18 | C2S Cocaine Use Disorder | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.19 | C2S Hallucinogens | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.2 | C2S Alcohol Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.20 | C2S Hallucinogens | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.21 | C2S Hallucinogens | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.22 | C2S Hallucinogens | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.23 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.24 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.25 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.26 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.27 | C2S HIV/AIDS Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.28 | C2S Inhalants | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.29 | C2S Inhalants | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.3 | C2S Alcohol Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.30 | C2S Inhalants | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.32 | C2S Mental Health Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.33 | C2S Mental Health Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.34 | C2S Mental Health Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.35 | C2S Mental Health Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.36 | C2S Mental Health Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.38 | C2S Opioids | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.39 | C2S Opioids | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.4 | C2S Alcohol Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.40 | C2S Opioids | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.42 | C2S Opioids | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.43 | C2S Other Psychoactive Substance
Use Disorder | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.44 | C2S Other Psychoactive Substance Use Disorder | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.45 | C2S Other Psychoactive Substance Use Disorder | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.46 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.47 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.48 | C2S Sedative Hypnotic, or anxiolytic related disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.49 | C2S Sexuality and reproductive health information sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.5 | C2S Alcohol Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.51 | C2S Tobacco Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.52 | C2S Tobacco Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.53 | C2S Tobacco Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.54 | C2S Tobacco Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.55 | C2S Substance Use Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.56 | C2S Substance Use Information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.58 | C2S Sensitive Categories | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.59 | C2S Opioids | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.6 | C2S Amphetamine Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.60 | C2S HIV/AIDS information Sensitivity | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.65 | Test C2S Alcohol Use Disorders | active | 2019-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.67 | Test C2S HIV/AIDS Information Sensitivity | active | 2019-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.7 | C2S Amphetamine Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.8 | C2S Amphetamine Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1142.9 | C2S Amphetamine Use Disorders | active | 2016-09 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.10 | Diphtheria (Tests for Corynebacterium diphtheriae by Culture and Identification Method) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1002 | Tuberculosis (Tests for Mycobacterium species by Culture and Identification Method) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1012 | S. Typhi Infection (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1016 | S. Paratyphi Infection (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1017 | S. Typhi Infection (Tests for S. Typhi by Culture and Identification Method) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1021 | Dark Urine (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1022 | Acute Onset [Qualifier Value] (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1024 | Acute Viral Hepatitis (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1027 | Sepsis [Septicemia] [Bacterial] [Unspecified Organism] (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1029 | Listeriosis [Listeria species] (Organism or Substance in Lab Results) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1030 | Meningitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1032 | Encephalitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1033 | Encephalitis [Unspecified Cause] (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1035 | Indeterminate or Equivocal Lab Result Value | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1037 | Smoking Status [Current Nonsmoker] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1040 | Organisms (Tests by Unspecified Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1041 | Organisms (Tests by Culture and Identification) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1044 | Candida auris Infection (Tests for Candida auris by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1045 | Candida auris Infection (Tests for Candida auris Nucleic Acid) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1047 | Parkinson’s disease (Disorders) (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1048 | Parkinson’s disease (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1049 | Parkinsonism [Secondary] (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1050 | Parkinsonism [Secondary] (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1053 | Carbidopa Levodopa Combination (RXNORM) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1065 | Consciousness [Decreased Level] (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1071 | Drug Use [IV Evidence] (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1072 | Miosis (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1076 | Opioid Overdose and Poisoning (Tests for Opioids [Quantitative]) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1077 | Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1078 | Opioid Overdose and Poisoning (Naloxone) (RxNorm) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1083 | Rash [Pustular Vesicular] (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1084 | Salivary Gland Swelling [Unspecified Cause] (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1090 | Syphilis [Congenital] (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1091 | Cataracts [Nonspecific]/Congenital glaucoma [Unspecified Cause] (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1092 | Congenital heart disease (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1093 | Hearing impairment (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1095 | Microcephaly (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1096 | Developmental delay (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1099 | Congenital heart disease (ICD10CM) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1100 | Hearing impairment (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1104 | Developmental delay (ICD10CM) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1106 | Listeriosis (Tests for Listeria monocytogenes Nucleic Acid in Specimen from Normally Sterile Site) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.112 | Tetanus (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1123 | COVID_19 (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1124 | COVID_19 (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1130 | Tickborne Relapsing Fever (Tests for Borrelia hermsii/miyamotoi/parkerii/turicatae Nucleic Acid) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1131 | Lyme Disease (Tests for Borrelia afzelii/garinii IgG Antibody by Immunoassay | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1138 | Staphylococcus Aureus (Tests by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1139 | VISA/VRSA (Tests for Vancomycin Resistance Gene) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1142 | COVID_19 (Tests for SARS_CoV_2 Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1143 | COVID_19 (Organism or Substance in Lab Results) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1145 | Resistant Lab Result Value | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1148 | Tests for Vancomycin Susceptibility [Ord] | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1149 | Proteinuria (Tests for Total Protein in 24H Urine) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.115 | Mumps (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1150 | Thrombocytopenia (Tests for Platelets [#/volume] in Blood) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1156 | Staphylococcus aureus (Organism or Substance in Lab Results) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1158 | COVID_19 (Tests for SARS_CoV_2 Antigen) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1169 | Chikungunya Virus Disease (Tests for Chikungunya virus Nucleic Acid) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.117 | Mumps (Disorders) (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1180 | Chikungunya Virus Disease (Tests for Chikungunya Virus Antibody [Quantitative]) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1186 | Eastern Equine Encephalitis Virus Disease (Tests for Eastern Equine Encephalitis Virus Antibody [Qualitative]) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1188 | Western Equine Encephalitis Virus Disease (Tests for Western Equine Encephalitis Virus Antibody [Qualitative]) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1189 | California Serogroup Virus Diseases (Tests for California Serogroup Virus Antibody [Qualitative]) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1196 | Anthrax (Tests for Bacillus cereus by Culture and Identification Method) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1197 | Cervical Lymphadenitis (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1207 | CRE (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1210 | Enterobacter spp., E. coli, or Klebsiella spp. (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1212 | Enterobacteriaceae species [Carbapenem Resistant] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1213 | NU_Enterobacteriaceae [Carbapenemase Producing] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1214 | Carbapenemase resistance mechanism (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1215 | Tests for carbapenemase production | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1216 | Tests for carbapenemase resistance mechanism | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1217 | Tests for carbapenem susceptibility [Meropenem, imipenem, and doripenem] | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1218 | Tests for carbapenem susceptibility [Ertapenem] | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1219 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. by Culture and Identification Method | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1220 | NU_Tests for Enterobacteriaceae species by Culture and Identification Method | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1224 | Therapeutic Response to Medication [Improved] | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1225 | Altered Mental Status (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1230 | Eschar (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1231 | Hypotension (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1233 | Localized Edema (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1234 | Localized Edema (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1237 | Tachycardia (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1238 | Tachycardia (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1239 | RCKMS Conditions (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.124 | Poliomyelitis (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1240 | Maternal Condition Puerperium (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1242 | Non pestis Yersiniosis Infection (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1244 | Blastomycosis (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1246 | Blastomycosis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1249 | Blastomycosis (Tests for Blastomyces species by Culture and Identification Method) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1250 | Non pestis Yersiniosis Infection (Tests for Yersinia non pestis species Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1251 | Blastomycosis (Tests for Blastomyces species Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1252 | Blastomycosis (Tests for Blastomyces species Antibody) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1253 | Blastomycosis (Tests for Blastomyces species Antigen) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1265 | Fatigue (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1269 | Tuberculosis [Latent Infection] (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1274 | Histoplasmosis (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1275 | Histoplasmosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1281 | Histoplasmosis (Tests for Histoplasma capsulatum H band or M band Antibody) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1294 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1295 | Seizure [Unspecified Cause] (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1298 | Abscess [Liver, Lung, Spleen, Prostate, or Brain] (ICD10CM) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1299 | Seizure [Unspecified Cause] (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.130 | Influenza (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1304 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species in Extrapulmonary Specimen by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1305 | Mycobacteria_Infection_NonTB_ExPulm (Tests for Mycobacterium species Nucleic Acid in Extrapulmonary Specimen) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1306 | Body Temperature (Vital Sign) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1307 | Respiratory Rate (Vital Sign) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1309 | RSV (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1310 | RSV (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1312 | RSV (Tests for RSV Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1314 | Wheezing (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1317 | Bronchiolitis (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1325 | Tobacco Use and Exposure (Social History) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1330 | Tobacco Smoking Status [Current] (Social History) (LOINC) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1335 | Hospitalized [Inpatient] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1336 | Creutzfeldt Jakob Disease (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1337 | Variant Creutzfeldt Jakob Disease (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1340 | Prion Disease (Tests for 14_3_3 Protein) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1341 | Prion Disease (Tests for Abnormal Prion Protein) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1349 | Cerebrospinal Fluid (Specimen Type) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.135 | Chronic Hepatitis B Virus Infection (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1350 | Endocervical (Specimen Type) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1351 | Tissue (Specimen Type) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1352 | Specimen from a Normally Sterile Site (Specimen Type)(SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1353 | Urethral Swab (Specimen Type) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1355 | Wound (Specimen Type) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1359 | Hepatitis E (Tests for hepatitis E virus IgM Antibody) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.136 | Invasive Pneumococcal Disease (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1360 | Hepatitis E (Tests for hepatitis E virus Antibody) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1363 | Epiglottitis (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1364 | Organisms (Tests by Microscopic Observation by Gram Stain) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1369 | Serum (Specimen Type) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1378 | Tests for Mycobacterium species Nucleic Acid in Unspecified XXX Specimen | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1379 | Fish Poisoning (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1388 | Occupational Asthma (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1389 | Asthma (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1390 | Asthma (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1391 | Respiratory Condition, due to inhalation of chemicals, gases, fumes or vapors (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1393 | WRA (Occupational Exposure to Potential Asthma Inducing Risk Factor) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1400 | Colorado tick fever (Tests for Colorado Tick Fever Virus Antibody [Qualitative]) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1402 | Cancer [Malignant Neoplasms] (Disorders) (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1403 | Cancer [Benign or Borderline CNS Tumors] (Disorders) (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1404 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1405 | Cancer [Unspecified Skin Cancer, Benign Carcinoid Tumor, in situ Cervical Cancer, Intraepithelial Neoplasia, History Cancer, Complication of Cancer or Treatment] (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1407 | Cancer [Malignant Neoplasms] (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1409 | COVID_19 (Tests for SARS_CoV_2 Genomic Sequence) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1418 | Alpha gal syndrome (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1420 | Alpha gal syndrome (Tests for Alpha gal IgE Antibody [Quantitative]) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1422 | Ptosis of Eyelid [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1423 | Ptosis of Eyelid [Unspecified Cause] (ICD10CM) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1424 | Constipation [Unspecified Cause] (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1426 | Intubation [Respiratory Tract] (Procedure) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1430 | Infant Botulism (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1446 | Viral Hemorrhagic Fever [Suspected] (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1447 | MRSA (Disorders (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1449 | Staphylococcus aureus infection (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.145 | Varicella (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1450 | Staphylococcus aureus infection (Disorders) (ICD10CM) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1452 | MRSA (Tests by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1453 | MRSA (Tests for Methicillin Resistance Gene) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1454 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1458 | Tests for Cefoxitin Susceptibility [OrdQn] | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1459 | Organisms (Tests in Blood by Culture and Identification) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1460 | Bacteria (Tests in Blood by Culture and Identification Method) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1461 | Organisms (Tests in Specimen from Normally Sterile Site by Culture and Identification) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1462 | Staphylococcus aureus (Tests for Staph aureus Nucleic Acid in Blood) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1463 | VRE (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1464 | VRE (Organism or Substance in Lab Results) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1465 | VRE (Tests by Culture and Identification Method) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1466 | Enterococcus species (Tests by Culture and Identification Method) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1468 | Enterococcus gallinarum or E. casseliflavus/E. flavescens (Organism or Substance in Lab Results) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1469 | Enterococcus faecium or E. faecalis (Organism or Substance in Lab Results) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1470 | Enterococcus species (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1471 | Amebiasis (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1473 | Amebiasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1476 | Amebiasis (Tests for Entamoeba histolytica Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1482 | Norovirus (Tests for Norovirus Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1485 | Norovirus (Organism or Substance in Lab Results) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1487 | Clostridioides difficile infection (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1491 | C. diff infection (Tests for C diff Toxin Nucleic Acid) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1492 | C. diff infection (Tests for C diff Toxin Nucleic Acid in Stool) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1505 | Acanthamoeba Disease [Keratitis] (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1507 | Arsenic Exposure and Toxicity (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1509 | Arsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1513 | Urine (Specimen Type) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1514 | Mercury Exposure and Toxicity (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1515 | Cryptococcosis (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1516 | Cryptococcosis (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1520 | Cryptococcosis (Tests for Cryptococcus species by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1523 | Cryptococcosis (Tests for Cryptococcus species Nucleic Acid) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1524 | Cryptococcosis (Tests for Cryptococcus species Antigen) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1525 | Mercury Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1528 | Mercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1532 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1533 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1534 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1538 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.154 | Hepatitis C Virus Infection (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1540 | Drug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1541 | Drug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1542 | Drug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1543 | Drug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1544 | Drug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1545 | Drug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1546 | Drug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1551 | Meningitis (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1552 | Bacterial Meningitis (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1553 | Fungal Meningitis (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1554 | Parasitic Meningitis (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1555 | Bacterial Meningitis (Disorders) (ICD10CM) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1559 | Photophobia (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1562 | Bacteria [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1563 | Fungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1564 | Viruses [Causing Meningitis] (Organism or Substance in Lab Results) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1565 | Viruses [Causing Meningitis] (Tests for Nucleic Acid) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1566 | Viruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1567 | Bacteria [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1574 | Invasive Group B Streptococcus (Disorders) (ICD10CM)) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1577 | Group A Streptococcus (Tests for Group A Strep by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1578 | Group B Streptococcus (Tests for Group B Strep by Culture and Identification Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1580 | Animal Bite [Dog] (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1581 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1582 | Animal Bite [Excluding Mammals] (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1584 | Animal Bite [Unspecified Animal] (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1585 | Animal Bite [Dog] (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1586 | Animal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1587 | Animal Bite [Excluding Mammals] (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1588 | Cadmium Exposure and Toxicity (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1594 | HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1595 | HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1597 | HIV Infection (ARV Combination Treatment for HIV) (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1598 | HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1600 | HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1604 | Vaccine Adverse Event (Disorders) (ICD10CM) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1605 | Vaccine Adverse Event (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1606 | Vaccinia disease or adverse event (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.161 | Vibriosis (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1612 | Blepharitis [Unspecified Cause] (ICD10CM) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1613 | Keratitis [Unspecified Cause] (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1614 | Keratitis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1618 | Smallpox Vaccine (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1620 | Anaphylaxis [Unspecified Cause] (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1626 | Thrombocytopenic Purpura [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1634 | Sofosbuvir Velpatasvir Combination (RXNORM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1640 | Typhus Fever (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1641 | Typhus Fever (Tests for Rickettsia Typhus Group IgG Antibody) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1642 | Typhus Fever (Tests for Rickettsia Typhus Group IgM Antibody) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1643 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1651 | Chagas Disease (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1654 | Chagas Disease (Tests for Trypanosoma cruzi Antibody) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1661 | Cervical lymphadenopathy [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1662 | Conjunctival injection (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1663 | Drying of lips (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1667 | Edema of hands or feet (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1676 | Tests for Acinetobacter baumannii Nucleic Acid | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1677 | Tests for Pseudomonas aeruginosa by Culture and Identification Method | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1678 | Tests for Pseudomonas aeruginosa Nucleic Acid | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1679 | Pseudomonas aeruginosa (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1687 | NU_Gunshot Wound (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1688 | NU_Gunshot Wound (Disorders) (ICD10CM) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.169 | Gonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.170 | Chlamydia trachomatis Infection (Organism or Substance in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1700 | Encephalitis [Viral] (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1702 | Encephalitis [Parasitic] (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1712 | Bacteria [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1714 | Parasites [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1715 | Viruses [Causing Encephalitis] (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1716 | Drowning and Submersion (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1717 | Drowning and Submersion (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1718 | Motor Vehicle Injury (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1719 | Motor Vehicle Injury (Disorders) (ICD10CM) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1720 | Enterovirus Infection [Non polio] (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1721 | Enterovirus Infection [Non polio] (Disorders) (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1722 | Enterovirus Infection [Non polio] (Organism or Substance in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1723 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1725 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1726 | Enterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1735 | Clostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1739 | Head Injury (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1740 | Head Injury (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1742 | Brain Injury [Traumatic] (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1745 | Rotavirus Disease (Organism or Substance in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1746 | Rotavirus Disease (Tests for Rotavirus Nucleic Acid) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1748 | Chemical Pneumonitis (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1749 | Chemical Pneumonitis (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1753 | Staphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1755 | Vomitus (Specimen Type) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1758 | Asbestosis (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.176 | West Nile Virus Infection (Disorders) (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1763 | Byssinosis (Disorders) (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1769 | Farmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1772 | Farmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1773 | CLABSI (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1775 | Ophthalmia neonatorum (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1778 | Genital herpes (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1779 | Genital herpes (Disorders) (ICD10CM) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1781 | Herpes (Tests for Herpes simplex virus Nucleic Acid) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1785 | Elevated liver enzyme (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1786 | Elevated liver enzyme (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1788 | Typhus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1789 | Granuloma Inguinale (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1791 | Ulcer [Genital, Perineal, or Perianal Area] (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1792 | Ulcer [Genital, Perineal, or Perianal Area] (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1797 | Bronchial Wash (Specimen Type) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1800 | Nontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1803 | Bacteria (Tests in Sputum Specimen by Culture and Identification Method) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.181 | Coccidioidomycosis (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1819 | Louseborne relapsing fever (Tests for Borrelia species) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1820 | Louseborne relapsing fever (Tests for Borrelia species in Blood) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1823 | Borrelia species (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1824 | Spirochetes (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1829 | Polyarthritis [Unspecified Cause] (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1835 | Rheumatoid nodules (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1842 | Ventilator associated event (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1844 | Leishmaniasis (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1846 | Leishmaniasis (Tests for Leishmania species Nucleic Acid) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1847 | Leishmaniasis (Tests for Leishmania species Antibody) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1848 | Leishmania species (Tests by Microscopic Observation in Tissue) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.185 | Brucellosis (Disorders) (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1864 | Taeniasis (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1866 | Taeniasis (Organism or Substance in Lab Results) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.187 | Dengue Virus Infection (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1875 | Cysticercosis (Tests for Taenia solium Antibody) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1878 | Surgical Site Infection (Disorders) (SNOMED) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1880 | Tests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acid | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1881 | NU_Tests for Enterobacteriaceae species Nucleic Acid | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1882 | Carbapenemase production (Organism or Substance in Lab Results) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1892 | Toxoplasmosis (Disorders) (SNOMED) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1893 | Toxoplasmosis (Disorders) (ICD10CM) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1895 | Toxoplasmosis (Organism or Substance in Lab Results) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1897 | Toxoplasmosis (Tests by Microscopic Observation) | active | 2023-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1898 | Toxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1901 | Toxoplasmosis (Tests for Toxoplasma gondii Antibody) | active | 2024-06 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1902 | Orthopox (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1908 | Organisms (Tests by Electron Microscopic Observation) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1912 | Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1913 | Penicillin G [Procaine] [Injectable] (RXNORM) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1919 | Fungi [Causing Meningitis] (Tests by Culture and Identification Method) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1923 | Coronary artery aneurysm (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1924 | Coronary artery dilatation (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1925 | Ectatic coronary artery (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1926 | Left ventricular ejection fraction [Decreased Level] (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1927 | Coronary artery aneurysm (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1928 | Shock (SNOMED) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1929 | Shock (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1930 | Troponin [Elevated Level] (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1931 | Oral mucosa Inflammation (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1932 | Oral mucosa Inflammation (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1933 | C reactive protein (Tests by Any Method) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1934 | Lymphocytes [Concentration] (Tests by Any Method) | active | 2024-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1935 | Strongyloidiasis (Disorders) (SNOMED) | active | 2025-02 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1936 | Strongyloidiasis (Disorders) (ICD10CM) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1937 | Strongyloidiasis (Tests for Strongyloides Nucleic Acid) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1938 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1939 | Strongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1940 | Organisms (Tests by Microscopic Observation in Stool) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1941 | Strongyloidiasis (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1942 | Strongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1943 | Jamestown Canyon Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1944 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1945 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1946 | Jamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1947 | Jamestown Canyon Virus Diseases (Organism or Substance in Lab Results) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1948 | Keystone Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1949 | La Crosse Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1950 | Snowshoe hare Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1951 | Trivittatus Virus Diseases (Disorders) (SNOMED) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1952 | La Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid) | active | 2023-01 | hl7 |
| us.nlm.vsac | R4 | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.1953 | Snowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid) | active | 2023-01 | hl7 |
XIG built as of 18 Jun 2025. Found 77274 resources in 1236 packages.
FHIR